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Epithelial cells have a highly polarized cytoskeleton, in which microvilli, finger-like 
protrusions with filamentous actin (F-actin) cores, protrude only from the apical side. Ezrin, a 
plasma-membrane-F-actin crosslinker, is highly enriched in microvilli, and required for their 
presence in some cultured cell-lines. Numerous binding partners of ezrin are known, including 
ezrin-binding phosphoprotein 50 (EBP50) and CD44, but no systematic analysis of ezrin-binding 
partners in epithelial cells has been undertaken. 
To better understand how ezrin works, we conducted a proteomic profiling of ezrin 
immunoprecipitates and identified 12 novel and 7 previously known interactors. The N- and C-
termini of ezrin interact forming a dormant molecule, and this autoinhibition is released in a 
process dependent upon phosphorylation of a critical C-terminal residue, threonine-567, so we 
can control it through mutation of T567. By quantitatively comparing immunoprecipitates from 
open vs. closed ezrin mutants, I found that different ezrin binding partners respond differently to 
changes in ezrin autoinhibition. 
 In the course of my studies, I made the surprising observation that open ezrin variants lost 
their polarized distribution within microvilli, while they remained on the plasma membrane. This 
implied that a local cue, operating just in the apical domain, controls the normal opening of 
ezrin. A likely candidate was the hypothetical T567 kinase. Among the 12 novel ezrin-binding 
proteins, I noticed 2 potential T567 kinases, LOK and SLK, and confirmed that their presence 
was required for T567 phosphorylation and microvilli in two cell-lines. In additional 
experiments, I determined that their apically-localized activity was required for ezrin’s apical 
localization, which in turn, was required for the de novo presence of microvilli. Thus, a critical 
aspect of epithelial cytoskeletal polarity is the control of ezrin’s partner interactions through the 
regulated release of autoinhibition mediated by apically polarized T567 phosphorylation. 
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CHAPTER 1 
INTRODUCTION TO ERMS AND MICROVILLI 
Life as we know it requires organizational and functional polarity at many levels. At its 
most fundamental level, that of the cell, life organizes spatially distinct regions specialized for 
particular functions. A few selected examples include polarization for bud-site selection which 
orients nuclear and cell division in the budding yeast Saccharomyces cerevisea (Pruyne et al., 
2004; Figure 1.1A); the outgrowth of neuronal protrusions and then their subsequent assignment 
as either axons or dendrites (Dent et al., 2011; Figure 1.1B) and the formation of nutrient-
absorptive microvilli just on lumen-facing side of intestine (Nambiar et al., 2010; Fehon et al., 
2010; Figure 1.1C). Not only is the yeast bud, the neurite, and the microvillus compositionally 
distinct from the rest of the cell, but each also adopts a characteristic morphology. This is 
accomplished by differential restructuring of the common manifold underlying the plasma 
membrane: the cytoskeleton. 
Microvilli: a model for cytoskeletal polarity 
The cytoskeleton is largely made up of three filament-forming protein types—actin, 
comprising actin filaments (F-actin); tubulin, comprising microtubules; and keratins, vimentin, 
lamins, neurofilaments, and desmins, comprising intermediate filaments. The yeast bud, the 
neurite, and microvilli are primarily composed of actin filaments, directional polymers of a 43 
kDa protein that grow and shrink from opposite ends (termed the plus and minus ends). 
Microvilli are composed of elongated F-actin bundles that protrude into the so-called terminal 
web region, where they connect with the underlying F-actin cortex (Figure 1.1C). 
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Figure 1.1 The eukaryotic cytoskeleton. Filamenous actin (red) and microtubule (green) 
cytoskeleton in a budding yeast (A), neuron (B), and epithelial cell (C). Note the apical 
microvilli rooted into the terminal web. Figures copyrighted 2011 by Felipe Santiago-Tirado. 
Used with permission. 
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The nucleation of actin from monomers into trimers is unfavorable in vivo and thus 
requires accessory proteins termed nucleation promoting factors (NPFs; Firat-Karalar and 
Welch, 2011). Particular NPFs appear to nucleate particular classes of actin filaments. For 
instance, the actin cables of the budding yeast are nucleated by formins whereas endocytic patch 
actin filaments are nucleated by the Arp2/3 complex (Evangelista et al., 2002). The microvillar 
F-actin core consists of parallel bundles with their growing end at the tip and their shrinking ends 
rooted in the terminal web. This suggests that the microvillar NPF is a component of the 
microvillar tip, which contains an electron-dense mass (Mooseker and Tilney, 1975), but due to 
pleiotropy and redundancy, the microvillar NPF has not yet been identified (Harris et al., 2010). 
A host of accessory proteins are additionally required to regulate filament elongation in vitro and 
in model systems (such as actin-based motility of invading bacteria and viruses). Several of these 
are present in microvilli, but only one has proved to be necessary for normal microvilli 
morphology in situ thus far, which is the processive capping-protein displacement factor Eps8 
(Croce et al., 2004; Tocchetti et al., 2010). Consistent with the notion that it may be a critical 
component of the F-actin generation machinery, Eps8 is found preferentially towards the tip of 
microvilli (Croce et al., 2004).  
Like most F-actin structures, microvillar cores consist of parallel actin bundles. The 
predominant F-actin bundling proteins in microvilli are fimbrin, espin, and villin, which were 
thought until recently to be necessary for microvillar core organization. In fact, fimbrin and 
villin, along with actin, ATP, and brush border myosin IA, are sufficient to form a microvillar 
core in vitro (Coluccio and Bretscher, 1989). Recent genetic analysis, however, has suggested 
that microvilli do not strictly require the major filament bundlers as slightly shortened but 
ultrastructurally intact microvilli are found in fimbrin-villin-espin triple knockouts (Revenu et 
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al., 2012). More detailed analysis suggested that actin bundlers are required to properly root the 
microvilli into the terminal web, but not for formation of the core, as their deletion led to fragile 
and leaky intestinal lumens (Revenu et al., 2012; Grimm-Gunter et al., 2009). 
Finally, purified intestinal microvilli contain significant amounts of actin-binding protein 
ezrin and motor protein myosin IA (Bretscher, 1983). Both proteins bind directly to membranes, 
and therefore have the capacity to serve as cross-linkers between the microvillar core and the 
plasma membrane, but the lack of ultrastructural defects in the microvilli of myosin IA knockout 
mouse and presumed redundancy with other myosins (including myosin IC) has hindered a study 
of its cross-linking function (Tyska et al., 2005). Instead, recent research has focused on its role 
in generating vesicles containing digestive and protective enzymes from brush border microvilli 
tips, which is discussed further below. Ezrin and two related proteins, on the other hand, have 
been thought to be the primary actin-plasma membrane crosslinkers in microvilli, and these are 
the subjects of my studies. 
Although microvilli are a common organelle, they have remained relatively understudied. 
The primary reason is that due to an exceptionally high degree of redundancy and pleiotropy 
among NPFs, actin cross-linking proteins, and membrane-actin cross-linking proteins, there is 
currently no gene knockout that selectively perturbs all of the microvilli in any organism. 
Furthermore, while a number of receptor signaling systems such as GluT receptor activation and 
internalization operate in microvilli (reviewed in Lange, 2011), to my knowledge, the need for 
these to be organized within microvilli has never been assessed. For instance, would signal 
transduction be attenuated in cells lacking microvilli or if the signaling apparatus was localized 
away from the apical plasma membrane? There are a few examples in which microvillus 
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organization per se has been shown or suggested to play a physiological role: photoreception, 
audition, nutrient absorption, and digestion. 
Photoreception. The Drosophila photoreceptors are organized into clusters with a distinct apical 
membrane, covered in microvilli, facing into the center. Light-sensitive transient receptor 
potential channels TRP and TRPL are located in microvilli and may be anchored via dMoesin 
(Chorna-Ornan et al., 2005). The microvilli, and thus the organization of the photoreceptor 
cluster, were shown to be sensitive to the removal of dMoesin (Karagiosis and Ready, 2004), 
and, moreover, the overexpression of dominant dMoesin mutants, presumably perturbing 
microvilli formation, was shown to affect photoreception and cause photoreceptor degeneration 
in low-light conditions (Chorna-Ornan et al., 2005). Recently, an in vitro model of Drosophila 
photoreceptors was prepared, and this suggested to the authors that the clustered organization of 
photoreceptors into microvilli provides increased sensitivity in low-light (Song et al., 2012). 
Thus microvilli organization per se, and not simply the presence of their components, appears to 
be critical for photoreception. 
Audition. The clearest model in which microvilli play a physiological role is in the specialized 
stereocillia of the inner ear, which function in vertebrate audition. Stereocilia, which are 
connected to one another by cadherin-based tip links, protrude into the vibration-sensing tectorial 
membrane. Shearing of the tectorial membrane by sound waves causes deflection of the 
stereocilia, resulting in a pulling force which opens stereocilia-resident voltage-gated calcium 
channels, resulting in a transient efflux of calcium ions, which activates neighboring neurons. 
This system relies on the ultrastructure of stereocilia to function in mechanotransduction. Many 
structural proteins such as myosins and actin-binding proteins are common between microvilli 
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and stereocilia. As mentioned below, radixin, one such actin-binding protein, was shown to be 
required for stereocilia (Kitajiri et al., 2004). 
Nutrient absorption. Classically, it is believed that nutrient absorption in the intestine requires 
microvilli to increase available surface area, but this assertion has never been tested directly. 
Pathogen barrier function. An intriguing aspect of microvillar organization has come from 
detailed analysis of the brush border myosin (MyoIA) knockout mouse. Wild-type brush border 
microvilli were shown to shed vesicles emanating from the distal tip into the intestinal lumen 
(McConnell et al., 2009). This activity was dependent on MyoIA, which can slide distally in 
vitro (Verner and Bretscher, 1983; Tyska et al., 2005; McConnell et al., 2009). The vesicles 
contained intestinal alkaline phosphatase (IAP), which was shown to inhibit bacterial colony 
formation in the intestinal lumen and in vitro (Shifrin et al., 2012). Thus the architecture of 
microvilli plays a role in epithelial barrier function. 
 Finally, microvilli are similar in morphology in invertebrates. Also, two gene deletions 
that cause complex microvillus abnormalities in mice, knockout of ezrin and Eps8, cause 
strikingly similar abnormalities in the invertebrate Caenorhabditis elegans (Tocchetti et al., 
2010; Saotome et al., 2004; Casaletto et al., 2011; Van Furden et al., 2004; Segbert et al., 2004; 
Croce et al., 2004) and suggest that both their ultrastructual appearance and regulation is 
conserved among animals. Such a conserved process must be performing an important function 
even if it is hard to identify. 
ERMs: regulated F-actin-plasma-membrane crosslinkers in cultured cell microvilli 
ERMs are named for the founding members: ezrin, radixin, and moesin. These proteins 
are similar in size, primary sequence, and structure (Figure 1.2.A). Early biochemical studies 
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Figure 1.2 ERM homology, conformational change, and translocation to the plasma membrane. 
(A) Cartoon diagram of ezrin domain structure, and homology to radixin and moesin. FERM, 
Band 4.1-ERM homology domain; C-ERMAD, C-terminal ERM association domain; ABS, F-
actin-binding site. Percent identities were calculated using CLUSTALW. (B) Conformational 
change in ezrin structure change the availability of the FERM domain and ABS. Star, T567 (in 
ezrin) which is phosphorylated to regulate the conformational change. (C) Translocation of 
dormant ezrin from the cytoplasm to microvilli is regulated by phosphorylation (yellow star) and 
PI(4,5)P2 (red circle) binding. In microvilli it is thought to engage with various transmembrane 
proteins directly (like the blue transmembrane protein) or indirectly through ERM-binding 
phosphrotein 50 (brown; like the green transmembrane protein). 
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used cultured cell models to characterize their function, and these will be discussed in the first 
section. As mentioned, ERM orthologs are clearly present in all animals (possibly also fungi; 
Dagdas et al., 2012), and studies of ERM gene deletions has revealed that ERM gene function is 
essential for cell and tissue morphogenesis. I will review ERM genetics in the second section. 
Whereas early biochemical data established that ERM proteins were regulated intrinsically 
through conformational changes, contemporary studies have asked which molecules regulate 
these changes extrinsically. In the third section, I will consider potential ERM regulators: 1) the 
plasma membrane and membrane proteins and 2) kinases and phosphatases. 
Initial observations pointed to the possibility that ezrin linked the plasma membrane and 
the underlying cytoskeleton in F-actin-rich protrusions. Ezrin was first isolated as a cytoplasmic 
protein enriched in brush border microvilli that localized to cell surface protrusions of numerous 
cell types (Bretscher, 1983). It was later revealed that ezrin is phosphorylated on serine, 
threonine, and tyrosine residues and hyperlocalizes in cell surface protrusions following EGF 
stimulation (Gould et al., 1986; Bretscher, 1989), an early indication that phosphorylation 
regulates its activity. By expressing and localizing tagged truncations, the N-terminal region of 
ezrin was found to localize at the plasma membrane whereas the C-terminal region localized 
indiscriminately to the F-actin cytoskeleton (Algrain et al., 1993). Finally, electron microscopy 
also supported this role. By immuno-ferritin electron microscopy of Jeg-3 cell microvilli 
(Pakkanen et al., 1987) or immuno-gold microscopy of chorionic and intestinal microvilli 
(Berryman et al., 1993), ezrin could be seen just beneath the limiting plasma membrane but some 
distance from the actin core. These initial observations led to studies of ezrin regulation in vitro 
and in the formation of cell surface protrusions. 
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ERMs undergo regulated intramolecular interaction. The critical inroads into understanding 
ERM regulation came from studies showing that the extreme N- and C-terminal regions of 
ERMs (termed the N- or C-terminal ERM association domain; N-/C-ERMAD) can directly bind 
to one another (Figure 1.2.B; Gary and Bretscher, 1995; Gary and Bretscher, 1993; Reczek et al., 
1997). This model has been upheld by the crystal structure of the moesin N-ERMAD/C-ERMAD 
complex (Pearson et al., 2000) and that of a dormant, full-length ERM (Li et al., 2007). 
Subsequently, platelet moesin was found to be phosphorylated primarily on C-terminal T558, 
which is homologous to T567 in ezrin and T564 in radixin, and this phosphorylation was found 
to activate it (Nakamura et al., 1995). Radixin and ezrin were subsequently found to undergo 
similar phosphorylation (Barret et al., 2000; Gautreau et al., 2000; Hamada et al., 2000; Hirao et 
al., 1996; Matsui et al., 1998; Simons et al., 1998; Turunen et al., 1994). These studies showed 
that the F-actin binding site in the C-terminal region, and the protein interaction domain in the N-
terminal region were self-masked in the dephosphorylated form and, together, established a 
coherent model: ERMs oscillate between a dormant, dephosphorylated state in which they are 
predominantly cytosolic, and then transition to an active, phosphorylated state, where they 
translocate to the plasma membrane and bind cortical or microvillar actin filaments (Figures 
1.2.B,C). The remaining mystery was the mechanism of the translocation. 
Phosphorylation influences ERM activity. The role of ezrin phosphorylation on serine and 
tyrosine is less well understood. While serine phosphorylation at position 66 has thus far only 
been shown to be relevant in gastric parietal cells (Zhou et al., 2003) and tyrosine 
phosphorylation appears to be relevant mainly in tubulogenesis in response to receptor tyrosine 
kinase activation (mostly hepatocyte growth factor receptor, HGF-R; Crepaldi et al., 1997; Prag 
et al., 2007; Naba et al., 2008; Zwaenepoel et al., 2012; Zaarour et al., 2012), neither the 
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interaction between these sites and the C-terminal threonine nor the effect on the open vs. closed 
state has been examined. Interestingly, tyrosine 477, which is phosphorylated directly by Src, is 
in the middle of the “acidic flap,” a region that modulates the PI(4,5)P2-dependent translocation 
of ezrin to the plasma membrane and will be discussed further below (Ben-Aissa et al., 2012).  
Phosphorylation at T235 by cyclin-dependent kinase 5 has also been shown to regulate ezrin 
activity in some contexts (Yang and Hinds, 2003; Yang and Hinds, 2006), but the generality of 
this regulation has not yet been demonstrated. The general sense in the field is that ERMs are 
primarily regulated by C-terminal threonine phosphorylation (T567 in ezrin; Figures 1.2.B,C). 
ERM C-terminal threonine phosophorylation in cell surface structure regulation. In order to 
understand ERM regulation, it was first necessary to determine the phenotype of cells lacking 
ERMs. Several attempts have been made to determine this. Tsukita and colleagues found that 
inhibiting ERM translation by antisense RNA injection prevented the formation of microvilli, 
cell-cell junctions, and peripheral ruffles (Takeuchi et al., 1994), a global loss of actin-structures 
that has not since been reproduced. In retinal pigment epithelial cells both cultured and in vivo, 
ERM knockdown eliminated microvilli and basal infoldings but not junctions (Bonilha et al., 
1999; Chuang et al., 2010; Bonilha et al., 2006). It is important to note that ezrin knockdown has 
not always resulted in the loss of microvilli, suggesting that the degree of ezrin suppression may 
need to be high in order to observe a defect, and that radixin and moesin may need to be 
suppressed along with ezrin (for example, D'Angelo et al., 2007). An alternative approach has 
been the use of dominant mutants. Overexpression of the FERM domain of ERMs inhibits the 
formation of microvilli and HGF signaling (Crepaldi et al., 1997) and has also been shown to 
inhibit the activity of a variety of interaction partners, the mechanism believed to involve the 
uncoupling of FERM domain binding partners away from endogenous ERMs, and thus F-actin. 
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Similarly, Arpin and colleagues have shown that the overexpression of dormant ezrin that cannot 
be activated by phosphorylation (T567A in ezrin) in epithelial cells impairs microvillus 
formation (Gautreau et al., 2000), while overexpression of phosphomimetic, constitutively 
activated ezrin (T567D) increases the density and length of microvilli (Gautreau et al., 2000; 
Fievet et al., 2006). The microvillus-formation ability of phosphomimetic ezrin appears to be 
more dramatic and reproducible in fibroblastic cell-lines which lack any apical protrusions under 
basal conditions that, when transfected with activated ezrin, produce microvilli-like actin-rich 
structures from their cell surface (Oshiro et al., 1998; Matsui et al., 1998; Yonemura et al., 
1999). Together, these observations suggest that ERMs function by linking the plasma 
membrane and F-actin, and that in some cases, the regulation of ezrin activation by 
phosphorylation of the C-terminal threonine residue is rate-limiting for microvillus formation. 
But phosphomimetic ezrin has not always been shown to enhance microvilli. First, it is 
worth noting that I and others could not reproduce the findings of Arpin and colleagues that 
epithelial cell microvilli elongate and grow denser when transfected with plasmids encoding 
activated ezrin (R. Viswanatha, J. Thoms and D. Chambers, unpublished), but this may have 
been due to the level of overexpression we were able to achieve. Second, in the developing 
mouse embryo, ezrin is polarized to microvilli and clears out of regions of cell-cell contact 
during the 4-cell stage (Dard et al., 2001; Louvet et al., 1996). This process was shown to be 
dependent upon both phosphorylation and dephosphorylation, as overexpression of either T567A 
or T567D ezrin-GFP but not wild-type ezrin-GFP interfered with the formation of microvilli 
(Dard et al., 2004). Finally, Karagiosis and Reddy found that Drosophila photoreceptor 
microvilli were sensitive to depletion of dMoesin, the ortholog of mammalian ERMs, and that 
phosphomimetic dMoesin failed to rescue the microvilli (Karagiosis and Ready, 2004). These 
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results suggest that in some cases, a complex interconversion between open and closed ezrin, and 
not simply the open form, is needed for ezrin function. Due to the complexity of these data, they 
have been summarized in Table 2. 
ERM recruitment of EBP50. The existing evidence from cell culture as well as whole organism 
knockouts (reviewed below) suggests that ezrin functions as a cross-linker in numerous cases, 
but in addition to this role, work from Bretscher and colleagues have highlighted what is likely to 
be a second role: binding, thus recruiting, FERM-domain interaction partner ERM-binding 
phosphoprotein 50 (EBP50) to the apical membrane, which is also essential for microvilli 
(Hanono et al., 2006; LaLonde et al., 2010; Garbett et al., 2010; Garbett and Bretscher, 2012). 
Cells lacking EBP50 or expressing versions of EBP50 that cannot bind ezrin fail to form 
microvilli (Garbett et al., 2010; Hanono et al., 2006). Additionally, the defect in EBP50-depleted 
cells is limited to microvilli: surface-touching structures such as lamelipodia and filopodia are 
not as dramatically affected (D. Garbett and R. Viswanatha, unpublished observations). 
Importantly, the EBP50 knockout mouse supports a physiological role for ezrin-EBP50 linkage 
in microvillar morphology in situ (Morales et al., 2004). EBP50 is a scaffolding protein which 
interacts with a wide array of interaction partners through tandem PDZ protein-protein 
interaction domains (reviewed in Fehon et al., 2010), but the ligand or ligands critical for the 
formation of microvilli has not yet been identified. EBP50 is discussed in Appendices B and C. 
In addition to EBP50, ERMs have been proposed to interact with numerous other 
transmembrane and cytoplasmic factors, but because it is unclear how these contribute to the 
regulation of its function in cell surface protrusions, they are listed in Table 1 but not discussed 
further. 
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ERM regulation of mitosis in Drosophila S2 cells. An intriguing role for dMoesin has emerged 
from studies of its function in Drosophila Schneider 2 and subline S2R+ cells (Carreno et al., 
2008; Roubinet et al., 2011; Kunda et al., 2008; Kunda et al., 2012). These immortal cell lines 
derived from this Drosophila macrophage-like cell-line lack apico-basolateral polarity, so they 
cannot be used to assess polarized cell surface structures. Instead, knocking down dMoesin 
perturbs mitosis (Kunda et al., 2008; Carreno et al., 2008), which Baum and colleagues 
determined through atomic force microscopy studies was due to a defect in cortical rigidity 
(Kunda et al., 2008). Moreover, the dMoesin T579D mutant induced a 2-fold increase in 
stiffness, indicating that dMoesin acts to increase cortex stiffness (Kunda et al., 2008). The result 
of dMoesin depletion in S2R+ cells grown in suspension is that many cells arrest in metaphase 
with misoriented spindles and large plasma membrane blebs that fail to reconnect to the cortex 
(Kunda et al., 2008; Carreno et al., 2008). Furthermore, depleting Slik, the dMoesin kinase, or 
expressing T579A moesin phenocopied these defects (Kunda et al., 2008; Carreno et al., 2008). 
Thus, dMoesin contributes stiffness to the cortex which is essential for mitosis under some 
conditions. 
More recent work in this system has revealed that the proper positioning of dMoesin 
activity is also important for mitosis (Roubinet et al., 2011; Kunda et al., 2012). Specifically, 
dMoesin activity is needed near to the presumptive cleavage furrow after metaphase, whereas it 
must clear out from the poles during the onset of anaphase (Roubinet et al., 2011; Kunda et al., 
2012). This is achieved by two different extrinsic signals: first, phosphorylation by Slik, the 
dMoesin kinase, located at the cleavage furrow and dephosphorylation by PP1 phosphatase, 
located at the poles. The second is production of the activating plasma membrane phospholipid 
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PI(4,5)P2 (see below), which is achieved by localization of specific enzymes (PTEN and Skittles) 
at the cleavage furrow. 
This work reveals a role for ERMs in manipulating cortical stiffness. To my knowledge, 
there is no other system in which ERM depletion has been shown to decrease cortical stiffness or 
interfere with mitosis. However, the converse is true, as overexpression of phosphomimetic ezrin 
was recently shown to increase cortical stiffness in lymphocytes (Liu et al., 2012). Despite the 
lack of in vivo correlates, the work offers interesting insights into the biophysical roles ERMs 
might play, and the extrinsic cues that might regulate them. These regulatory mechanisms are 
discussed in a more physiological context in Chapter III. 
Tagging ERMs. Epitope- or GFP-tagging ERMs has been shown to interfere with their function. 
The clearest example of this is in Drosophila, where two groups found that larval lethality due to 
dMoesin knockout could be partially rescued either by N-terminally myc-tagged dMoesin or 
dMoesin-T579D (Speck et al., 2003; Hipfner et al., 2004). By contrast, two groups showed that 
expression of dMoesin-T579D without a tag or with a C-terminal tag failed to rescue (Karagiosis 
and Ready, 2004; Roubinet et al., 2011). Especially given that the rescue was only partial even 
with wild-type dMoesin bearing an N-terminal myc tag (Hipfner et al., 2004) whereas it was 
complete with untagged or C-terminally GFP-tagged dMoesin (Roubinet et al., 2011), these 
results suggest that the presence of an N-terminal epitope tag reduces the activity and 
presumably the molecular openness of dMoesin. 
This result from Drosophila is dramatically supported in Jeg-3 placental epithelial cells, 
where N-terminally Xpress-tagged ezrin accumulates diffusely similar to T567A ezrin, whereas 
C-terminally Xpress-tagged ezrin accumulates along with endogenous ezrin in microvilli (J. 
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Thoms, unpublished). Ezrin bearing a mutation in the N-ERMAD partially blocking association 
with the C-ERMAD (termed the N-mutant; Chambers and Bretscher, 2005) hyper-localizes to 
the cortex and fails to accumulate in microvilli, but strikingly, coupling this mutation with an N-
terminal Xpress tag causes it to localize exclusively in microvilli (D. Chamers, J. Thoms, and R. 
Viswanatha, unpublished). This supports the notion that N-terminal tags reduce ERM openness. 
C-terminal GFP tagging maintains dMoesin’s functionality (Roubinet et al., 2011; 
Polesello et al., 2002) and ezrin’s competence to form microvilli in Jeg-3 cells (Figure 3.6), 
causes aberrant localization to the plasma membrane in the background of the T567A mutation, 
which is cytoplasmic with an internal tag (R. Viswanatha, unpublished). This indicates that the 
presence of a C-terminal GFP tag partially increases openness, consistent with the extreme C-
terminus of ezrin’s being involved in critical contacts in the dormant ERM (Pearson et al., 2000; 
Li et al., 2007). 
Thus ERMs have been proposed to have three related roles: 1) producing cell-surface 
structures; 2) serving as a scaffold for EBP50 and other binding partners (Table 1), increasing 
cortical rigidity, and these roles can be affected by the presence of epitope or GFP tags. 
ERM knockouts support a role in microvillus formation 
Due to redundancy and pleiotropy, mammalian ERMs have been difficult to functionally 
characterize. By contrast, in the fly Drosophila melanogaster as in the worm Caenorhabditis 
elegans, there is only one homolog of these three proteins, called dMoesin or ERM-1, 
respectively. The results in the vertebrate and invertebrate systems have been complementary, so 
both will be discussed. 
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Mouse ERM knockouts. All three ERM proteins have been knocked out of the mouse 
individually. Supporting the notion of functional redundancy among ERMs, moesin knockout 
mice are viable without any overt defects (Doi et al., 1999). The phenotypes of radixin knockout 
and ezrin knockout, however, are more informative. 
The predominant tissue expression pattern of each ERM in the mouse (Ingraffea et al., 
2002) correlates with the phenotypes of the knockouts. Radixin is predominantly expressed in 
the hair cell stereocilia and in the liver where it localizes to the apical bile canaliculi. 
Consequently, radixin knockout mice are deaf (Kitajiri et al., 2004). Deafness occurs despite 
upregulation of ezrin, which localizes aberrantly to the stereocilia during development but cannot 
fully compensate (Kitajiri et al., 2004). In addition to deafness, the mice display 
hyperbilirubinemia, due to mislocalization of multidrug-resistance protein 2 (MRP2), the 
conjugated bilirubin transporter, away from the bile canalicular membrane (Kikuchi et al., 2002). 
Moreover, it has been demonstrated that the apical localization of MRP2 is dependent on its 
binding to EBP50 (Harris et al., 2001; Li et al., 2010), and EBP50 knockout mice also display 
hyperbilirubinemia (Li et al., 2010). Thus, radixin knockout results in a defect in stereocilia 
(mechanism as yet unclear) and the loss of specific transporters from the liver cell apical 
membrane through defects in positioning of EBP50 and MRP2. 
Although ezrin is distributed widely across all tissues examined (Ingraffea et al., 2002), it 
is the sole ERM expressed in intestinal epithelia. McClatchey and colleagues therefore generated 
ezrin null mice in order to examine the intestinal epithelium. Ezrin-null mice were born, but die 
of malnourishment shortly after weaning due to intestinal malformation (Saotome et al., 2004): 
specifically, a developmental transition, villi segregation at embryonic day 15.5, fails. The 
intestinal microvilli indeed lack all three ERMs; surprisingly, microvilli are present in the ERM-
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null intestinal cells, but they are aberrant in morphology: the terminal web region is enlarged and 
the microvilli are short and disorganized (Saotome et al., 2004). McClatchey and colleagues have 
interpreted this as a defect in the terminal web, however, this type of defect might be envisioned 
if plasma membrane-cytoskeleton crosslinking were partially perturbed, the plasma membrane 
failing to wrap tautly around the microvillus core and splaying out like an opened umbrella. 
Importantly, the results argue for the existence of other plasma membrane-cytoskeleton cross-
linkers exist in addition to ERMs in these cells. When a conditional ezrin allele was knocked out 
in the adult, multiple phenotypes were revealed. These included disorganization of microvilli and 
failure of villus fusion (as is seen in the embryonic null); blebs and breaks in the apical 
membrane where it appears to peel away from the F-actin cortex; mislocalization of apical 
junction components; a partial defect in mitotic spindle positioning leading to polarity defects; 
and the upregulation of activated RhoA (Casaletto et al., 2011). The basis for the additional 
defects is unclear. Thus, ezrin is required for multiple aspects of intestinal epithelial polarity, but 
importantly, one of those is structuring and shaping apical microvilli. 
It will be interesting to cross the moesin or radixin knockout mice with the ezrin 
knockout mouse heterozygote to uncover further roles of ERMs during early development in the 
progeny, as has been predicted by dominant ezrin mutant expression during early embryogenesis 
(Dard et al., 2001). 
Invertebrate ERM knockouts. In the Drosophila oocyte, three independent P-element insertions 
within the dMoesin gene have been shown to cause a defect in tethering the membrane to the F-
actin cytoskeleton and a lack of retention of Oskar mRNA onto cortical F-actin, leading to larval 
lethality (Speck et al., 2003; Polesello et al., 2002; Jankovics et al., 2002). In the wing imaginal 
disc, the microvilli in the apical domain were replaced with large blebs, and the amount of F-
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actin in the apical domain was increased (Speck et al., 2003). Whether the allele used in this 
study was a true null has been questioned (Karagiosis and Ready, 2004), but most of these 
defects were subsequently upheld by examining other alleles (Roubinet et al., 2011). In the 
photoreceptor cells, two dMoesin alleles or dMoesin RNAi disorganized the microvilli and 
caused loss of the photoreceptors, which normally reside in the microvilli (Karagiosis and 
Ready, 2004). Taken together, these results suggest that dMoesin functions in the maintenance of 
cross-linking between the F-actin cortex and the apical plasma membrane in multiple cell-types 
leading to the functional organization of microvilli. 
A stunning finding from one dMoesin allele was that the mutant was partially rescued by 
suppressing the small GTPase Rho1, which is the homolog of mammalian RhoA/B/C (Speck et 
al., 2003). Furthermore, suppression of dMoesin rescued defects associated with a second 
mutant, Dishevelled, which causes a decrease in Rho1 activity on its own (Speck et al., 2003). 
These results have been doubted because the allele used in these experiments was conclusively 
shown not to be a null in some adult tissues (Karagiosis and Ready, 2004). However, the result 
has gained traction recently because knocking out ezrin in the adult mouse also elevates RhoA 
activity (Casaletto et al., 2011). Thus RhoA and ERM function appear to be antagonistic, but the 
molecular details remain elusive. 
The worm Caenorhabditis elegans also possesses only one ERM family member called 
ERM-1, an essential gene. RNAi depletion of ERM-1 led to stage L1 lethality but also caused 
more informative phenotypes: cysts and obstructions along the intestine, as well as defects in 
properly positioning the apical domain as moves from a more lateral position during intestinal 
development (Van Furden et al., 2004; Gobel et al., 2004). Electron microscopy showed that 
microvilli were lost in the disorganized lumena and revealed regions where the plasma 
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membrane was peeling away from the cortex, consistent with the mouse and fly data (Gobel et 
al., 2004). Interestingly, ERM-1 depletion enhanced the loss of continuous apical junction 
staining incurred by loss of E-cadherin or α-catenin (Van Furden et al., 2004). This implied that 
ERM-1 collaborates to position apical junction components appropriately. The data suggest that 
ERM-1 has roles in apical membrane integrity and lumenogenesis, as well as a possible second 
role in apical junction positioning. To bring the latter role into the fold, Fehon and colleagues 
have suggested an alternative explanation: that ERM-1 may be facilitating formation of cell-cell 
boundaries under chaotic conditions, when cells are sliding past each other or dividing during 
lumen formation (Fehon et al., 2010). 
Thus genetic ERM removal has suggested that ERMs have multiple roles in situ: microvillus 
morphology; scaffolding of protein interaction partners; villus fusion; cell-cell junction 
morphology; apical lumenogenesis; Rho GTPase regulation; and mitotic spindle polarization. 
The mechanism is unclear in most cases, and will depend on careful analysis of cell culture 
models as well as the identification of mutants in new genes that phenocopy some but not all of 
these defects. 
Extrinsic regulation of ERM activation by PI(4,5)P2, ERMBPs, kinases, and phosphatases 
To date, two models for how ERMs bind membranes have been proposed. In the first, 
plasma membrane phospholipid PI(4,5)P2 recruits ezrin to the plasma membrane. In the second, 
transmembrane ERM-binding partners (ERMBPs), interacting through the FERM domain, 
recruit and stabilize activated ezrin on the plasma membrane. Neither has been conclusively 
shown to be necessary and sufficient, so an interplay between them is the most likely scenario. 
As mentioned earlier, a second requirement for ERM activation is phosphorylation of a C-
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terminal threonine (T567 in ezrin). The regulation of this phosphorylation has also received 
considerable attention and will be discussed in the third section. In the final section, I will try to 
integrate these regulatory modes with ERM function in vivo. 
PI(4,5)P2. The emerging model for ERM activation is that it involves synergy or coincidence 
detection between PI(4,5)P2 on the plasma membrane and protein kinases that phosphorylate the 
C-terminal threonine. Functional evidence for an involvement with PI(4,5)P2  was the discovery 
that PAO, which reduces the synthesis rate of its precursor, PI(4)P, also reduced moesin 
phosphorylation (Nakamura et al., 1995). In fibrobasts, PI(4)P-5 kinase Iα (PIPKIα, which 
generates PI(4,5)P2, was strictly required for moesin phosphorylation, and microinjection of high 
doses of a PI(4,5)P2 inhibitor, neomycin, reduced membrane-bound moesin (Matsui et al., 1999). 
The relevant protein kinase in fibroblasts has not yet been discovered, but this set up the 
possibility that binding PI(4,5)P2 is required for subsequent C-terminal threonine 
phosphorylation by the kinase. Two groups showed that the FERM domain can specifically bind 
PI(4,5)P2-containing liposomes, and that the accessibility of the FERM domain to bind the 
cytoplasmic region of CD44 is dependent on the presence of PI(4,5)P2 (Hirao et al., 1996; Niggli 
et al., 1995). Finally, a recent study has confirmed that PI(4,5)P2-liposome-bound ERMs undergo 
conformation opening in vitro (Maniti et al., 2012). These results suggest that PI(4,5)P2 recruits 
ERMs to membranes via the FERM domain, allowing for subsequent phosphorylation (Figure 
1.3.A). 
Where on ezrin does PI(4,5)P2 interact? Subsequently, Niggli and colleagues mutated 
four surface lysine residues to asparagine, severely impairing the interaction with PI(4,5)P2 in 
vitro (Barret et al., 2000). These mutations (K253N, K254N, K262N, K263N in moesin; now 
referred to as K4N or PATCH mutations; Figure 1.3.B; Ben-Aissa et al., 2012) prevent the 
20
AB.
K63
K60 K278
K253/254
K262/263
POCKET
PATCH
A
B
C
α-helix
Figure 1.3 PI(4,5)P2’s role in ezrin activation. (A) The current model for ERM activation. 
PI(4,5)P2 recruits dormant ERM to the plasma membrane, and this interaction stabilizes a 
conformation in which the kinases and phosphatases can reversibly phosphorylate the C-terminal 
threonine. (B) The FERM domain (1NI2) of ezrin with POCKET and PATCH residues 
illuminated. Based on Ben-Aissa et al., 2012. 
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translocation of full-length ERM to the membrane, but if PATCH-mutated ERM is additionally 
mutated to mimic C-terminal phosphorylation or truncated to just the FERM domain, membrane 
translocation is restored (Barret et al., 2000; Hao et al., 2009). A similar yin-yang effect between 
C-terminal phosphorylation and PI(4,5)P2-engagement has been observed with Drosophila 
dMoesin (Roch et al., 2010). These results indicate that PI(4,5)P2 engagement through PATCH 
residues regulates ERM autoinhibition. A detailed molecular mechanism has recently been 
proposed. The FERM PATCH can be seen overlapping with a portion of the C-ERMAD called 
the FLAP in the crystal structure of full-length, closed ERM (Li et al., 2007). It was recently 
demonstrated that competition between the FLAP and PI(4,5)P2 binding at the PATCH can 
regulate the accessibility and membrane occupancy of moesin (Ben-Aissa et al., 2012), but the 
applicability of these observations in vivo and to radixin and ezrin remain to be determinined. 
PI(4,5)P2 binding has been shown to additionally require positive charges on K63 and 
K64 (now called the POCKET; Figure 1.3.B; Barret et al., 2000; Ben-Aissa et al., 2012). This 
site was shown to interact with PI(4,5)P2’s head group, IP3 in crystals (Hamada et al., 2000). 
Furthermore, recent work suggests that the same molecule of PI(4,5)P2 cannot simultaneously 
bind both the PATCH and the POCKET (Ben-Aissa et al., 2012). The authors favor a model in 
which one molecule of PI(4,5)P2 translocates along the surface of the FERM domain from the 
PATCH to the POCKET as the FERM domain becomes progressively more accessible. 
However, the authors overlooked an important test: mutation of both the PATCH and the 
POCKET simultaneously. As early work shows that there is synergy between these mutations 
(Barret et al., 2000), ERMs may bind two molecules of PI(4,5)P2 simultaneously. In vivo studies 
have not yet examined the effects of mutating these sites on the plasma-membrane localization of 
the isolated FERM domain, leaving room for debate as to whether PI(4,5)P2-engagement is 
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sufficient for the plasma-membrane localization of the FERM domain, and leave open the 
possibility of partner interactions regulating ERM occupancy at the membrane. 
Functional studies have confirmed that PI(4,5)P2 is required for ERM activation, but have 
been similarly ambivalent as to whether an exposed FERM domain can still be enriched on the 
plasma membrane independently of PI(4,5)P2. Using rapamycin-induced plasma membrane-
translocation of a cytoplasmic PI(4,5)P2 phosphatase, Shaw and colleagues showed that both 
ezrin and moesin are efficiently removed from the lymphocyte plasma membrane concomitant 
with the loss of a PI(4,5)P2 reporter (Hao et al., 2009). This agrees with long-term PI(4,5)P2 
depletion studies in other systems (Matsui et al., 1999; Gervais et al., 2008). However, the loss of 
phosphomimetic moesin from the membrane following PI(4,5)P2 depletion was incomplete (Hao 
et al., 2009). Thus, although PI(4,5)P2 has a clear role in ERM activation and tethering, it has not 
yet been conclusively demonstrated whether there is still room for other determinants. Also, the 
localization of these determinants to the plasma membrane may also require the presence of 
PI(4,5)P2. 
Regulation by ERM Binding Proteins (ERMBPs). A hypothesis that has received relatively less 
attention is that many transmembrane proteins might coordinately regulate ezrin’s attachment to 
the plasma membrane by recruiting ezrin via the basic patches in their cytoplasmic tails. 
According to this hypothesis, ezrin may have evolved to bind a large number of transmembrane 
proteins, which may explain the large number of diverse ligands proposed for ERMs (Table 1). 
Moreover, removal of no single ERMBP would cause microvilli collapse, consistent with the 
existing data (for instance, CD44 knockdown does not alter microvilli appearance; Legg et al., 
2002). Tsukita and colleagues reasoned that the overexpression of ERMBPs, however, might 
increase the clustering of activated ezrin, leading to the formation of microvilli-like structures in 
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fibroblasts (Yonemura et al., 1999). They found this to be the case with the intracellular portions 
of ICAM-2, CD44, and CD43 artificially fused to E-cadherin’s extracellular and transmembrane 
domains for normalization and detection purposes. Furthermore, microvilli-like structures failed 
to coalesce when mutations to block ezrin binding were introduced into the cytoplasmic tails. 
This effect was not observed in epithelial cells, where, perhaps, ERMBP availability is not rate-
limiting for microvilli formation (Yonemura et al., 1999). Thus, ERMBPs may anchor ezrin to 
the plasma membrane in addition to PI(4,5)P2. 
In reality, a combination of both strategies may be operational. This is supported by the 
fact that in vitro, phosphomimetic ezrin is not fully open, but only partially open (Chambers and 
Bretscher, 2005), suggesting that the binding of accessory factors in vivo may be needed to 
sustain active, membrane-linked molecules. 
ERM regulation by kinases and phophatases. A primary role for kinases and phosphatases in 
regulating ERM accessibility was recognized early on. Early in vitro experiments suggested that 
Protein kinase C Ө was capable of phosphorylating moesin at T558, but no functional data 
connected these two in vivo (Simons et al., 1998; Pietromonaco et al., 1998). Initial in vivo work 
from Tsukita and colleagues suggested that Rho-activated kinase (ROCK) was the relevant 
kinase in tissue culture fibroblasts (Oshiro et al., 1998; Matsui et al., 1998), but this has been 
questioned (Matsui et al., 1999; Yokoyama et al., 2005). Subsequently, myotonic dystrophy 
related Cdc42-interacting kinase (MRCK), a known effector of Cdc42 and regulator of microvilli 
(Leung et al., 1998), was suggested to phosphorylate ERMs only in filopodia stimulated by 
activated Cdc42, but not in microvilli-like structures stimulated by activated RhoA (Nakamura et 
al., 2000). However, this result has not been consistent with subsequently identified phenotypes 
associated with MRCK depletion. Protein kinase C α was shown to regulate ERM 
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phosphorylation during fibroblast migration, but the relevance to microvilli has not been 
investigated (Ng et al., 2001). Finally, Salas and colleagues showed that PKCι, one of the 
isoforms of atypical protein kinase C known to be involved in determining the polarity of the 
apical domain of epithelial cells, could phosphorylate ezrin at T567 in Caco-2 cells and be 
required for microvilli (Wald et al., 2008), but an unbiased in vitro screen for ERM-
phosphorylating kinases by a different group failed to detect any activity for the activated PKCι 
kinase domain towards ezrin at T567 in vitro in direct contradiction to the Salas group (ten 
Klooster et al., 2009). Thus, the identity of the ERM kinase operational in mammalian tissue 
culture cells has remained elusive. 
A key contribution of the identification of the ERM ortholog in Drosophila was the 
ability to identify genetically interacting kinases based on whole-organism phenotypes. A gain-
of-function screen for genes whose overexpression leads to an increase in tissue size identified 
Sterile-20 kinase-like (Slik; Hipfner and Cohen, 2003). The authors then generated mutations in 
the Slik gene. Slik mutants gave two distinct defects: 1) reduced proliferation, consistent with the 
Slik overexpression phenotype, which could be suppressed by the overexpression of Raf (Hipfner 
and Cohen, 2003), and 2) a loss of apical integrity in the wing imaginal disc epithelial and 
photoreceptor cells (Hipfner et al., 2004). Based on the appearance of the photoreceptors in 
dMoesin knockouts (Karagiosis and Ready, 2004), the authors reasoned that one defect could be 
in the phosphorylation of dMoesin, and they subsequently showed that dMoesin phosphorylation 
was compromised in Slik knockout larvae and in S2 tissue cultured cells knocked down for Slik 
(Hipfner et al., 2004). Finally, they showed that activated dMoesin (overexpressed dMoesin 
bearing an N-terminal myc tag and T579D mutation) can partially rescue Slik mutants, consistent 
with some of the Slik mutant phenotype’s being due to reduced dMoesin phosphorylation 
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(Hipfner et al., 2004). That Slik is genetically upstream of dMoesin has been upheld by a number 
of subsequent studies (Kunda et al., 2008; Hughes et al., 2010; Yang et al., 2012). Furthermore, 
while one group has claimed that dRok, ortholog of mammalian ROCK, can also control 
dMoesin phosphorylation during larval development using immunostaining techniques (Verdier 
et al., 2006), their result was directly contradicted by another group using quantitative Western 
blotting (Neubueser and Hipfner, 2010). This leaves the general sense in the field that Slik is the 
predominant upstream kinase for dMoesin in all cell-types in Drosophila.  
A side-point is that the proliferative defect in Slik mutants may be due to a defect in 
phosphorylation of dMerlin, the ortholog of mammalian merlin, as marked Slik mutant imaginal 
disc clones have a defect in dMerlin phosphorylation, and Slik can directly phosphorylate 
dMerlin in vitro (Hughes and Fehon, 2006). This is not terribly surprising as merlin and ezrin are 
similar in primary sequence, and since the phosphorylation site is roughly conserved between 
them (reviewed in McClatchey and Fehon, 2009). Only one publication has examined the role of 
mammalian merlin phosphorylation at this site (T576 in mouse and human merlin), and, 
unbelievably, they concluded that phosphorylation at T576 does not contribute to regulation, 
whereas phosphorylation at an adjacent site, S518, mediated by p21-activated kinase, does 
(Surace et al., 2004). The interplay between phosphorylation at the two sites has not yet been 
examined, so whether this regulatory mode contributes anything in mammalian cells remains to 
be addressed. Thus Slik appears to be upstream of both ERMs and merlin in Drosophila. 
Recent studies of ERM regulation in mammalian cells have offered fresh insights. There 
are two orthologs of Slik in mammalian cells: lymphocyte-oriented kinase (LOK) and Ste20-like 
kinase (SLK). Knockout of LOK in mice yields no overt phenotype, but a careful examination of 
several tissues shows a slight decrease in phosphorylation of all three ERMs systemically 
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(Belkina et al., 2009). The mice also show a deficiency in lymphocyte activation in response to 
SDF-1, similar to moesin knockdown (Belkina et al., 2009). SLK has not yet been connected 
with ERM regulation. These results suggest that LOK is necessary for a portion of ERM 
phosphorylation, in agreement with Drosophila studies, but suggests that other kinase(s) are also 
involved. 
Surprisingly, an entirely different model has been put forth by Clevers and colleagues 
(ten Klooster et al., 2009; Baas et al., 2004; Gloerich et al., 2012). Using the W4 enterocyte-
derived cell line in which the membrane localization and activation of polarity-inducing Lkb1, 
the mammalian homolog of C elegans PAR-4, can be synchronously triggered by doxycycline 
treatment, they showed that polarization of an apical domain containing microvilli can occur in 
suspension-growing, isolated cells (Baas et al., 2004). Furthermore, an examination of cells 
made to lack Lbk1 by RNAi (Baas et al., 2004) or cells with greatly reduced Lkb1 (Xu et al., 
2010) suggests that Lkb1 expression is part of the normal apical polarity pathway. Clevers and 
colleagues later identified proteins interacting with the membrane-bound Lkb1 complex and 
identified the serine/threonine kinase MST4 (ten Klooster et al., 2009). According to this group, 
MST4 expression was necessary for ezrin phosphorylation and brush border formation following 
Lkb1 translocation in Ls174T-W4 cell-lines, and that it was capable of phosphorylating ezrin in 
vitro with a catalytic rate similar to those of several kinases previously identified as ERM 
kinases in various other systems (ten Klooster et al., 2009). Its reduction in Caco-2 cells also 
caused a decrease in the formation of microvilli, suggesting a general role (ten Klooster et al., 
2009). MST4 has a clearly discernible ortholog in Drosophila, called germinal center kinase III 
(GCKIII). The homology is evident not only on the basis of protein identity within the catalytic 
domain, but in the regulatory domain outside the catalytic domain, clearly establishing their 
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evolutionary origin (R. Viswanatha, data not shown). Thus, the existing data support the 
intriguing notion that while the predominant kinase for ERMs in Drosophila is Slik (LOK/SLK), 
in mammalian cells it is MST4 (GCKIII), suggesting a major evolutionary switch in pathway 
wiring with only minor changes in the key players. Two alternative solutions are 1) both kinases 
are capable of phosphorylating ezrin in vitro, whereas only one of them directly phosphorylates 
ezrin in both in vivo systems; and 2) both kinases lie in the same pathway; i.e., the activation of 
one leads ultimately to the activation of the other. This remains to be tested. Thus, MST4 is 
claimed to be important for ezrin phosphorylation in vivo. 
Nonetheless, the currently held notion is that a strikingly wide array of kinases 
phosphorylates ezrin at T567 in vitro and in vivo (Figure 1.4). These kinases fall into two broad 
evolutionary categories, the PKC A/γ/C (AGC) branch and the germinal center kinase (GCK) 
branch (Figure 1.4). The diversity is also apparent by their enormously different regulatory 
domains, which directly interact with various signaling inputs such as calcium (in the case of 
PKC isoforms) and activated Cdc42 (in the case of PKCι, ROCK, or MRCK; Figure 1.4). Thus 
numerous already-established molecular pathways may have evolved connectivity to ezrin 
through these kinases as a means by which to couple various signals to cytoskeleton regulation. 
In contrast to kinases, phosphatases have received less attention. Protein phosphatase 1’s 
(PP1s), very large multisubunit complexes, have been most often invoked as the ERM 
phosphatase. Calyculin A and okadaic acid treatment has long been known to inhibit ERM 
dephosphorylation, but these drugs target PP1, PP2, and PP6 catalytic subunits, so it is unclear 
from these experiments which phosphatase is actually required. In support of a general role for 
PP1s, Sds22, a common structural subunit of PP1 complexes including those based on catalytic 
subunits PP1-87B (α/β) and Flapwing (δ/γ), was shown to be necessary for dMoesin 
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Figure 1.4 The ERM-kinome. (A) The human kinome with illuminated proteins known to 
phosphorylate ezrin in vivo or in vitro. (B) Cartoon diagram of kinases in A, homology to LOK 
and SLK kinase domain, and catalytic rate of indicated isolated kinase domain for ezrin C-
terminal domain in vitro. CNH, Citron homology, a small GTPase effector binding domain; 
SARAH, Salvador/Rassf/Hippo homology, a protein-protein interaction domain and dimerization 
domain; C1, C2, cysteine-rich domains mediating divalent ion-dependent protein-lipid 
interactions; PH, Phox homology, lipid-binding domains; CRIB, Cdc42/Rac1-interaction 
domain; PB1, Phox and Bem1p homology, a heterodimerization domain. 
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dephosphorylation in Drosophila imaginal discs (Kunda et al., 2012; Grusche et al., 2009), and 
its human homolog, PPP1R7, was shown to be necessary for ERM dephosphorylation in human 
A431 cells (Grusche et al., 2009). DFlapwing was uncoupled from dMoesin in Drosophila S2 
cells but necessary for dMoesin dephosphorylation in vivo (Roubinet et al., 2011; Yang et al., 
2012), whereas PP1-87B has been shown to be necessary for dMoesin dephosphorylation in S2 
cells (Roubinet et al., 2011). PP1s are targeted via another set of accessory subunits. While the 
situation may be complicated in vivo (Lee and Treisman, 2004), in cultured mammalian cells, 
MYPT1/MBS (myosin-binding subunit) is thought to target PP1’s catalytic subunit to moesin 
(Fukata et al., 1998). This was difficult to test because the regulation of MYPT1’s localization 
was unclear in early reports. However, the finding that PP1Cδ, a mammalian homolog of 
DFlapwing, could translocate to the cytoplasm from the nucleus upon co-overexpression with 
MYPT1 (Eto et al., 2005) may prove a useful tool. Thus PP1 appears to mediate ERM 
dephosphorylation in most cases, and the details remain to be elucidated. 
Regulating the regulators. The ERM regulators mentioned here (PI(4,5)P2, transmembrane 
ERMBPs, and kinases and phosphatases) must be integrated to regulate ERM-dependent 
processes. In selected cases, this regulation has been fleshed out. 
PI(4,5)P2 is one of the critical determinants of the apical domain, as reversing its mild 
gradient towards the apical domain leads to a general loss of apical polarity (Martin-Belmonte et 
al., 2007). Overexpressing type I phosphatidylinositol-4-phosphate 5 kinase α (PIP5KIα) causes 
a dramatic increase in PI(4,5)P2 at the expense of PI(4)P (Yamamoto et al., 2001). This has 
multiple effects on actin-binding proteins, including increasing actin-bound ezrin (Matsui et al., 
1999; Yamamoto et al., 2001). In turn, this was shown to increase phosphorylated ezrin and 
microvillus formation in NIH 3T3 fibroblasts (Matsui et al., 1999). Furthermore, when PIP5KIα 
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was very highly overexpressed in A431 cells, it accumulated in vesicles also containing 
phosphorylated ezrin (Yonemura et al., 2002). As an aside, Yonemura et al. go further and 
conclude that ERM activation can be accomplished by high enough PI(4,5)P2 levels, bypassing 
the need for phosphorylation (Yonemura et al., 2002). They suggest this because A431 cells can 
be made to ruffle in response to EGF even following pre-treatment with staurosporine to 
completely dephosphorylate their ERMs (Yonemura et al., 2002). This argument is incorrect 
because it presupposes that the ezrin is necessary for ruffling in response to EGF, which was 
proposed because it unquestionably localizes to the ruffles (Bretscher, 1989) but never verified 
by ezrin gene disruption. By contrast, my findings are that ezrin depletion by RNAi has no 
statistically significant effect on EGF-induced ruffling in A431 or Jeg-3 cells (R. Viswanatha, 
unpublished). Thus PI(4,5)P2 levels could be limiting for ERM engagement relative to potential 
tethering factors and kinase activity under some circumstances, so regulating its levels could 
regulate ERM phosphorylation. 
How might PIP5KIα be regulated? Two pathways have been proposed: a Rho-ROCK 
pathway and Rho-dependent, ROCK-independent pathway (Yamamoto et al., 2001). Since 
ROCK inhibition is uncoupled from ERM phosphorylation in some systems (Matsui et al., 
1999), the most likely scenario is that PIP5KIα is activated directly by Rho GTPases. Thus, Rho 
GTPase activation should act synergistically with ERM phosphorylation, which it does in some 
cases (Matsui et al., 1999; Yonemura et al., 2002; Hayashi et al., 1999; Antoine-Bertrand et al., 
2011; Batchelor et al., 2007; Pujuguet et al., 2003). However, in ERM-deficient mouse intestinal 
cells (Casaletto et al., 2011a) and Drosphila wing epithelial cells (Speck et al., 2003), RhoA and 
ezrin act antagonistically. The reason for this difference is unclear. 
31
Relatively less is known about the regulation of ERM kinases. Although much is known 
about ROCK regulation, its identity as an ERM kinase is suspect (Matsui et al., 1999), and 
nothing is known about its regulation of ERM phosphorylation. In Drosophila, Slik is the ERM 
kinase, which also controls proliferation presumably through dMerlin (Hipfner and Cohen, 2003; 
Hughes and Fehon, 2006). Slik’s proliferative role may be regulated by Raf (Hipfner and Cohen, 
2003), but nothing is known about how its role in ERM phosphorylation is regulated. ten 
Klooster et al. (2009) have shown that the ERM kinase in polarized single-cells is MST4 (ten 
Klooster et al., 2009). MST4 activation requires an apically-localized Lkb1 complex, but 
additionally requires a complex signaling pathway originating from activated small GTPase 
Rap2A (Gloerich et al., 2012). Curiously, MST4 is concentrated not in the microvilli, the site of 
activated ezrin, but in the terminal web region below the brush border, suggesting an action-at-a-
distance or molecular hand-off mechanism (ten Klooster et al., 2009). Also, its distribution at the 
plasma membrane is presumably regulated by polarized membrane trafficking due to its partial 
co-localization in vesicles with Rab11 (ten Klooster et al., 2009). Thus there is an as yet murky 
view of ERM kinase regulation. 
Finally, several lines of evidence have pointed out an interesting requirement of any 
ERM regulatory mechanism: it has to be fast! First, microvilli have been shown to come and go 
with a half-life of approximately 5 minutes (Garbett and Bretscher, 2012; Gorelik et al., 2003). 
Ezrin’s steady-state enrichment in microvilli suggests that it is constantly trained on a moving 
target. Consistently, measurement of ezrin turnover rates from the plasma membrane using 
fluorescence bleaching techniques of ezrin-GFP have suggested that it turns over with a half-life 
of 40 seconds – 2 minutes (Garbett and Bretscher, 2012; Coscoy et al., 2002), slightly faster than 
that of microvilli, themselves, allowing dynamic ezrin redirection to growing microvilli as 
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needed. Two groups have examined the redirection of ERMs during more dramatic 
morphological transitions. Sanchez-Mateos and colleagues examined moesin recruitment to the 
dorsal region of adhering melanoma cells as they were plated from suspension and found that it 
cleared from the ventral side within 5 minutes of re-plating, suggesting dynamic cellular control 
of the ERM regulatory network (Estecha et al., 2009). Similarly, Simons and colleagues showed 
that podocalyxin, a transmembrane protein that interacts with EBP50, cleared from the ventral 
surface of freshly plated MDCK cells within 1 hour of plating and accumulated in dorsal domain 
(Meder et al., 2005). This clearing was faster than non-EBP50-binding apical transmembrane 
proteins which take greater than 4 hours and is thought to depend upon polarized membrane 
trafficking, and it also required that podocalyxin contain a motif that allows interaction with 
EBP50 (Meder et al., 2005). Because EBP50 requires ezrin to localize at the plasma membrane 
(R. Viswanatha, unpublished; Garbett et al., 2010), this suggests that ezrin can identify and target 
the dorsal surface specifically before it is defined by polarized membrane trafficking, a 
hypothesis that has been upheld by a very recent study (Galvagni et al., 2012). These 
observations suggest that ERM regulation by PI(4,5)P2, transmembrane ERMBPs, and/or 
kinases/phosphatases is a system tuned to functioning in chaotic and rapidly changing situations. 
 
This thesis will address two of the issues brought forth in this discussion. If there are 
ERM membrane tethers, they would be expected to interact directly with ERMs. In the first 
chapter, I conduct an unbiased proteomic screen of ezrin-bound material in a microvillus-
decorated cell-line to determine the identity, location, and function of ERMBPs. In the second 
chapter, I address the ERM regulatory network, asking how the influence of kinases affects ERM 
polarity. 
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Most of this work was performed in Jeg-3 choriocarcinoma cells. In the first appendix, I 
attempt to recapitulate the findings in a kidney epithelial cell-line, LLC-PK1.CL4. 
As mentioned above, interaction between ezrin and scaffolding protein EBP50 is required 
for microvilli in Jeg-3 cells. EBP50 can simultaneously bind to a number of ligands through two 
PDZ protein-protein interaction domains. In the second and third appendices, I conducted an 
unbiased proteomic profiling of EBP50-bound proteins to ask which of these ligand(s) of EBP50 
is required for this function. 
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Table 1  Ezrin interactions and selected publication list 
Interaction 
partner 
Selected 
References 
Proposed binding mode Proposed function Expressed in 
Jeg-3/Identified 
here? 
Aquaporin-0 1 Unknown Unknown ND/No 
CD146 2 Unknown ERM regulation of melanoma 
cell migration through control 
of ERM-RhoGDI interaction 
ND/No 
CD43 3-7 Positive cluster in 
cytoplasmic tail interacts 
with acidic groove in FERM 
domain lobe F3 
ERM regulation of 
lymphocyte migration via 
PKCӨ-mediated 
phosphorylation of CD43 tail; 
tethering of ERMs to plasma 
membrane for micovillus 
formation 
No/No 
CD44 3, 5, 8-14 Positive cluster in 
cytoplasmic tail interacts 
with acidic groove in FERM 
domain lobe F3 
ERM regulation of migration 
speed and directionality; 
lymphocyte polarization; 
tethering of ERMs to plasma 
membrane for micovillus 
formation 
No/No 
Clic-3/-4/-5 15, 16 Unknown Microvillus formation in RPE 
cells 
Yes/Yes (Clic-3 
and Clic-4) 
Dbl 17-22 Ezrin FERM interacts with a 
basic cluster within the PH 
domain of Dbl  
ERM modulation of Cdc42 
signaling, general function 
unknown  
ND/No 
DCC 23, 24 Positive cluster in 
cytoplasmic tail interacts 
with acidic groove in FERM 
domain lobe F3 
Ezrin regulation of Netrin-
induced axon guidance 
ND/No 
Dlg 25, 26 FERM domain of ezrin 
interacts with Dlg1 
Ezrin regulation of immune 
synapse formation 
Yes/No 
EBP50/E3KARP 27-32 Occupies a region of the 
FERM domain which 
overlaps with C-ERMAD 
interaction site 
ERM regulation of microvilli 
formation and receptor 
clustering 
Yes/Yes 
E-cadherin 33 T567D only binds E-
cadherin 
Activated ezrin-dependent 
interference with E-cadherin 
trafficking 
Yes/No 
Eps8 /-L1a 34 Coiled-coil domain of ezrin 
harboring an NPxY motif 
interacts with the SH3 
domain of Eps8 when ezrin 
is phosphorylated on Y477 
ERM regulation of microvillus 
length and spacing 
Yes/No 
Fes 35 Coiled-coil domain of ezrin 
harboring an NPxY motif 
interacts with the SH2 
domain of Fes when ezrin is 
phosphorylated on Y477 
ERM control of cell spreading 
and migration in response to 
HGF 
ND/No 
ICAM-1/-2/-3 36-41 Positive cluster in 
cytoplasmic tail interacts 
with acidic groove in FERM 
domain lobe F3 
Polarization of ICAMs to the 
urpod in migrating 
lymphocytes; tethering of 
ERMs to plasma membrane 
for micovillus formation 
ND/No 
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L1CAM 42, 43 FERM domain binds 
L1CAM 
ERM regulation of neurite 
outgrowth 
ND/No 
Myo18aα 44 Unknown Unknown, detected in 
activated B cells 
ND/No 
NHE-1 45, 46 Positive cluster in 
cytoplasmic tail interacts 
with acidic groove in FERM 
domain lobe F3 
ERM regulation of migration 
speed and directionality 
ND/No 
NHE-3 47 Positive cluster in 
cytoplasmic tail interacts 
with acidic groove in FERM 
domain lobe F3 
ERM regulation of NHE-3 
surface distribution in OK 
cells 
Yes/No 
PACE-1 48 C-terminal region of ezrin Unknown Yes/Yes 
Palladin 49, 50 Residues 278-585 of ezrin 
interact with Ig2 or Ig3 of 
palladin. 
Unknown Single enriched 
peptide detected 
PDZD8 51 Unknown Moesin control of 
glutamylated microtubule 
abundance and HSV-1 viral 
entry 
ND/No 
PLEKHG6 52 FERM domain of ezrin 
interacts with a C-terminal 
region of unknown function 
in PLEKHG6 
ERM regulation of 
macropinocytotic ruffling 
Yes/No 
Podocalyxin 53 Unknown Unknown ND/No 
PSGL-1 39, 54-57 Positive cluster in 
cytoplasmic tail interacts 
with acidic groove in FERM 
domain lobe F3 
ERM regulation of 
lymphocyte rolling on P-
selectin 
ND/No 
Ras 58 FERM domain of ezrin 
interacts with activated Ras 
Promotes Ras activity ND/No 
RhoGDI 17, 59, 60 FERM, details unknown ERM modulation of the RhoA 
signaling, general function 
unknown 
ND/No 
S100P 61, 62 FERM domain lobe F2 of 
ezrin, in a region that 
partially overlaps with 
PI(4,5)P2 binding site 
interacts with S100P  
Ezrin regulation of cell 
migration 
ND/No 
SAP97 63 Unknown Unknown ND/No 
SOS 58 FERM domain of ezrin 
interacts with the DH/PH 
domain of SOS 
Promotes SOS activity, and 
thus active Ras 
ND/No 
Syndecan-2 64, 65 Positive cluster in 
cytoplasmic tail interacts 
with acidic groove in FERM 
domain lobe F3 
Unknown Yes/Yes 
Vps11/HOPS 66 Coiled-coil domain of ezrin 
interacts with Vps11 
ERM regulation of 
endocytosis 
ND/No 
WWOX 67 Coiled-coil domain of ezrin 
harboring an NPxY motif 
interacts with WWOX when 
ezrin is phosphorylated on 
Y477 
Control of ERM-mediated 
secretion in gastric parietal 
cells 
ND/No 
WWP-1 68 Coiled-coil domain of ezrin 
harboring an NPxY motif 
ERM control of HGF-induced 
migration, requiring 
ND/No 
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interacts with WWP-1 when 
ezrin is phosphorylated on 
Y477 
ubiquitylation by WWP-1 
ZAP-70 69 Unknown Ezrin regulation of immune 
synapse formation 
ND/No 
β4 integrin 70 FERM domain of ezrin 
interacts with β4 integrin 
Regulation of β4 integrin level ND/No 
β-Dystroglycan 20, 71 Positive cluster in 
cytoplasmic tail interacts 
with acidic groove in FERM 
domain lobe F3 
ERM regulation of filopodia 
formation in C2C12 cells co-
transfected with active Cdc42 
Yes/Yes 
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photoreceptor 
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T567D 8 
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T567D-VSV-G 
overexpression 1, 2 
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Moesin 
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CHAPTER 2 
DEFINING THE ACTIVATION-DEPENDENT EZRIN INTERACTOME 
Numerous ERM binding partners have been identified (Table 1), but binding partners 
have never been identified systematically from epithelial cells. Experiments in which affinity 
matrices were pre-adsorbed with ezrin (“GST-pulldown-type” experiments) have concluded that 
CD44 (Hirao et al., 1996; Yonemura et al., 1998; Legg and Isacke, 1998; Mori et al., 2008) or 
EBP50 (Reczek et al., 1997; Reczek and Bretscher, 1998) are the tightest-binding interaction 
partners of the isolated ezrin FERM domain. However, these experiments overlook several key 
issues: 1) interactions of weaker affinity could proceed in cells if the local concentration of the 
binding partner is higher at sites of ezrin enrichment; 2) ERMs could interact with partners 
through motifs other than the FERM domain, and could interact with proteins in the dormant 
state rather than the open state; 3) the interactions could be transient. 
To address these issues, I used the method of cross-linking co-immunoprecipitation to 
capture tagged ezrin along with proteins in its proximity without the bias of interaction strength 
or longevity. Using mass spectrometry, I identified 19 ezrin interactors, some of which represent 
novel microvillar components. I also took advantage of the ezrin activation cycle to show that 
ERM-interaction partners respond differently to changes in ERM activation. 
MATERIALS AND METHODS 
Plasmid construction, cell-lines, and antibodies. Transient ezrin expression constructs were 
generated in pIRES2EGFP (Clontech) for bicistronic expression with EGFP. T567A and T567E 
mutations were generated by Julie Thoms in pENTR3C (Invitrogen) between EcoRI and XhoI. 
pIRES2EGFP was cut BamHI and appended by direct ligation with annealed primers 
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RV20F1/R1 (5’-TCGACCGGATCCGAATTCTCGCGGCCGCACTCGAG-3’ and 5’-
GATCCTCGAGTGCGGCCGCGAGAATTCGGATCCGG-3’) to generate 
pIRES2EGFP_ReMCS, introducing an EcoRI and XhoI site in MCS. pIRES2EGFP_ReMCS 
was then cut with EcoRI and XhoI, and ezrin mutants introduced from pENTR3C. All mutants 
were initially mutagenized to generate resistance to siEzrin2 using QuickChange mutagenesis 
(Agilent) and RV39F1/R1 (5'-
GCTCAGGACCTGGAAATGTATGGAATCAATTACTTTGAAATAAAAAACAAGAAAGG
AACAGACCTTTG-3' and 5'-
CAAAGGTCTGTTCCTTTCTTGTTTTTTATTTCAAAGTAATTGATTCCATACATTTCCAG
GTCCTGAGC-3'). Additional ezrin mutations were created in this backbone. 
An internal flag tag was introduced into pIRES2EGFP_ReMCS/Ezrin T567E by inverse 
tailored PCR using RV29F1/R1 (5’-
GACTACAAAGACGATGACGACAAGgagagcttgcaggatgagggc, 5’-gtacacgggtggtggtggaggc-
3’). The resulting vector was further reverted or mutated to 567T or 567A using RV30F1/R1 (5’-
Gccgggacaagtacaagacgctgcggcagatc-3’ and 5’-Gatctgccgcagcgtcttgtacttgtcccggc-3’) or 
RV30F2/R2 (5’-Gggacaagtacaaggccctgcggcagatccgg-3’ and 5’-
Ccggatctgccgcagggccttgtacttgtccc-3’), respectively. 
The K4N mutations (K253N, K254N, K262N, K263N; Barret et al., 2000) were 
generated using the QuickChange kit and primers RV71F1/R1 (5’- CCCATCGAC AAC AAC 
GCACCTGACTTTGTGTTTTATGCCCCAC-3’ and 5’- 
TTTAATGACAAAGTTATTGTCATTGAAAGAGATGTTCCTGATTTCACTCC-3’). 
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To generate stable cell-lines, ezrin mutants were amplified using primers RV33F1/R1 
(5’- TTCACT GCGGCCGC ATGCCGAAACCAATCAATGTCCGAGTTAC-3’ and 5’- 
ACGAAGAATTCTTACAGGGCCTCGAACTCGTCGATG-3’) and ligated into the NotI-
EcoRI of pQCXIP. These were then transiently transfected into Pheonix-Ampho packaging cells, 
and the resulting viral supernatant was used to infect log-phase Jeg-3 cell cultures, which were 
then selected in 2 μg/mL puromycin. 
Ezrin 1-478-Flag was generated using RV20F2/36R3 (5’- AGTGGTTCGA GAATTC 
ATGCCGAAACCAATCAATGTCCGAGTTAC-3’ and 5’-
GATCAACTCTCGAGTTACTTGTCATCGTCGTCCTTGTAGTCGTACACGGGTGGTGGT
GGAGGC-3’) and then cloning the resulting fragment into pIRES2EGFP or using 
RV33F1/38R1 (5’- TTCACT GCGGCCGC ATGCCGAAACCAATCAATGTCCGAGTTAC-3’ 
and 5’- ACGAAGAATTCTTACTTGTCGTCATCGTCTTTGTAGTCgtacac-3’) and cloning the 
resulting fragment into pQCXIP.  Ezrin 1-583-iFlag was generated using RV20F2/36R5 (5’- 
AGTGGTTCGA GAATTC ATGCCGAAACCAATCAATGTCCGAGTTAC-3’ and 5’- 
GATCAACTCTCGAGTTACTCGAACTCGTCGATGCGCTGC-3’) and then cloning the 
resulting fragment into pIRES2EGFP or using RV33F1/38R2 (5’- TTCACT GCGGCCGC 
ATGCCGAAACCAATCAATGTCCGAGTTAC-3’ and 5’-
ACGAAGAATTCTTACTCGAACTCGTCGATGCGCTGC-3’) and cloning the resulting 
fragment into pQCXIP. 
Ezrin-GFP was made by amplifying ezrin mutants using RV72F1/R1 (5’- 
TTCACTCTCGAGATGCCGAAACCAAT-3’ and 5’- 
ACGAAGAATTCcagggcctcgaactcgtcgatgc-3’) and ligating the resulting product into pEGFP-
N2 (Clontech) cut with XhoI/EcoRI. Ezrin-GFP and variants were then amplified using 
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RV33F1/53R1 (5’-5’- TTCACT GCGGCCGC 
ATGCCGAAACCAATCAATGTCCGAGTTAC-3’ and 5’- 
ACGAAGAATTCTTACTTGTACAGCTCGTCCATGCCGAG-3’), cut with NotI, and the 
products were inserted into pQCXIP cut with EcoRI, flushed with mung bean nuclease (New 
England Biolabs) to generate a blunt end, and cut with NotI. 
Full-length TROP-2 was amplified from Jeg-3 cDNA using RV56F2k/R2 (5’- GTTCGA 
GGATCC ATGGCTCGGGGCCCCGGC-3’ and 5’-
TCGAACGAATTCCAAGCTCGGTTCCTTTCTCAACTCCC-3’) and inserted into 
pcDNA3.1/MycHis (Invitrogen) or pcDNA3.1/V5His (Invitrogen) cut with BamHI/EcoRI. To 
engineer TROP-2 lacking an extracellular domain, TROP-2 was amplified using RV56F2k/R3 
(5’- GTTCGA GGATCC ATGGCTCGGGGCCCCGGC-3’ and 5’- 
TCGAACGAATTCGATCACCAGGACGGCCATGCCG -3’) and inserted into 
pcDNA3.1/V5His. 
The following primers were used to engineer basic patch mutations within 
pcDNA3.1/TROP-2-V5His: 
“ΔA”, R300A, 
R301A, K302A 
RV84F1/R1 5’- GGC CGT CCT 
GGT GAT CAC CAA 
CGC GGC AGC GTC 
GGG GAA GTA 
CAA GAA GGT G-3’ 
5'- CAC CTT CTT 
GTA CTT CCC CGA 
CGC TGC CGC GTT 
GGT GAT CAC CAG 
GAC GGC C-3' 
“ΔA6”, K305A, 
K307A 
RV84F2/R2 5'- CGT CCT GGT 
GAT CAC CAA CGC 
GGC AAA GTC 
GGG GAA GTA 
CAA G -3' 
5'- CTT GTA CTT 
CCC CGA CTT TGC 
CGC GTT GGT GAT 
CAC CAG GAC G-3' 
“ΔA1”, K300A RV84F3/R3 5'- CCT GGT GAT 
CAC CAA CGC 
GAG AAA GTC 
GGG GAA G-3' 
5'- CTT CCC CGA 
CTT TCT CGC GTT 
GGT GAT CAC CAG 
G-3' 
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“ΔBC”, K305A, 
K307A, K308A 
RV78F2/R2 5'-ACC AAC CGG 
AGA AAG TCG 
GGG GCG TAC 
GCG GCG GTG 
GAG ATC AAG 
GAA CTG GG-3' 
5'-CCC AGT TCC 
TTG ATC TCC ACC 
GCC GCG TAC GCC 
CCC GAC TTT CTC 
CGG TTG GT-3' 
 
For stable cell-lines expressing TROP-2-V5His, TROP-2 was amplified with 
RV56F2k/83R1 (5’- GTTCGA GGATCC ATGGCTCGGGGCCCCGGC-3’ and 5’-
ACGAACAATTGTCAATGGTGATGGTGATGATGACCGGTAC -3’), cut with BamHI/MfeI 
and inserted into pQCXIP cut with BamHI/EcoRI. This was then transiently transfected into 
Pheonix-Ampho packaging cells, and the resulting viral supernatant was used to infect log-phase 
Jeg-3 cell cultures, which were then selected in 2 μg/mL puromycin. 
To create GST-TROP-2-tail, residues 298-323 were amplified using RV50F1/R1 (5’- 
GTTCGA GGATCC ACCAACCGGAGAAAGTCGGGGAAG-3’ and 5’- 
CCACTGCGGCCGCCTACAAGCTCGGTTCCTTTCTCAACTCC-3’) and pasted into 
pGEX6P1 cut with BamHI/NotI. The following mutations were engineered in the tail using the 
following primers and the QuickChange kit: 
“ΔA”, R300A, 
R301A, K302A 
RV78F1/R1 5’- GGC CCC TGG 
GAT CCA CCA ACG 
CGG CAG CGT 
CGG GGA AGT 
ACA AGA AGG-3’ 
5'-CCT TCT TGT 
ACT TCC CCG ACG 
CTG CCG CGT TGG 
TGG ATC CCA GGG 
GCC-3' 
“ΔBC”, K305A, 
K307A, K308A 
RV78F2/R2 5'-ACC AAC CGG 
AGA AAG TCG 
GGG GCG TAC 
GCG GCG GTG 
GAG ATC AAG 
GAA CTG GG-3' 
5'-CCC AGT TCC 
TTG ATC TCC ACC 
GCC GCG TAC GCC 
CCC GAC TTT CTC 
CGG TTG GT-3' 
“ΔD”, K312A RV78F3/R3 5'-TAC AAG AAG 
GTG GAG ATC 
GCG GAA CTG 
GGG GAGT TGA G-
5'-CTC AAC TCC 
CCC AGT TCC GCG 
ATC TCC ACC TTC 
TTG TA-3' 
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3' 
S303D RV78F4/R4 5'-GAT CCA CCA 
ACC GGA GAA 
AGG ATG GGA 
AGT ACA AGA 
AGG TGG A-3' 
5'-TCC ACC TTC 
TTG TAC TTC CCA 
TCC TTT CTC CGG 
TTG GTG GAT C-3' 
R300A,R301A, from 
ΔA 
RV81F6/R6 5’-GGG ATC CAC 
CAA CGC GGC 
AAA GTC GGG 
GAA GTA C-3’ 
5’- GTA CTT CCC 
CGA CTT TGC CGC 
GTT GGT GGA 
TCC-3’ 
R301A,K302A, from 
ΔA 
RV81F7/R7 5’-ATC CAC CAA 
CCG GGC AGC GTC 
GGG GAA GTA 
CAA G-3’ 
5’- CTT GTA CTT 
CCC CGA CGC TGC 
CCG GTT GGT GGA 
T-3’ 
R300A,K302A, from 
ΔA 
RV81F8/R8 5’-GAT CCA CCA 
ACG CGA GAG 
CGT CGG GGA 
AGT ACA AGA-3’ 
5’- TCT TGT ACT 
TCC CCG ACG CTC 
TCG CGT TGG TGG 
ATC-3' 
R300A RV81F1/R1 5’- CTG GGA TCC 
ACC AAC GCG 
AGA AAG TCG 
GGG AA-3’ 
5’-TTC CCC GAC 
TTT CTC GCG TTG 
GTG GAT CCC AG-
3’ 
R301A RV81F2/R2 5’-GGG ATC CAC 
CAA CCG GGC 
AAA GTC GGG 
GAA GTA C-3’ 
5’-GTA CTT CCC 
CGA CTT TGC CCG 
GTT GGT GGA TCC 
C-3’ 
K302A RV81F3/R3 5’- GAT CCA CCA 
ACC GGA GAG 
CGT CGG GGA 
AGT ACA AGA-3’ 
5’- TCT TGT ACT 
TCC CCG ACG CTC 
TCC GGT TGG TGG 
ATC-3’ 
K300R,K301R,R302K RV81F4/R4 5’- GCC CCT GGG 
ATC CAC CAA CAA 
GAA AAG GTC 
GGG GAA GTA 
CAA GAA G-3’ 
5’- CTT CTT GTA 
CTT CCC CGA CCT 
TTT CTT GTT GGT 
GGA TCC CAG 
GGG C-3’ 
N299R,K300N RV81F5/R5 5’- CAG GGG CCC 
CTG GGA TCC ACC 
AGG AAT AGA 
AAG TCG GGG 
AAG TAC-3’ 
5’- GTA CTT CCC 
CGA CTT TCT ATT 
CCT GGT GGA TCC 
CAG GGG CCC 
CTG-3’ 
 
ATP11C was obtained from the ATCC, Clone ID 40146750, and amplified using primers 
RV48F1/R1 (5’- GTTCGA GGTACC A ATGCAGATGGTCCCATCTCTCCCTCC-3’ and 5’- 
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TCGAACCTCGAGTTACAATACATTAGATTCGTCTGAGAATGTTCGTAAAAGAAG-3’) 
and inserted into pFLAG-CMV7.1 (Sigma) cut with KpnI/XhoI which placed it in-frame of an 
N-terminal 3XFlag tag. Additional experiments verified that the tag had to be on the N-terminus 
to express any protein (data not shown). 
PACE-1-myc expression plasmid was a generous gift from Dr. Rick Thorne (University 
of Newcastle). 
ATB(0) was cloned from Jeg-3 cDNA using primers RV58F2k/R1 (5’- 
GTTCGAGAATTCACCATGGTGGCCGATCCTCCTCGAGAC-3’ and 5’- 
TCGAACGCGGCCGCTTCATGACTGATTCCTTCTCAGAGGCGACC-3’). 
BASP-1 was cloned from Jeg-3 cDNA using primers RV66F1/R1 (5’- GTTCGA 
GGATCC ACC ATGGGAGGCAAGCTCAGCAAGAAGAAG-3’ and 5’-
TCGAACGAATTCCTCTTTCACGGTTACGGTTTGGTCGG-3’) and inserted into 
pcDNA3.1/MycHis to generate BASP-1-MycHis or pEGFP-N2 to generate BASP-1-EGFP. 
BASP-1-EGFP was further mutated using the following primers in tailored inverse PCR: 
“ΔEDA”, K7-
10AAAA 
RV68F2/R1 5’-GCG GCG GCT 
GCC GGC TAC AAT 
GTG AAC GAC 
GAG AAA GCC-3’ 
 
5’- GGC TAC AAT 
GTG AAC GAC 
GAG AAA GCC-3’ 
“ΔED” RV68F3/R1 5’-GGC TAC AAT 
GTG AAC GAC 
GAG AAA GCC 
 -3’ 
 
5’- GGC TAC AAT 
GTG AAC GAC 
GAG AAA GCC-3’ 
G2A RV68F1/R2 5’ GGC TAC AAT 
GTG AAC GAC 
GAG AAA GCC-3’ 
5’- GCT GAG CTT 
GCC TGC CAT GGT 
AGA TCT GAG TCC 
GG-3’ 
ΔED, G2A RV68F3/R2 5’-GGC TAC AAT 5’- GCT GAG CTT 
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GTG AAC GAC 
GAG AAA GCC 
 -3’ 
GCC TGC CAT GGT 
AGA TCT GAG TCC 
GG-3’ 
 
SiRNA sequences for Ezrin (5’-GGAAUCAACUAUUUCGAGAtt-3’), BASP-1 (5’- 
CAACAGUAAUAAAGUUAAAtt-3’ and 5’- GAUUUCUCAUGACGAGUUAtt-3’), and 
ATP11C (5’-CCCAAUAACUCUGUCGAUAtt-3’) were from Ambion. Dicer substrate dsRNAs 
for TROP-2 knockdown were 5’-GCUUAAAUGAGUUUAGAUGGGAAAT-3’ and 5’-
AGUUGAGAAAGGAACCGAGCUUGTA-3’ from Integrated DNA Technologies. 
For SILAC, cells expressing ezrin-iFlag  or empty vector were grown for at least 2 weeks 
in MEM (Pierce) containing dialyzed FBS (Invitrogen) and either C-13 arginine and lysine or C-
12 arginine and lysine (Sigma), respectively. 
TROP-2 antibody was mouse monoclonal GA733.1 (Abcam) or a rabbit polyclonal 
antibody (Santa Cruz). Flag M2 antibody and affinity gel were from Sigma. Myc antibody was 
mouse monoclonal 9E10 (Roche). GFP antibody was from Santa Cruz. V5 antibody was mouse 
monoclonal V5.11 (Invitrogen).  
Immunoprecipitations and mass spectrometry. Prior to lysis, cells were treated with warm PBS 
containing 1.25 mM DSP (Pierce), a cell permeable, thiol-reversible crosslinking agent, for 2 
minutes at 37ᴼC. Excess crosslinker was quenched by extensive washing in TBS for 15 minutes 
at room temperature. Cells were then solubilized in cold IP buffer (25 mM Tris pH 7.4, 5% 
glycerol, 150 mM NaCl, 50 mM NaF, 0.1 mM Na3VO4, 10 mM βGP, 8.7 mg/mL pNPP, 0.5% 
Triton X-100, 0.1 μM calyculin A, Roche protease inhibitor tablet) and immunoprecipitated for 2 
hours using Flag M2 Affinity Gel (Sigma). For western blots, immunoprecipitates were 
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extensively washed in IP wash buffer (25 mM Tris pH 7.4, 5% glycerol, 150 mM NaCl, 50 mM 
NaF, 0.2% Triton X-100) and then eluted in 200 μg/mL 3XFlag peptide, and then denatured in 
Laemmli buffer, resolved by SDS-PAGE, transferred to PVDF and then interrogated with 
specific antibodies. 
For mass spectrometry, immunoprecipitates were eluted in 50 mM Tris pH 8.0 containing 
1% SDS, trypsin-digested, desalted, dried, and reconstituted in 80% acetonitrile and 1% formic 
acid, and fractionated by hydrophilic interaction chromatography. Fractions were dried, 
reconstituted in 0.1% trifluoroacetic acid, and analyzed by LC-MS/MS using an Orbitrap XL 
mass spectrometer (Thermo). Database search and quantitation of heavy/light peptide isotope 
ratios were performed as previously described (Smolka et al., 2007) with the following 
modification: interacting proteins were limited to those for which at least 2 peptides were 
discovered with a Sorcerer probability score of greater than 90% and a heavy-vs.-light 
enrichment greater than 3.0. 
Immunofluorescence and image analysis. Cells grown on glass coverslips were fixed in 3.7% 
formalin/PBS for 15 minutes at room temperature for most experiments Cells were then washed 
with PBS and blocked with IF buffer (PBS + 0.5% BSA + 0.5% goat serum + 0.1% Triton-X 
100) for 10 minutes. Primary and secondary antibodies were then applied in IF buffer containing 
1% FBS. Alexa-fluor conjugated phalloidin (Invitrogen), to stain F-actin, was added to the 
secondary as required. The cells were mounted in Vectashield reagent, imaged using a CSU-X 
spinning disk microscope (Intelligent Imaging Innovations) with spherical aberration correction 
device, 63x 1.4 NA objective on an inverted microscope (Leica), acquired with either a 
QuantEM EMCCD camera or an HQ2 CCD camera (Photometrics) using Slidebook software 
(Intelligent Imaging Innovations). Maximum or summed intensity projections were assembled in 
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Slidebook and exported to Adobe Illustrator software. For clarity, side projections were 
vertically expanded 5-fold using Illustrator.  
Plasmid and siRNA transfection. All transient plasmid DNA transfections were performed for 
~18 hours using Polyethylenimine reagent (PolyPlus) using a previously established protocol 
(Hanono et al., 2006). Phoenix-Ampho retrovirus producer cells (ATCC) were cultured in 
DMEM (Invitrogen) with 10% FBS. Retroviruses were prepared following a standard 
transfection protocol using the Phoenix-Ampho cell-line and the retroviral vector pQCXIP. The 
recombinant retroviruses were used to transduce Jeg-3 cells, which were then selected with 2.0 
μg/ml puromycin (Sigma). All siRNAs were transfected at 30 nM into ~25% confluent cultures 
of Jeg-3 cells using Lipofectamine RNAiMAX (Invitrogen) using the manufacturer’s protocol.  
Cells were processed for immunofluorescence or lysis 3 days after transfection. 
The presence or absence of microvilli was scored as described previously (Hanono et al., 
2006; LaLonde et al., 2010; Garbett et al., 2010). 
Ezrin FERM domain was produced and purified in vitro according to Reczek et al., 1997. 
PI(4,5)P2 (Avanti) micelles were prepared and added to interaction assays at either 25 or 50 
μg/mL according to Hirao et al., 1996. 
RESULTS 
Tagged ezrin binds to EBP50 in a cross-linker and activation-dependent manner 
In order to examine the localization and interaction partners of ezrin mutants, it was 
necessary to tag them. Functional studies that have tagged both the N-terminus and C-terminus 
of ERMs have generally concluded that N-terminal tags are function-disrupting due to favoring a 
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more closed conformation whereas C-terminal tags are function-preserving, although there have 
been some exceptions (Figure 2). The recent crystal structure of full-length ERM (Li et al., 2007) 
as well as biochemical experiments (Chambers and Bretscher, 2005) have hinted that the extreme 
C-terminus participates in important contacts in the closed ERM. To avoid disrupting either 
terminus by tag addition, I introduced a flag tag (DYKDDDK) into a disordered loop in the ERM 
crystal structure (Li et al., 2007) which is poorly conserved amongst ERM family members 
(Figure 2.1.A). Activation mutants were then introduced into this construct, which was cloned 
into an internal-ribosome-entry-site-puromyicin-resistance vector which allows stable batch 
selection of Jeg-3 choriocarcinoma cells. Following selection in 2 μg/mL puromycin beyond two 
weeks, the level of transfected ezrin-iFlag per population was less than or equal to the level of 
endogenous ezrin (Figure 2.1.B), and 85-90% of cells in the population expressed ezrin-iFlag 
regardless of mutation (data not shown). Interestingly, the expression level of activated mutants 
was always less than that of deactivated mutants (data not shown). Furthermore, microvilli 
(quantified in Figure 3.3.B) and the localization of EBP50 (data not shown) were unaltered in the 
stable cell-lines. 
To determine whether in vivo EBP50 interaction was dependent on conformation 
switching as it is in vitro (Reczek and Bretscher, 1998), I immunoprecipitated EBP50 in the 
stable cell-lines and revealed bound ezrin-iFlag. Chemical cross-linker DSP was used to preserve 
the otherwise transient interaction between ezrin and EBP50 (Figure 2.1.C). DSP-assisted 
immunoprecipitation experiments demonstrated a minor but reproducible increase in the amount 
of EBP50 that bound to wild-type ezrin relative to T567A ezrin (Figure 2.1.D), consistent with a 
role for activation in regulating this interaction in cells. Unexpectedly, there was no increase in 
EBP50-binding to T567E ezrin, but an alternative constitutively open form, 1-583, bound vastly 
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Figure 2.1 Creation of stable cell-lines expressing internally-flag tagged ezrin and interaction 
with EBP50. 
(A) Multiple sequence alignment of the region between the ERM coiled-coiled domain and the 
C-ERMAD (residues 467-503 in ezrin) from various ERMs highlighting the disordered region in 
the SfMoesin structure (italics) and the substitution made to introduce an internal flag tag into 
HsEzrin (red). (B) Anti-flag and anti-ezrin two-color fluorescent Western blot showing the stable 
incorporation of internally flag-tagged ezrin (which runs faster than untagged ezrin) and 
phosphomutants in Jeg-3 cells. (C) EBP50 immunoprecipitates from cells treated or untreated 
with DSP as indicated, Western blotted with anti-Flag. (D) EBP50 immunoprecipitates from 
stable cell-lines expressing indicated ezrin-iFlag protein and treated with DSP, Western blotted 
with anti-Flag. 
56
Radixin Flag F-actin
ez
rin
-iF
la
g
ez
rin
-T
56
7A
-iF
la
g
ez
rin
-T
56
7E
-iF
la
g
ez
rin
-1
-5
83
-iF
la
g
Free GFP Flag Radixin
ez
rin
-iF
la
g
ez
rin
-K
4N
-iF
la
g
A B
Figure 2.2 Ezrin-iFlag localization in microvilli is dependent on phosphocycling, conformation 
switching, and lipid interaction . 
(A) Three-color, confocal immunofluorescent detection of radixin, flag, and F-actin (phalloidin) 
in stable cell-lines expressing indicated ezrin-iFlag protein shown en face (upper panels) and as a 
projection of Z-stacks through a vertical cross-section, stretched 5-fold (lower panels). (B) 
Transient transfection of wild-type ezrin-iFlag or K4N mutant (K253N,K254N,K262N,K263N) 
expressed in internal-ribosome-entry vectors, allowing bicistronic expression of free GFP as a 
reporter of the transfection level. 
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more. The difference between T567E and 1-583 can be accounted for by considering the 
difference in openness between these two mutants, as Chambers and Bretscher measured in 
similar mutants (Chambers and Bretscher, 2005). 
I next examined the localization of the ezrin-iFlag constructs in the stable cell-lines 
(Figure 2.2). Ezrin and radixin have identical localizations in Jeg-3 cell microvilli (D. Chambers, 
unpublished). Wild-type ezrin-iFlag localized just like endogenous radixin in microvilli, whereas 
the T567A mutant was predominantly cytoplasmic (Figure 2.2.A). Interestingly, the amount of 
staining was also reduced, suggesting that the protein was partially extracted during the 
immunofluorescence procedure. Both the T567E mutant and the 1-583 mutant were distributed 
evenly along the membrane rather than being concentrated in microvilli (Figure 2.2.A), 
suggesting that conformation switching is important for accumulation of ezrin in apical 
microvilli, which is explored further in chapter 3. Importantly, taken together with the EBP50 IP 
results (Figure 2.1.D) and the fact that 1-583 is more open that T567E (Chambers and Bretscher, 
2005), these data suggest that DSP-assisted immunoprecipitations integrate binding affinity and 
localization: whereas wild-type ezrin co-localizes with EBP50 very well, only a portion (the 
activated form) binds tightly; whereas T567E ezrin binds tightly to EBP50, only a portion of it 
co-localizes with EBP50; 1-583 localizes as poorly with EBP50, but binds it extremely tightly 
whenever it comes in contact with it. 
Activation of ezrin by phosphorylation has been suggested to be preceded by PIP2 
binding both in vitro (Pietromonaco et al., 1998; Hirao et al., 1996) and in vivo (Fievet et al., 
2004). Therefore, I also examined the effect of mutations that block PIP2-binding. The so-called 
K4N (K253N, K254N, K262N, K263N) mutant, which has reduced binding to PI(4,5)P2 in vitro 
(Barret et al., 2000) also failed to localize to microvilli in Jeg-3 cells (Figure 2.2.B). 
58
A.
Ezrin-iFlag/Control # Peptides
Candidates
FHOD-1 18.9 13
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Figure 2.3 The ezrin interactome as identified by SILAC-mass spectometry 
(A) Graphical outline of the stable-isotope labeling of amino acids in cell culture (SILAC) 
procedure as applied to identifying the ezrin interactome. Peptides are labeled by feeding C-13- 
(heavy) or C-12- (light) -containing amino acids (1), the DSP-assisted immunoprecipitation is 
performed from cells stably expressing ezrin-iFlag or control cells (2), the immunoprecipitates 
are combined (3), and fractionated using hydrophobic interaction liquid chromatography (4). 
Proteins are then proteolyzed and subjected to mass spectrometry, where the sequence and 
heavy/light ratio is determined. Proteins bound to ezrin will have high ratios, whereas bead-
binding background proteins will have ratios close to 1. (B) Fractions from the 
immunoprecipitations resolved by SDS-PAGE. (C) A list of candidate interactors (those for 
which two peptides were found with an average enrichment greater than 3.0) and selected bead-
binding background (those for which at least 40 peptides were found with an average enrichment 
less than 3.0) highlighting known ERM interactors (red asterisks). 
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Identification of 19 proteins bound to ezrin-iFlag 
In order to determine whether the interaction of other proteins with ezrin also depended 
upon conformational and phosphorylation status, I compared ezrin-iFlag mutant 
immunoprecipitates. To begin these studies, it was necessary to first determine the interactome 
of wild-type ezrin-iFlag in Jeg-3 cells. To do this, I used the SILAC procedure (Ong et al., 2002). 
Briefly, two populations of cells were shifted into medium containing heavy (C-13) or light (C-
12) arginine and lysine. One population was stably transfected with an empty vector, whereas the 
other expressed ezrin-iFlag. Both populations were subjected to parallel DSP-assisted 
immunoprecipitations, which recovers bead-binding background proteins in both populations, 
but also ezrin-iFlag-binding proteins in one population. The immunoprecipitates are combined 
and trypsin-digested. The tryptic fragments are subjected to hydrophobic interaction liquid 
chromatography, an orthogonal separation technique, and fractionated to reduce complexity. 
Each fraction is then analyzed by an Orbitrap mass spectrometer (Figure 2.3.A), which 
determines the ratio of heavy to light peptides and then determines the sequence of the peptide. 
Prior to trypsin-digestion, a small aliquot of the sample was resolved by SDS-PAGE (Figure 
2.3.B). This revealed a host of proteins bound to ezrin-iFlag, whereas no single binding partner 
approached ezrin-iFlag abundance (Figure 2.3.B) This suggests that the vast majority of ezrin is 
unbound to any specific ligand in cells (Figure 2.3.B). 
A list of proteins for which greater than two peptides with a mean enrichment greater 
than 3.0 is presented in Figure 2.3.C. Besides EBP50, other candidates have been previously 
identified as ERM-binding proteins (Figure 2.3.C, red asterisks), validating the results. These 
included proteins interacting with the ezrin FERM domain such as radixin, syndecan-2 (Granes 
et al., 2000; Granes et al., 2003), β-dystroglycan (Spence et al., 2004; Batchelor et al., 2007), as 
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C.
CLIC-4
Class I - EBP50
EBP50 3.2 1.2 46.9 152
WT/T567A T567E/WT 1-583/WT # of peptides
Class III - CLIC-4-like
CLIC-3 2.3 1.5 0.9 108
CLIC-4 1.9 1.2 1.3 29
Class IV - FHOD-1-like
FHOD-1 1.3 0.4 0.1 231
RasGAP-1 1.2 0.4 0.1 44
PACE-1 1.2 0.4 0.2 39
Inadequate data
BASP-1 2.7 1.5 ND 21
WT/T567A T567E/WT 1-583/WT
Class II - β-Dystroglycan-like
Radixin (Unique) 2.0 1.2 2.7 460
LOK 2.2 1.3 2.4 85
β-Dystroglycan 4.4 1.9 4.7 76
β1-Integrin 1.4 1.6 2.6 68
SLK 2.0 1.5 5.5 60
ATB(0) 2.4 1.2 2.7 58
ATP11C 3.8 2.4 6.8 57
JAM-A 1.8 1.7 4.0 54
TROP-2 3.3 1.2 2.6 39
EGF-R 1.4 1.1 2.6 39
Syndecan-2 2.4 1.5 1.7 21
Claudin-6 1.6 1.4 2.5 13
# of peptides
Selected Background
Fatty acid synthase 1.0 0.7 0.6 856
IQGAP 1.0 1.2 1.0 745
GRP78 1.0 1.2 1.3 515
Dynein-1 H. C. 1.0 0.8 0.5 486
α-Enolase 1.0 0.9 0.5 408
52 kDa Ro Protein 1.3 1.2 1.1 347
p97 VCP 0.9 1.3 0.7 284
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T567E / WT
Pearson r = 0.74
Pearson r = 0.86
D. Pearson r p-value Significant?
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Background 0.31 0.68 No
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WT/T567A T567E/WT 1-583/WT # of peptides
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*
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Figure 2.4 The candidate ezrin interactors respond in four different ways to manipulations of 
ezrin conformation. 
(A) Result of SILAC experiment comparing wild-type ezrin-iFlag (Figure 2.3) to each indicated 
conformation mutant showing which population was labeled heavy (blue) or light (pink). Plots 
enrichment of each candidate ezrin interactor or selected bead-binding background protein in 
Figure 2.3.C on the heavy vs. light ezrin-iFlag protein highlighting a representative of each 
interactor class. Red line indicates mean enrichment of all proteins plotted. Class I (green): 
prefers wild-type to T567A, no preference for T567E, and an enormous preference for 1-583 
(note: Y-axis cut); Class II (magenta): prefers wild-type to T567A, mild preference for T567E, 
and a slightly greater preference for 1-583; Class III (purple): prefers wild-type to T567A, no 
preference for T567E, no preference for 1-583; Class IV (orange): no preference for wild-type 
vs. T567A, prefers wild-type  over T567E, prefers wild-type over 1-583. (B) Plot of each 
biological replicate for given SILAC experiment against the other, showing that the enrichment 
statistics are reproducible. (C) List of proteins contained in each class highlighting known 
interactors (red asterisks). (D) Pearson correlation between WT vs. T567A and T567E vs. WT 
for Class II and bead-binding background proteins. 
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well as proteins interacting with C-terminus of ezrin, including chloride ion chanel-3 and -4 
(CLIC-3 and -4; Berryman and Bretscher, 2000) and Protein Associated with the C-terminus of 
Ezrin (PACE-1; Sullivan et al., 2003). Representative bead-binding background proteins were 
also selected as controls in future analyses (Figure 2.3.C, lower section). I did not obtain the very 
first ERM-binding protein ever identified, CD44, as it is not expressed in these cells (data not 
shown). I also failed to identify many of the known mammalian ERM interaction partners 
(Figure 2.3.C; Table 1.1), but I have not explored the reason in any other case. 
Interactors respond differently to changes in ezrin activation 
To determine how ezrin conformation affects its interactome, I performed SILAC 
comparisons of DSP-assisted immunoprecipitates from wild-type ezrin-iFlag (‘WT’) relative to 
either ezrin-T567A-iFlag (‘T567A’), ezrin-T567E-iFlag (‘T567E’), or ezrin-1-583-iFlag (‘1-
583’). The results are presented in Figure 2.4. Two biological replicates of WT vs. T567A and 
T567E vs. WT were performed, and a moderately high Pearson’s correlation suggests that the 
enrichment statistics of the binding partners are reasonably reproducible (Figure 2.4.B), but more 
importantly, the same proteins were found in both sets with almost no deviations. I found that the 
ezrin interaction partners fell into four classes (I-IV). Class I was EBP50, which reacted to the 
ezrin changes uniquely. EBP50-binding was decreased by ezrin T567A mutation, unmoved by 
T567E mutation, and dramatically increased by 1-583 mutation. I propose that these changes are 
an integration of binding and co-localization between ezrin-iFlag and EBP50, the latter only 
present on the plasma membrane in microvilli, regardless of ezrin location (data not shown). 
Binding to Class II partners (the predominant and expected class) was also decreased by T567A 
mutation, but moderately increased by either T567E mutation or 1-583 truncation. Interestingly, 
there was a statistically significant correlation between the decrease in affinity for T567A and the 
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Figure 2.5 Confirmation of selected interactions by DSP-crosslinking immunoprecipitation and 
Western blot. 
(A,B) Crosslinking flag immunoprecipitates from stable cells expressing the indicated ezrin-
iFlag protein were Western blotted for indicated protein with indicated class designation (Figure 
2.4). 
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increase in affinity for T567E (Figure 2.4.C). Thus binding to these ligands may be largely based 
on ezrin conformation, but their weak affinity for open ezrin may preclude spectacular binding as 
is seen with EBP50. Binding to Class III partners (the CLICs) was also decreased by T567A 
mutation, but it was unchanged in both hyperactivated mutants. Ezrin interaction with these 
proteins may be limited by another mechanism besides conformation switching, such as binding 
to a second ligand or membrane translocation. Finally, binding to Class IV partners (the formin 
FHOD-1, PACE-1, and RasGAP-1) was largely unchanged by T567A mutation and decreased in 
hyperactivated mutants. Thus conformation is perceived differently for different ligands. 
Along with Jessica Wayt, I confirmed the results of the mass spectrometry experiments 
by manual immunoprecipitation and western blotting using available antibodies. As predicted 
EBP50, β-dystroglycan, and LOK preferred more open forms of ezrin, whereas FHOD-1 
preferred more closed forms of ezrin (Figure 2.5). 
Some novel Class II interactors localize in microvilli 
I next examined the localization of several candidates. Given that they consistently bind 
more activated ezrin, Class I and Class II interactors should be components of microvilli. 
Consistently, EBP50  (Reczek et al., 1997) and β-dystroglycan (Spence et al., 2004) are highly 
enriched in microvilli. Although we did not verify the localization of Syndecan-2 and β-1 
integrin, each (Granes et al., 2000; Garbi et al., 1996) has been shown to be a component of 
filopodia in fibroblastic cell-lines. Next, I focused on the novel candidates. These were expressed 
as affinity tag-fusions and localized in Jeg-3 cells. TROP-2 strongly localizes in microvilli, and 
ATP11C, ATB(0), and BASP-1 were distributed throughout the plasma membrane, although 
they demonstrated an apical bias (Figure 2.6). CLIC-4 and a related family member CLIC-5 were 
66
TROP-2-Myc F-actin EzrinA.
3XFlag-ATP11C F-actin EzrinB.
C.
D.
ATB(0)-GFP F-actin Ezrin
BASP-1-GFP F-actin Ezrin
Tg tmTg Tg
1 323
1 1129
P4 ATPase, phospholipid
1 553
Na+ dicarboxylate sympoter
1 197
EDMy
r
TROP-2
ATP11C
ATB(0)
BASP-1
67
  
 
 
 
 
 
 
 
 
 
Figure 2.6 Microvillus localization of selected novel candidates. 
(A,B) Three-color, confocal immunofluorescent detection of TROP2-myc (A) or 3XFlag-
ATP11C (B) along with F-actin (phalloidin) and ezrin following transient transfection of Jeg-3 
cultures en face (upper panels) or as a projection of Z-stacks through a vertical cross-section, 
stretched 5-fold (lower panels).  (C,D) Three-color, confocal immunofluorescent detection of 
ATB(0)-GFP (C) or BASP1-GFP (D) along with F-actin (phalloidin) and ezrin following stable 
transfection and selection of Jeg-3 cultures. Schematics of the proteins are provided at right. Tg, 
Thyroglobulin repeat; ED, Basic Effector Domain. 
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Figure 2.7 BASP-1 is marginally required for microvilli and localizes to the microvilli through 
its basic effector domain which may interact with negatively-charged plasma membrane 
phospholipids. 
(A) Ezrin-iFlag or an empty vector were co-transfected with BASP-1-GFP expression plasmid 
into Jeg-3 cells, and ezrin-iFlag immunoprecipitated with or without DSP cross-linking. The 
results show very marginal, DSP-independent co-precipitation of BASP1-GFP. (B) Cells were 
transfected with the indicated siRNAs for 3 days, then fixed and stained for ezrin, and the 
percentage of cells with microvilli scored. Ezrin depletion causes the loss of ~40% of microvilli-
baring cells, while two siRNAs targeting BASP1 but not control cause a very mild loss  of ~20% 
of microvilli-baring cells. Non-targetting GL2 luciferase siRNA (‘siGL2’) or an siRNA against 
ATP11C had no effect. (C) Immobilized, CNBr-coupled ezrin FERM domain was incubated 
with Jeg-3 cell extract transfected with BASP1-GFP expression plasmid where indicated in the 
presence or absence of PI(4,5)P2 micelles. The results suggest that PIP2 can bridge an interaction 
between ezrin and BASP1-GFP in vitro. (D) BASP1-GFP or mutants were transfected and 
localized relative to ezrin staining in Jeg-3 cells. Deletion or mutation of the basic effector 
domain of BASP1 prevents localization to microvilli and the plasma membrane. (E) A small 
region of the apical domain of a BASP1-GFP-expressing, ezrin-stained cell was blown up to 
reveal that BASP1-GFP can be seen in a number of apical membrane structures devoid of ezrin 
staining. 
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both shown to be components of microvilli, correlating with their activation-dependent 
interaction with ezrin (Berryman and Bretscher, 2000; Chuang et al., 2010). By contrast, the two 
examined Class IV members, PACE-1 and FHOD-1, were not found in microvilli: PACE-1 
accumulates on Golgi membranes and in the cytoplasm (Sullivan et al., 2003), while FHOD-1 is 
predominantly cytoplasmic (Jessica Wayt, personal communication). Thus the dependence of an 
interactor on ezrin conformational openness appears to be a clear predictor of its localization in 
microvilli. 
Investigations of BASP-1 in Jeg-3 cells 
In order to investigate the role of the novel interactions, I more closely examined BASP-1 
(brain acid-soluble protein-1) and TROP-2 (trophoblast antigen-2). BASP-1 interacted very 
weakly with ezrin-iFlag, but the interaction did not depend upon DSP cross-linking (Figure 
2.7.A). Two siRNAs against BASP-1 were found to cause mild loss of microvilli compared to 
ezrin depletion (Figure 2.7.B), suggesting that BASP-1 is necessary for ezrin accumulation in 
microvilli. In vitro (Zakharov and Mosevitsky, 2010; Takaichi et al., 2012) and in vivo (Takaichi 
et al., 2012; Toska et al., 2012) analysis of BASP-1 and its homology to MARCKS and GAP43 
(Mosevitsky et al., 1997) suggest that it binds to and regulates PI(4,5)P2 levels or clustering in 
cells through a group of basic residues in the extreme N-terminus called a “basic effector 
domain” or “ED” (see diagram in Figure 2.6). To test whether PI(4,5)P2 was necessary for the 
interaction between BASP-1 and ezrin, bacterially-expressed FERM domain was purified, 
coupled to resin by CNBr crosslinking, and added to cell extract containing BASP-1-GFP. I 
found that the FERM domain could pull down BASP-1-GFP only if it was mixed with micellar 
PI(4,5)P2 in the method of Tsukita and colleagues (Hirao et al., 1996; Figure 2.7.C), suggesting 
that the interaction is dependent upon high levels of PI(4,5)P2. Others have determined that the 
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Figure 2.8 Immobilized TROP-2 binds to ezrin in cell lysate prepared in low-ionic strength 
buffers 
(A) Alignment of the TROP-2 and TROP-1 cytoplasmic tails. (B) Glutathione resin containing 
GST-fused TROP-2 but not TROP-1 cytoplasmic tail retrieves ezrin from a complex lysate 
prepared in 40 mM salt buffer, similarly to the positive control CD44 cytoplasmic tail. (C) The 
GST-fused TROP-2 and CD44 tails but not GST alone selectively retrieve more 
conformationally open forms of ezrin from a cell lysate prepared in 40 mM salt buffer. (D) 
Sequence alignment of TROP-2 tail highlighting three basic segments (A, B, C) and two mutants 
which remove selected patches by alanine mutagenesis as indicated. (E) Glutathione resin 
containing GST-fused TROP-2 but not TROP-2 basic patch mutants retrieves ezrin from a 
complex lysate prepared in 40 mM salt, whereas other such as actin are left behind. 
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ED is needed for the interaction with PI(4,5)P2 (Takaichi et al., 2012; Toska et al., 2012). 
Consistently, the ED was necessary for BASP-1’s localization to the plasma membrane and 
microvilli, as deleting or neutralizing it greatly diminished its plasma-membrane and microvilli 
enrichment (Figure 2.7.D). BASP-1-GFP also marked regions of the plasma membrane that were 
not (yet) positive for ezrin following fixation and immunostaining, suggesting that BASP-1 can 
translocate to the plasma membrane independently of ezrin. 
Investigations of the TROP-2-ezrin interaction in vitro 
I also examined the Class II interactor TROP-2, a transmembrane protein highly 
expressed in normal trophoblasts as well as in gastrointestinal and pancreatic cancers, where its 
upregulation may be necessary for cancer progression (Basak et al., 1998; Fornaro et al., 1995; 
Wang et al., 2008; Schon and Orfanos, 1995; Guerra et al., 2012; Trerotola et al., 2012; Wang et 
al., 2011). I began by attempting GST-pulldowns according to Legg and Isacke to see whether 
GST-fusions of the short TROP-2 intracellular tail can precipitate ezrin from a lysate prepared in 
low (40 mM) salt as has been shown for that of CD44 (Legg and Isacke, 1998). Both GST-
TROP-2 tail and control tail GST-CD44 could precipitate endogenous ezrin whereas GST alone 
could not (Figure 2.8.A). Furthermore, when ezrin-iFlag mutants were transfected into Jeg-3 
cells, both GST-TROP-2 and GST-CD44 displayed a preference for binding to only the activated 
forms of ezrin-iFlag from low-salt extracts (Figure 2.8.A). Ezrin binding in these assays has been 
proposed to proceed through ezrin recognition of juxtamembrane basic patches within the 
intracellular tails (Yonemura et al., 1998; Legg and Isacke, 1998; Serrador et al., 2002; Hamada 
et al., 2000). The sequence of the predicted cytoplasmic tail of TROP-2 contains three such 
patches of basic residues (A, B, C; Figure 2.8.B). Mutating patch A, or B and C in combination 
to alanine, effectively neutralizing the charge, prevents the interaction with ezrin (Figure 2.8.C). 
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Figure 2.9 Immobilized TROP-2 strongly interacts with the FERM domain of ezrin in vitro in 
physiological buffer, but there are additional determinants for the interaction in vivo. 
(A) Glutathione resin containing GST-fused TROP-2 but not TROP-2 basic patch mutants 
retrieves ezrin FERM in physiological salt buffer. (B) GST-fused TROP-2 but not TROP-2 basic 
patch mutants retrieves full-length ezrin in physiological buffer only when soluble PI(4,5)P2  is 
added to the solution, similarly to the positive control CD44 cytoplasmic tail. (C) Ezrin FERM 
was depleted from solution by addition of varying concentrations of immobilized GST-TROP-2 
or GST-CD44 cytoplasmic tails, and the flow-through analyzed by Western blot. (D) The percent 
of starting FERM domain bound to the resin was calculated and plotted, and the resulting curve 
used to determine the Kd. (E) Indicated, immobilized, GST-fused cytoplasmic tail was mixed 
with FERM domain mutants baring indicated mutations and the flow-through analyzed by 
Western blot. (E) Indicated TROP-2 mutants in the context of full-length TROP-2-V5 were 
transiently transfected in cells along with indicated ezrin-iFlag mutant. Mutations in TROP-2 
that block the interaction with the FERM domain in vitro (panels A, B, E) and ezrin in lysate 
binding experiments (Figure 2.7.D,E) fail to disrupt the interaction in vivo. 
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Interestingly, while GST-pulldown-type interactions with either TROP-2 or CD44 were 
exquisitely salt-sensitive (disappearing entirely in 75 mM salt), in vitro binary interactions in the 
absence of lysate was more tolerant of buffers containing salt concentrations (up to 175 mM; 
data not shown). This may have been because the presence of some factor in cell lysate affects 
charge-screening. Nonetheless, it allowed me to more stringently analyze the interaction entirely 
in vitro. I used the physiological salt buffer system of Denker and Barber to test binding of GST-
tagged tails to the untagged FERM domain of ezrin in vitro (Denker et al., 2000; Denker and 
Barber, 2002). Similar to the GST-pulldown experiment, GST-TROP-2 tail bound to the FERM 
domain only when the basic patches were present (Figure 2.9.A). Full-length ezrin is 
autoinhibited in vitro, but this inhibition can be released by addition of PI(4,5)P2 micelles, which 
then allows binding of the FERM domain to transmembrane tails (Hirao et al., 1996). I used this 
system to test whether basic patch interaction with the FERM domain was entirely sufficient to 
explain ezrin interaction with TROP-2. Even full-length ezrin activated by PI(4,5)P2 micelles 
failed to interact with TROP-2 lacking the basic patches, thus confirming that the interaction 
between TROP-2 and ezrin proceeds through the juxtamembrane basic patches (Figure 2.9.B). 
To explore this interaction further, I measured the Kd by varying the concentration of 
GST-fusion protein and measuring the amount of ezrin depleted from the flow-through. These 
experiments determined that the Kd was around 1 μM for both TROP-2 and CD44 tails (Figure 
2.9). By crystalizing radixin bound to CD44 tail, the interaction was thought to proceed by the 
cytoplasmic tail lying in a groove created by an α-helix and a β-strand in the third subdomain of 
the clover-shaped FERM domain (Mori et al., 2008), but surprisingly, mutation of several of 
these residues to remove hydrogen bond coordination (H288A), hydrophobic interaction 
(L248A, D250A, F252A), or to create charged protrusions into the groove (L281R, M285R), all 
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Figure 2.10 Endogenous TROP-2 is an important component of Jeg-3 microvilli and promotes 
dorsal F-actin-containing protrusion formation when overexpressed in COS7 cells. 
(A) Three-color, confocal immunofluorescent detection of endogenous TROP-2 (GA733.1 
monoclonal antibody), F-actin (phalloidin), and DNA in Jeg-3 cells en face (upper panels) or as a 
projection of Z-stacks through a vertical cross-section stretched 5-fold (lower panels). (B) RNAi 
knockdown of TROP-2 with either of two siRNA sequences in Jeg-3 cells causes an occasional 
loss of microvilli. (C) Quantification of B. (D) Cells stably overexpressing TROP-2-V5 were 
transiently transfected with siRNAs as in B and C, then analyzed by Western blot. As expected, 
siTROP2-1, which targets the 3’-UTR (not present in the overexpression plasmid), fails to 
reduce TROP-2-V5 levels. However, TROP2-2, which targets the ORF, is capable of 
diminishing the overexpression by >4-fold. (E) Immunofluorescent detection of V5 tag, F-actin 
(phalloidin) and ezrin in COS7 cells transfected with empty vector or TROP-2-V5. (F) 
Quantification of the results in panel E with additional controls. 
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failed to disrupt either the TROP-2 or CD44 interaction (Figure 2.9.E). These results strongly 
suggest that the solution interaction between CD44 tail and the FERM domain occurs differently 
than it does in the crystal structure (Mori et al., 2008), also throwing into question other such 
crystal structures (Takai et al., 2007; Hamada et al., 2003). 
Investigations of a possible functional interaction between TROP-2 and ezrin in vivo 
I next examined TROP-2 function in Jeg-3 cells. I first examined the distribution of 
endogenous TROP-2 in Jeg-3 cells using the GA733.1 monoclonal antibody. This antibody 
preferentially illuminated microvilli (Figure 2.10.A), agreeing with the distribution of tagged 
TROP-2 (Figure 2.6.A). Knockdown of TROP-2 with two independent siRNAs showed that 
TROP-2 is partially required for microvilli (Figure 2.10.B,C). Because our TROP-2 antibodies 
could not easily detect endogenous TROP-2 by western blot, to confirm that TROP-2 levels were 
reduced upon siRNA transfection, a stable cell-line expressing TROP-2-V5 was generated, and 
the siRNA treatment repeated in these cells. siTROP-2-2, which targets the TROP-2 ORF, was 
capable of knocking down the stably overexpressed TROP-2-V5 as expected. Unexpectedly, the 
stable TROP-2-V5-expressing cell-line had inconsistent microvilli, and was not suitable for 
knockdown-rescue experiments. Nonetheless, microvilli formation appears to partially require 
TROP-2. 
The excessive activation of ezrin (Oshiro et al., 1998) or the overexpression of ezrin-binding 
transmembrane proteins (Yonemura et al., 1999) has been shown to increase the number of 
microvilli-like structures in fibrobastic cell-lines such as COS and L cells. To explore whether 
the overexpression of TROP-2 has a similar effect, COS7 cells were transfected with high levels 
of ezrin, ezrin phospho-mutants, or TROP-2-V5 and assessed for the number of cells with finger-
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like, F-actin-containing structures on their dorsal surface. Overexpression of TROP-2-V5 (Figure 
2.10.E,F) or ezrin or phosphomimetic ezrin (Figure 2.10.F) all led to an increase in microvilli-
like structures, whereas overexpression of ezrin-T567A partially suppressed microvilli-like 
structures (Figure 2.10.F). Consistent with Figure 2.9.F, the basic patch mutations did not inhibit 
binding to ezrin-iFlag in COS7 cells, and all led to a similar increase in microvilli-like structures 
as wild-type TROP-2-V5 overexpression (data not shown). These data suggest that the presence 
of TROP-2 can stimulate microvillus formation. 
DISCUSSION 
The results presented in this chapter represent a pioneering attempt to discover the 
interaction partners of ERM proteins systematically. These interaction partners have been elusive 
due to the transient nature of the interactions coupled with the fact that modulating the openness 
of ezrin changes its distribution in cells. I took the approach of chemical cross-linking coupled 
with an analysis of how the ezrin interactome responds to ezrin mutations rendering it more 
closed or more open. Consistent with the proposed function of ezrin activation to increase its 
partner binding, I find that most interaction partners favor more open ezrin, although there are 
some exceptions, i.e., proteins that interact preferentially with the closed form. It will be 
interesting to repeat these studies in other cell-lines of epithelial and other origin to determine 
their generality. 
Among the unknown proteins identified, I discovered a new interaction with Ig-CAM-
like molecule TROP-2. Ezrin can interact with the very short intracellular tail of TROP-2 in 
vitro, although whether the in vitro binding proceeds in the same manner as the interaction by 
co-immunoprecipitation is questionable. In support of a functional role between the two, TROP-
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2 depletion causes a partial loss of microvilli in Jeg-3 cells, a phenotype also caused by depletion 
of ezrin, while TROP-2 overexpression creates microvilli-like dorsal structures in COS7 cells, a 
phenotype also caused by activation of ezrin. Another connection between ezrin and TROP-2 is 
that both molecules are upregulated in cancer, elevate metastatic potential, and are being 
considered as drug targets in human chemotherapy. It will be interesting to investigate whether 
ERMs are functionally connected with TROP-2 in other ways. 1) Adding antibodies against the 
extracellular domain of TROP-2 was shown to induce calcium transients in cells (Ripani et al., 
1998), so it would be interesting to repeat this experiment in cells depleted of ezrin and radixin 
(see Figure 3.1.A) to determine the contribution of ERM engagement in this system. 2) 
Trypsinized cell aggregation was shown to be dependent on TROP-2 homotetramerization 
(Trebak et al., 2001; Basak et al., 1998), so it would be interesting to determine the contribution 
of ERM engagement in this assay. 3) TROP-2 expression assists in anchorage-independent 
growth and invasion into Matrigel (Schon and Orfanos, 1995; Trerotola et al., 2012; Basak et al., 
1998), so it would be interesting to determine whether and to what extent ERM-knockdown cells 
are defective in these functions. 
My results have also raised question about the nature of solution interactions between the 
FERM domain and transmembrane tails in solution, as mutations predicted to abolish these 
interactions based on co-crystal structures (Mori et al., 2008; Takai et al., 2007; Hamada et al., 
2003) failed to affect them in solution binding experiments (Figure 2.9.E). It will be interesting 
to undertake 5-residue-by-5-residue alanine scanning mutagenesis of the FERM domain to 
determine the regions critical for the solution interactions. A problem plaguing the analysis 
ERM-binding transmembrane tails is potential redundancy among them. Having such mutants 
may be helpful here, as well. For instance, one could identify the general role of transmembrane 
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tail binding in the context of ezrin function in microvilli by testing the mutants in microvillar 
complementation assays as described below (Figure 3.5 and 3.6). 
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CHAPTER 31 
PHOSPHORYLATION CYCLING BY LOK AND SLK KINASES RESTRICTS EZRIN 
APICALLY 
Ezrin and radixin are exquisitely localized in epithelial microvilli, but how this strikingly 
polarized distribution is achieved is unknown. The hypothesis driving the experiments in the 
previous chapter was that unknown transmembrane ligands direct ezrin toward the apical 
domain. Indeed, such a mechanism seems likely because transmembrane ERM binding partners 
can cluster ERMs on the cell surface (Yonemura et al., 1999), and apical polarity proteins are 
thought to interact directly with ERMs (Pilot et al., 2006; Medina et al., 2002). Additionally, 
PI(4,5)P2 which binds directly to the ezrin FERM doamin (Nakamura et al., 1996; Hirao et al., 
1996; Matsui et al., 1998; Simons et al., 1998; Pietromonaco et al., 1998; Fievet et al., 2004; 
Gautreau et al., 2000; Pearson et al., 2000) is preferentially localized in apical membranes in 
polarized cells (Martin-Belmonte et al., 2007). In the course of the experiments, however, I 
realized that this is incorrect: in fact, ezrin apical-vs.-basolateral polarity can be explained simply 
by extrinsic regulation by apically localized kinases and delocalized phosphatase activity. 
First, I examine the dynamics of ezrin phosphorylation in human epithelial cells and 
show that cycling of T567 phosphorylation is required to restrict ezrin function to the apical 
membrane. I find that two related serine-threonine kinases, LOK and SLK, associate specifically 
with ezrin-iFlag, and are together required for ezrin phosphorylation in a number of cell-lines.  
Moreover, I show that the kinases themselves are components of apical microvilli and their local 
activation is required for the polarized distribution of ezrin. 
                                                     
1 Some of the experiments presented in this chapter were published in Viswanatha et al., 2012. 
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MATERIALS AND METHODS 
Reagents, cDNAs, and siRNAs. Phos-Tag reagent (Wako Chemicals, USA) was added at 50 μM 
to standard Tris-Glycine-SDS polyacrylamide gels according to the manufacturer’s 
recommendations. Krypton (Pierce) staining was performed according to the manufacturer’s 
protocol. Calyculin A and staurosporine were from Enzo Lifesciences. Erlotinib was from 
Cayman Chemical. 
Ezrin antibody was CPCT-Ezrin-1 from the Developmental Studies Hybridoma Bank or a 
previously characterized rabbit polyclonal antibody (Bretscher, 1989). Pan-ERM antibody was 
from Cell Signaling. Anti-Radixin (Shcherbina, 1999) and anti-phospho ERM (Hanono et al., 
2006) have also been described. Anti-LOK was from Bethyl Laboratories. Anti-Flag and anti-
Tubulin were from Sigma. Anti-E-cadherin was from BD Biosciences. Anti-TagRFP was from 
Evrogen. Anti-GFP was from Santa Cruz. 
The pDEST47 Gateway vector (Invitrogen) so that it encoded a C-terminal EGFP 
(pDESTCEGFP), C-terminal TagRFP-T (pDEST47red), or C-terminal TagRFP-T-integrin 
binding site (pDEST47IBR) instead of C-terminal Cycle3GFP. pDESTCEGFP was made by 
replacing the NheI-XhoI fragment in pDEST47 with EGFP, amplified pEGFP-N2 using 
RV94F4/R4 (5’- TCTAGAATGGCTAGCATGGTGAGCAAGGGCGAGGAGCTG-3’ and 5’- 
GTTGTACTCGAGTTACTTGTACAGCTCGTCCATGCCGAG-3’). pDEST47red was made 
by replacing the NheI-XhoI fragment with TagRFP amplified from pcDNA3/TagRFP-T using 
RV94F1/R1 (5’- TCTAGAATGGCTAGCAAGGGCGAAGAGCTGATTAAGGAGAAC-3’ and 
5’-GTTGTACTCGAGTTAATTAACTTGTACAGCTCGTCCATGCCATTAAGTTTG-3’), 
which also adds a 3’ PacI site. This vector was then cut with PacI/XhoI and talin 1958-2541, 
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which was amplified from Jeg-3 cDNA using RV94F2/R2 (5’- TACAACCGATCGAA 
GCTGTGTCTGGTATCATTGCTGACCTC-3’ and 5’-
GTTGTACTCGAGTTAGTGCTCATCTCGAAGCTCTGAAGGC-3’), was ligated into it. All 
cloning to this point was done in the DB3.1 E coli strain in the presence of chloramphenicol to 
maintain the ccdB-resistance cassette in the Gateway constructs. 
LOK and truncations thereof were generated by tailored PCR using whole cDNA, which 
was made using mRNA isolated from Jeg-3 cells and the SuperScript III kit (Invitrogen), and 
subcloned into pDONR221 by BP recombination (Invitrogen) using primers RV59F1/R1 (5’- 
GGGG ACA AGT TTG TAC AAA AAA GCA GGC TTT 
ATGGCTTTTGCCAATTTCCGCCGCATC-3’ and 5’- GGGG AC CAC TTT GTA CAA GAA 
AGC TGG GTA AGAAGCATCCGCAGAACTGTAGGGGAAG-3’). They were then 
transferred into the modified destination vectors as indicated above. The linking region between 
the ORF and the tags encoded the following peptide sequence: Y-P-A-F-L-Y-K-V-V-R-S-R. The 
K65R mutation was generated using the QuickChange kit and primers RV90F1/R1 (5’- 
Gtgctttggctgcggccagagtcattgaaaccaag-3’ and 5’-cttggtttcaatgactctggccgcagccaaagcac-3’). 
Additional truncations of LOK were generated using the following primers. 
LOK 757 reverse RV93R1 GGGG AC CAC TTT GTA CAA GAA AGC 
TGG GTA 
CAGCTGGTGCCTCTCCTGCAGCT 
LOK 589 reverse RV93R2 GGGG AC CAC TTT GTA CAA GAA AGC 
TGG GTA 
GCAGCTCATGCTTGTTACTCAGCTR 
LOK 310 forward RV93F4 GGGG ACA AGT TTG TAC AAA AAA 
GCA GGC TCC ATG 
GCCAAGGCCGAGGTGATGGAAG 
 
LOK 586 forward RV93F3 GGGG ACA AGT TTG TAC AAA AAA 
GCA GGC TCC ATG 
AAGCATGAGCTGCAGCTGGAGCAAAT 
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LOK 348 reverse RV93R4 GGGG AC CAC TTT GTA CAA GAA 
AGC TGG GTA 
ACTCACCTCAGAGGAGTTCTGAGTATGG 
LOK 715 forward RV93F5 GGGG ACA AGT TTG TAC AAA AAA 
GCA GGC TCC ATG 
GACAACAGGCGGGAGATCTGTG 
LOK 615 forward RV93F6 GGGG ACA AGT TTG TAC AAA AAA 
GCA GGC TCC ATG 
AACCTGGAGCGTCAGCAAAAGCAGC 
LOK 801 reverse RV93R7 GGGG AC CAC TTT GTA CAA GAA AGC 
TGG GTA 
CTGTTGCTGCCGCACCTTCAGC 
LOK 884 reverse RV93R8 GGGG AC CAC TTT GTA CAA GAA AGC 
TGG GTA 
CTGCTGCAGCTCGCTCATGTTGC 
 
The murine long isoform of SLK and truncations thereof were amplified by PCR from 
EST # BC131675 from Open Biosystems and then cloned into pDONR223 by BP recombination 
using RV91F1/R1 (5’- GGGG ACA AGT TTG TAC AAA AAA GCA GGC TTT ACC 
ATGTCCTTCTTCAATTTCCGTAAGAT-3’ and 5’- GGGG AC CAC TTT GTA CAA GAA 
AGC TGG GTA TGATCCGGTGGAATGCAAGCTGGGAATAGG-3’). They were then 
transferred into the same set of modified Gateway vectors by LR recombination, with one 
exception: SLK-310-1233 was transferred into pcDNA-DEST53 (Invitrogen), which adds an N-
terminal (rather than C-terminal) GFP because this resulted in higher expression of this 
construct. K63R mutant of SLK was a kind gift of Dr. Luc Saborin (Inst. de Recherche de 
l’Hopital d’Ottowa). Various truncations of SLK were prepared using the following primers: 
SLK 353 reverse RV91R2 GGGG AC CAC TTT GTA CAA GAA AGC 
TGG GTA 
AAGTTTATCTTCTTCAGAGCTGGCAATG 
SLK 310 forward RV91F3 GGGG ACA AGT TTG TAC AAA AAA 
GCA GGC TTT ACC 
GAAGTAACAGAAGAAGTTGAAGATGG 
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For kinase assays, a C-terminal Flag tag was added to the 3’ end by tailored PCR of 
LOK-GFP or SLK-GFP and derivatives using primers RV97F1 for LOK (5’- TTCACT 
GCGGCCGC ATGGCTTTTGCCAATTTCCGCCGCATC-3’) or F2 for SLK (5’- TTCACT 
GCGGCCGC ACCatgtccttcttcaatttccgtaagatcttcaag-3’) and RV97R1 (5’- 
CATGGACGAGCTGTACAAG ATG gac tac aag gac gac gat gac aag TAA CAATTG AGTTG-
3’), digested with NotI and MfeI, and the products ligated into pQCXIP cut with NotI and 
EcoRI. 
The actin binding sequence of espin was a generous gift of James Bartles (Northwestern 
University). It was cloned first into pEGFP by Damien Garbett, and then the Espin-EGFP 
cassette was then cloned by tailored PCR into pQCXIP, and ezrin deriviates were ligated 5’ of 
the cassette as needed. 
siRNAs were from Ambion or Dharmacon with the following sequences: 5’-
AAAGUCAGGUGCCUUCUUGuu-3’ (Ezrin, sequence 1); 5’-
GGAAUCAACUAUUUCGAGAtt-3’ (Ezrin, sequence 2); 5’-
UGAAGAUGUUUCUGAGGAAuu-3’ (Radixin); 5’-GAAGAGCAUCGGAACCAGAtt-3’ 
(LOK, sequence 1); 5’-GGACUACACCAGGUUCCAAtt-3’ (LOK, sequence 2); 5’-
GAUCGAUAUCUUUACAAGAtt-3’ (SLK, sequence 1); 5’-
GCAGAAACAGACUAUCGAAtt-3’ (SLK, sequence 2); 5’-GCUUUACCACCGUACGAAAtt-
3’ (MST4); 5’-GAAUCCCGCUGACAAACCAtt-3’ (MINK1). siGL2, targeting GL2 luciferase, 
was previously described (Hanono et al., 2006). 
Caco-2 cells (American Type Culture Collection, ATCC) were maintained in a 5% CO2 
humidified atmosphere at 37°C in MEM (Invitrogen) with 20% FBS (Invitrogen). LLC-
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PK1.CL4 cells were kindly provided by Matthew J.Tyska (Vanderbilt University). They were 
grown in MEMα + 10% FBS. MDCK cells were kindly provided by Keith Mostov, and 
HEK293T cells originally by Gary Nolan (Stanford University), and primary mouse embryo 
fibroblasts by Jan Lammerding (Cornell University). All were grown in DMEM + 10% FBS. 
All transient plasmid DNA transfections were performed for ~18 hours using 
Polyethylenimine reagent (PolyPlus) using a previously established protocol (Hanono et al., 
2006). Phoenix-Ampho retrovirus producer cells (ATCC) were cultured in DMEM (Invitrogen) 
with 10% FBS. Retroviruses were prepared following a standard transfection protocol using the 
Phoenix-Ampho cell-line and the retroviral vector pQCXIP. The recombinant retroviruses were 
used to transduce Jeg-3 cells, which were then selected with 2.0 μg/ml puromycin (Sigma). 
SILAC, mass spectrometry, and immunoprecipitations were as described in Chapter 2. 
All siRNAs were transfected at 30 nM into ~25% confluent cultures of Jeg-3 cells or 
Caco-2 cells using Lipofectamine RNAiMAX (Invitrogen) using the manufacturer’s protocol.  In 
all but one case, cells were processed for immunofluorescence or lysis 3 days after transfection. 
For combined siRNA transfection of LOK and SLK, cells were treated with the indicated first 
siRNA for 2 days, reseeded, and then, on the third day, transfected with the indicated second 
siRNA for an additional 3 days, and processed on the sixth day. 
For analysis of tagged ezrin phosphorylation, cells transfected with ezrin-iFlag plasmid 
plus LOK or SLK expression vector were rapidly boiled in 50 mM Tris pH 8.0 containing 1% 
SDS. Lysates were then diluted 10-fold with IP buffer, clarified, the protein abundance 
quantified and adjusted using the Pierce 660 nm assay (Thermo), and immunoprecipitated as 
described above. 
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Western blotting and densitometry. Western blots were performed as previously described 
(Hanono et al., 2006). For all densitometry, western blotting was carried out with a mixture of 
mouse CPCT-Ezrin-1 or mouse Flag and rabbit pERM antibodies, detected with infrared 
fluorescent secondary antibodies (Invitrogen or LI-COR). Membranes were imaged using an 
Odyssey scanner (LI-COR). On every membrane in this study, dilutions of lysate were run 
alongside the samples so that standard curves for both total ezrin and pERM could be generated 
in the Odyssey software (LI-COR). These were then used to determine the relative intensity of 
in-range pERM and ezrin or Flag signals from experimental lanes. These data were exported to 
Graphpad Prism software where all further quantitative and statistical analyses were performed. 
Immunofluorescence microscopy and image analysis. Cells grown on glass coverslips were fixed 
in 3.7% formalin/PBS for 15 minutes at room temperature for most experiments except where 
indicated. In the remaining cases, cells were fixed in cold 10% trichloroacetic acid for 15 
minutes as described (Hayashi et al., 1999). Cells were then washed with PBS and blocked with 
IF buffer (PBS + 0.5% BSA + 0.5% goat serum + 0.1% Triton-X 100) for 10 minutes. Primary 
and secondary antibodies were then applied in IF buffer containing 1% FBS. Alexa-fluor 
conjugated phalloidin (Invitrogen), to stain F-actin, was added to the secondary as required. The 
cells were mounted in Vectashield reagent, imaged using a CSU-X spinning disk microscope 
(Intelligent Imaging Innovations) with spherical aberration correction device, 63x 1.4 NA 
objective on an inverted microscope (Leica), acquired with either a QuantEM EMCCD camera 
or an HQ2 CCD camera (Photometrics) using Slidebook software (Intelligent Imaging 
Innovations). Maximum or summed intensity projections were assembled in Slidebook and 
exported to Adobe Illustrator software. For clarity, side projections were vertically expanded 5-
fold using Illustrator.  
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The presence or absence of microvilli was scored as described previously (Hanono et al., 
2006; LaLonde et al., 2010; Garbett et al., 2010). 
For scoring of ezrin localization to the basolateral domain induced by delocalized LOK 
expression, the cell middle or cell base was identified by confocal microscopy using F-actin 
staining for 50 transfected cells per sample per trial, and the presence or absence of ezrin stain in 
transfected cells relative to surrounding non-transfected cells was reported. 
For line-intensity analysis, a line was drawn along a single microvillus from base to tip 
(the orientation was verified by scanning through multiple Z sections), the intensity of ezrin 
immunofluorescent staining, GFP, and F-actin were each calculated in Slidebook, and exported 
into Microsoft Excel software. Ezrin and GFP were each divided by F-actin to minimize 
aberrations in microvilli geometry, and the resulting data were plotted in Prism. 
Kinase assays. Kinase assays were essentially as described (Jackson and Dickson, 1999). GST-
ezrin-474-585 was purified from Rosetta2DE3pLysS bacteria (Novagen) onto glutathione 
agarose (Sigma) and then washed extensively in TBS. pQCXIP plasmids encoding kinase 
constructs were transiently transfected into Phoenix-Ampho cells for ~18 hours, and cells were 
Flag immunoprecipitated in IP Buffer for 2 hours, and the resin extensively washed in TBS. 
Immunoprecipitates were eluted in TBS containing 200 μg/mL 3XFlag peptide and quickly 
resolved by SDS-PAGE to verify purity and determine concentration. ~0.2 μM GST-ezrin-474-
585 beads were added to ~0.2 μM soluble kinase in kinase assay buffer (150 mM NaCl, 20 mM 
Tris pH 7.4, 50 mM MnCl2, 100 mM MgCl2, 0.1 μM Na3VO4, 0.1 μM calyculin A, 20 μM ATP) 
and the reactions incubated at 30ᴼC for 1 hour with agitation and then terminated by boiling in 
Laemmli buffer. 
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RESULTS 
ERMs are required for microvilli in Jeg-3 cells 
In order to investigate the role of ERMs, it was first necessary to find a way to reduce 
their expression and observe the phenotype. ERMs have been suppressed in tissue culture by 
antisense oligonucleotide expression or RNAi with a wide range of effects including ablation of 
all F-actin-containing structures (Tsukita et al., 1994), destruction of microvilli and basal 
infoldings (Bonilha et al., 1999), and reduction in circular dorsal ruffles with no effect on 
microvilli (D'Angelo et al., 2007). In situ, ezrin-lacking epithelial cells that do not express 
radixin or moesin have terminal web defects leading to stunting and deformation of the 
microvilli, while the structures themselves are intact (Saotome et al., 2004). These variations 
perhaps reflect differences in experimental procedure and cell type. By contrast, the Bretscher 
lab has found that Jeg-3 placental cells transfected with siRNAs targeting EBP50, a key ERM 
binding partner, lose microvilli without apparent defects in any other F-actin-containing structure 
(Hanono et al., 2006). Thus, I used the same methods in this cell-line to generate ezrin-
suppressed cells. 
Cells were transfected with either of two ezrin siRNAs for 3 days. Western blots using a 
pan-ERM antibody showed that both were specific for ezrin, because ezrin expression decreased 
while radixin expression was mildly elevated, perhaps due to compensatory gene upregulation 
(Figure 3.1.A). Approximately 80% of Jeg-3 cells have microvilli (Hanono et al., 2006; LaLonde 
et al., 2010; Garbett et al., 2010), and transfecting either siEzrin1 or siEzrin2 led to a reduction in 
microvilli-baring cells to 26% or 47%, respectively (Figure 3.1.B), while microvilli always seem 
to remain along the regions of cell-cell contact. Since siEzrin1 had a greater effect but knocked 
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Figure 3.1 Ezrin and radixin RNAi-mediated depletion causes a loss of microvilli in Jeg-3 cells 
(A) Western blot showing depletion of ezrin relative to E-cadherin by two siRNA sequences. (B) 
Quantification of the Western blot in panel A and determination of microvilli abundance by 
WGA-staining or radixin and F-actin staining. siEzrin1 causes greater microvillus loss, but less 
ezrin depletion, and therefore must have off-targets, whereas siEzrin2 results in ezrin depletion. 
Additionally, siEzrin1 causes many more cells with abnormal cytoskeletons. (C) Representative 
images from one of the analyses quantified in panel B, showing abnormality caused by siEzrin1 
(arrow). (D) Cells were treated with ezrin and/or radixin siRNA as indicated, analyzed by 
western blot to determine amount of ezrin and radixin remaining following the knockdown and 
fixed and stained for various microvillar markers (EBP50, β-dystroglycan, or WGA) and scored 
to determine the degree of microvillus loss. Ezrin depletion leads to the mild compensatory 
upregulation of radixin. Ezrin and radixin are each independently required for microvilli, and 
microvilli are almost entirely dependent on ezrin and radixin.  
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down ezrin more poorly, I more closely examined the effects. siEzrin1 transfection caused the 
formation of circular dorsal ruffles (Figure 3.1.C, arrow; scored as ‘abnormal’ cells in A), 
skewing the scoring results perhaps as a consequence of an off-target suppression of another 
protein, while siEzrin2 caused the loss of microvilli without grossly affecting the F-actin 
cytoskeleton in any other way (Figure 3.1.C,B). Thus siEzrin2 (hereafter simply called ‘siEzrin’) 
was used for the subsequent studies. 
To determine whether ezrin and radixin act in parallel to form microvilli, they were 
silenced individually or together. Western blots and densitometry confirmed the specificity of 
each knockdown (Figure 3.1.D). The cells were fixed and stained for the presence of microvillar 
markers EBP50 or β-dystroglycan and additionally stained with fluorescent wheat germ 
agglutinin (WGA) prior to permeablization to localize the dominant cell-surface proteoglycans 
which illuminate the plasma membrane. Cells were scored for the presence or absence of 
microvilli, and the scores pooled. The results show that regardless of the marker observed, ezrin 
and radixin are each required for microvilli individually, and there was statistically significant 
enhancement of the phenotype when the two siRNAs were co-transfected, even though their 
protein levels were not further diminished in the combined knockdown. Thus, ezrin and radixin 
act in parallel to generate microvilli in Jeg-3 cells, and Jeg-3 cells are almost entirely dependent 
upon ERMs for microvilli. 
Ezrin undergoes rapid threonine-567 phosphorylation cycling 
Threonine 567 (T567) is the major site of phosphorylation regulating ezrin activation, yet 
the fraction of the protein phosphorylated in epithelial cells has not been explored.  Using Phos-
Tag gels (Kinoshita et al., 2006), in which the mobility of phosphorylated proteins is specifically 
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retarded, ezrin from Jeg-3 cells resolves into two species of approximately equal abundance 
(Figure 3.2.A). The slower migrating band is selectively recognized by an antibody specific for 
ERM C-terminal threonine phosphorylation (pERM), and is absent from expressed T567A ezrin 
(Figure 3.1.A,B). The cell-permeable phosphatase inhibitor calyculin A is known to reduce ezrin 
dephosphorylation (Chen et al., 1995), so I explored if treatment enhances the relative abundance 
of ezrin T567 phosphorylation. Five minutes’ treatment with 1 μM calyculin A resulted in 
essentially complete ezrin phosphorylation (Figure 3.1.A,B). These results show that about half 
of the ezrin is phosphorylated in these cells, and the other half can be rapidly phosphorylated in 
vivo in the absence of opposing phosphatase activity. 
To explore the dynamics of phosphorylation of ezrin on T567 in more detail, I followed 
the extent of phosphorylation as a function of time after adding either the general kinase inhibitor 
staurosporine (1 μM) or calyculin A (1 μM). Of the ERM proteins, Jeg-3 cells express ezrin and 
radixin, which have an identical sequence in the region of ezrin T567, so the antibody detects the 
phosphorylated state of both proteins. In all experiments, the percentage of ezrin and radixin that 
is phosphorylated is similar so I considered them together. Quantitative western blotting with the 
pERM antibody was used to determine the degree of C-terminal threonine phosphorylation. The 
lifetime of the dephosphorylated species in the presence of phosphatase inhibitor and that of the 
phosphorylated species in the presence of kinase inhibitor were each approximately 2 minutes 
(3.1.C,D). The results show that ezrin and radixin undergo constant C-terminal phosphocycling 
in vivo. 
Ezrin phosphocycling is necessary for ezrin localization to microvilli 
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Figure 3.2 Half of ezrin is phosphorylated, and phospho-ezrin has a turnover time of 
approximately 2 minutes. 
(A) A 5-fold dilution series of lysates of Jeg-3 cells treated as indicated was resolved by SDS-
PAGE with or without Phos-Tag and western blotted for ezrin. The abundance of phosphorylated 
and non-phosphorylated ezrin is nearly equal; ezrin is nearly quantitatively phosphorylated after 
treatment with calyculin A for five minutes. (B) Cells transiently transfected to express ezrin-
T567A-iFlag (see Figure S2A) does not shift on Phos-Tag gels, so the majority of ezrin 
phosphorylation is on T567. Note that transiently transfected ezrin-iFlag is phosphorylated to a 
lesser extent than endogenous ezrin. (C)  Time-course of treatment of cells with 1µM 
Staurosporine or 1µm CalyculinA on the level of phospho-ERM (pERM) and total ezrin as seen 
by western blotting. (D) Quantification of data in B from three independent experiments. Means 
± s.d. are shown. 
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I next explored whether the T567E phosphomimetic mutant of ezrin, or the T567A 
phosphodeficient mutant, localizes appropriately. Numerous previous studies have used a C-
terminal tag to follow expressed ezrin. However, as the C-terminus makes important contacts 
with the FERM domain to maintain an inhibited conformation (Pearson et al., 2000), I was 
concerned that a C-terminal tag might affect the regulation of the protein.  I therefore explored 
the possibility of introducing an internal tag, and chose a region between the α-helical ERM 
coiled-coil and the tail that is not ordered in the X-ray structure and also poorly conserved within 
the ERM family (Li et al., 2007; Figure 3.3.A). Cell-lines were stably transfected and selected 
such that they expressed nearly identical levels of ezrin-iFlag compared with endogenous ezrin 
(Figure 2.1.B). The ezrin-iFlag reagent proved useful for immunoprecipitation analyses and 
recapitulates many aspects of ezrin regulation, so I asked whether it can complement ezrin 
depletion. I engineered ezrin-iFlag stable cell-lines resistant to siEzrin, and confirmed the 
expression by western blot (Figure 3.3.C). I then scored microvilli in the cells treated with 
control siRNA or depleted of endogenous ezrin (Figure 3.3.D). The results show Ezrin-iFlag 
partially complements the depletion of endogenous ezrin, although to a lesser extent than 
untagged ezrin. As expected, the tagged protein localized precisely in microvilli and therefore 
served as a good control for testing the effect of targeted mutations on ezrin distribution 
Wild-type ezrin-iFlag localized precisely in microvilli with endogenous radixin, whereas 
ezrin-T567A-iFlag could not be detected in microvilli and showed dim fluorescence in the 
cytoplasm (Fig 3.4.A). Unexpectedly, ezrin-T567E-iFlag was poorly concentrated in microvilli, 
with the vast majority mislocalized all over the plasma membrane, including to the basolateral 
membrane, a site where wild-type ezrin is never enriched, and importantly without disturbing the 
apical localization of radixin (Fig 3.4.A). To see if this is a general property of open ezrin 
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Figure 3.3 Characterization of the ezrin-iFlag stable cell-lines 
(A) Sequence alignment of ezrin-iFlag along with indicated ERMs, based upon Li et al., 2007. 
(B) Western blots of ezrin-iFlag and phosphomutant stable cell-lines. Note the shift due to the 
internal flag tag. (C) Western blots of ezrin-iFlag and phosphomutants  treated with indicated 
siRNA. (D) Analysis of microvilli-baring cells from panel A. Ezrin-iFlag reproduces some 
aspects of ezrin, but is incapable of restoring normal microvilli in the absence of endogenous 
ezrin. 
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mutants, I also explored the localization of ezrin-1-583-iFlag and ezrin 1-479-Flag, in which the 
C-terminal tail of ezrin is truncated or deleted rendering the protein completely open, and ezrin 
Nm-iFlag, which is open due to a mutation in the FERM domain that blocks binding to its 
otherwise functional C-terminal tail (Chambers and Bretscher, 2005; Finnerty et al., 2004). All 
constructs localized more generally to the plasma membrane than wild-type ezrin-iFlag, and 
none affected the localization of radixin (Fig 3.4.B). 
To explore the effect of stable C-terminal threonine phosphorylation of endogenous ezrin, 
I examined the localization of ezrin after brief calyculin A treatment.  This resulted in the 
localization of ezrin not only in microvilli, but also generally to the plasma membrane, including 
the basolateral membrane (Figure 3.4.C). Taken together, these results imply that 
phosphocycling of ezrin regulates its distribution by controlling its open state. 
Phosphoregulatory control of ezrin localization is necessary for microvilli formation 
As my data show that ezrin hyper-phosphorylation resulting from phosphatase inhibition 
results in partial mislocalization, I wished to determine if T567 phosphocycling is necessary for 
microvilli formation. Depletion of ezrin alone by siRNA reduces the number of cells expressing 
microvilli on their surface from about 80% to about 47%, with some microvilli remaining over 
regions of cell-cell contact (Figure 3.1, 3.5), as is also seen when the microvillar component 
ERM-binding phosphoprotein 50 kDa (EBP50) is depleted (Hanono et al., 2006; Garbett et al., 
2010). Therefore, this provides a system to ask if phosphomimetic variants of ezrin can 
contribute to the formation of microvilli. Jeg-3 cells stably expressing siRNA-resistant untagged 
wild-type ezrin, ezrin-T567A or ezrin-T567E at near-endogeneous ezrin levels were generated 
and all found to have microvilli as seen by radixin staining. Endogeneous ezrin was then 
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Figure 3.4 Constitutively open ezrin loses apical-
versus-basal polarity. 
(A) Jeg-3 cells expressing ezrin-iFlag or its T567 
phospho-mutants (see Fig. S1C,D) were stained 
using a Flag antibody and the localization compared 
to endogenous radixin and F-actin. For every 
sample, a maximum-intensity projection of the 
apical surface en face as well as a vertical cross-
section is shown. (B) Cells stably expressing ezrin 
C-terminal truncation mutants or the N-mutant 
(Nm), all of which are known to be constitutively 
open, were processed and imaged as in A. 
Compromising the FERM/C-terminus interaction in 
ezrin reduces ezrin-iFlag accumulation in 
microvilli, without affecting the polarized 
distribution of radixin. (C) Cells were treated with 
DMSO or 0.1 μM calyculin A for 5 minutes, and 
ezrin and F-actin localized. Calyculin A treatment 
causes ezrin to mislocalize. Scale bars, 10 μm. 
Vertical sections were expanded 5-fold for clarity. 
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Figure 3.5 Phosphomimetic, activated ezrin cannot rescue microvilli when endogenous ezrin is 
depleted by RNAi. 
(A) Cells stably expressing the indicated ezrin protein or vector control were treated for 3 days 
with siRNA to deplete endogenous ezrin, and microvilli were revealed by radixin and F-actin 
staining. (B) Quantification of the presence of microvilli as reported by radixin or F-actin 
staining. Wild-type ezrin but neither phosphodeficient nor phosphomimetic ezrin restores 
microvilli after knockdown of endogenous ezrin. Data are means ± s.d. of four independent 
experiments, and >150 cells were scored per treatment in each experiment. Scale bars, 10 μm. 
Cross-sections were expanded 5-fold vertically for clarity. 
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depleted in these cells by siRNA treatment and the presence of microvilli scored (Figure 3.5). 
Whereas expression of wild-type ezrin completely restored the presence of microvilli, neither 
ezrin-T567A nor ezrin-T567E was able to bring back microvilli.  
I also examined the functionality of the widely used C-terminally-tagged GFP constructs. 
In contrast to untagged or internally tagged ezrin-T567A, I found that ezrin-T567A-GFP is 
membrane-targeted, consistent with my concern that it might be slightly activated. Nonetheless, 
neither siRNA-resistant T567A nor T567E in the context of ezrin-GFP rescued microvilli, 
whereas siRNA-resistant wild-type ezrin-GFP rescued microvilli in the absence of endogenous 
ezrin (Figures 3.6). I conclude that while ezrin-GFP may be partially activated relative to 
untagged ezrin, it still requires phosphocycling to perform its function in microvillus biogenesis. 
Taken together, these results indicate that the precise spatial control of ezrin phosphocycling is 
necessary for microvilli. 
The ability to tag ezrin on the C-terminus without grossly interfering with its function 
allowed me to ask what would happen to an ezrin molecule that was constitutively open due to a 
second actin-binding site which could not be masked by the FERM domain. For these 
experiments, I expressed the actin-binding site (ABS) of espin, which nonspecifically localizes 
with the bulk of F-actin (Figure 3.7.A) and does not affect the presence of Jeg-3 microvilli on its 
own (Figure 3.7.B). I fused the ABS to the C-terminus of ezrin to create a constitutively F-actin-
targetted molecule (Figure 3.7.C). Intriguingly, while siRNA-resistant ezrin-GFP accumulated in 
and rescued microvilli following siEzrin transfection, ezrin-GFP-ABS mislocalized to all cortical 
F-actin and failed to rescue completely (Figure 3.7.D,E). Furthermore, when T567E ezrin was 
replaced within the construct, it became partially deleterious towards endogenous ezrin function 
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Figure 3.6 C-terminally GFP-tagged ezrin also rescues microvilli in a phosphocycling-
dependent manner 
(A) Cells stably expressing indicated RNAi-resistant ezrin-GFP or vector control were treated for 
3 days with siRNA to deplete endogenous ezrin, and microvilli were revealed by radixin and F-
actin staining. Similar to Figure 3.5, where untagged ezrin is employed, RNAi knockdown of 
ezrin causes ~40% of cells to lose central microvilli as revealed by radixin or F-actin staining, 
and the re-expression of GFP-tagged, wild-type ezrin reverses the deficiency. However, 
microvilli are not restored by expression of T567A- nor T567E-ezrin-GFP. (B) Quantification of 
cells with microvilli as seen by radixin or F-actin staining. Expression of the ezrin-GFP 
constructs was verified by western blot. Data are means ± s.d. of three independent experiments. 
All scale bars, 10 μm. Cross-sections were expanded 5-fold vertically for clarity. 
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Figure 3.7 Appending the actin binding/bundling sequence from espin to ezrin-GFP causes it to 
mislocalize and inhibits its activity 
(A) Cells stably expressing GFP-tagged F-actin binding site (ABS) from espin were fixed and 
stained as indicated. GFP-ABS is found within most F-actin containing structures. (B) Cells 
stained as in A were scored for radixin-containing microvilli. GFP-ABS does not promote 
microvilli in the absence of ezrin. (C) Schematic of constructs. Espin ABS is expected to be 
available even when the endogenous ABS within ezrin is self-masked. (D) Cells stably 
expressing RNAi-resistant ezrin-GFP or ezrin-GFP-ABS were depleted of endogenous ezrin, 
stained with indicated markers. (E). Cells stained as in B or control siRNA-transfected cells were 
scored for the presence or absence of radixin-containing microvilli. Fusion with the ABS causes 
ezrin to fail to rescue microvilli. (F) Cells expressing indicated constructs and transfected with 
indicated siRNAs and scored for the presence or absence of microvilli. Activating ezrin in the 
context of the ezrin-GFP-ABS chimera causes a mild synthetic enhancement of microvilli 
defects. All scale bars, 10 μm. Cross-sections were expanded 5-fold vertically for clarity. 
 
 
 
 
 
 
 
105
on its own (Figure 3.7.F). These results suggest that appending an unmasked actin-binding site to 
ezrin exerts a dominant inhibition of its apical localization and its ability to form microvilli. 
LOK and SLK are the major kinases involved in ezrin phosphorylation  
The results presented so far hint that phosphoregulatory control of ezrin controls its 
localization, and that tightly compartmentalized ezrin localization is necessary for microvilli. To 
test this hypothesis, we hunted for the relevant kinase(s).  I reexamined my mass spectrometry of 
ezrin-iFlag immunoprecipitates (Figure 2.3) to identify the kinases in Jeg-3 cells responsible for 
phosphorylating ezrin. Although more than 18 kinases were identified, the four enriched more 
than two-fold in ezrin-iFlag immunoprecipitates are shown in Figure 3.8.A. The most highly 
enriched serine/threonine kinases were the evolutionary homologs LOK and SLK (Delpire, 
2009). Immunoprecipitation of ezrin-iFlag co-precipitates some LOK-GFP (Figure 3.8.B) 
thereby supporting the mass spectrometry results. 
If LOK and SLK are the relevant kinases for ezrin phosphorylation, I would expect the 
level of T567 phosphorylation to decrease when the level of LOK and/or SLK is reduced. 
Depletion of LOK by siRNA treatment resulted in about a 50% decrease in T567 
phosphorylation (Figure 3.8.C). SLK depletion had a minimal effect on T567 phosphorylation, 
but, importantly, knocking down both LOK and SLK reduced ezrin T567 phosphorylation even 
further to about 20% of control levels (Figure 3.8.C), implying that ezrin is a substrate of both 
LOK and SLK in these cells. Consistent with a major role for LOK, fewer cells knocked down 
for LOK exhibited microvilli on their apical surface (Figures 3.8.D,E), an effect similar to that 
seen when ezrin is depleted by siRNA (Figure 3.1,3.5,3.6). 
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Figure 3.8 LOK and SLK are responsible for ezrin/radixin C-terminal phosphorylation in Jeg-3 
cells. 
(A) Enrichment statistics for LOK and SLK from mass spectrometry analysis of ezrin-iFlag 
cross-linking immunoprecipitates. LOK and SLK were the most highly enriched serine/threonine 
kinases binding to ezrin-iFlag. (B) LOK-GFP was co-expressed with empty vector or Ezrin-iFlag 
and cells were subjected to cross-linking immunoprecipitation using anti-Flag (Flag IP). LOK-
GFP co-immunoprecipitates with ezrin-iFlag. (C) Cells were treated with indicated combinations 
of validated siRNAs against LOK (siLOK1) or SLK (siSLK2) or control (siGL2) and western 
blotted for LOK to measure knockdown efficiency. The level of phosphorylated ezrin and 
radixin was determined by western blot and quantified by densitometry. (D) Cells were treated 
with siLOK1 for 3 days and then fixed and stained for ezrin and F-actin. Knockdown of LOK 
causes loss of microvilli similar to the knockdown of ezrin (Fig. 3). (E) The presence of 
microvilli on cells treated with indicated siRNA was assessed following ezrin and F-actin 
staining. (F) Cells were treated with DMSO, staurosporine, or erlotinib at indicated 
concentrations for 5 minutes at 37ᴼC and phospho-ERM levels measured by western blot. (G) 
Cells treated as in F were fixed and stained for ezrin and F-actin. Erlotinib treatment causes a 
severe reduction in ezrin-containing microvilli. (H) GFP-Flag-tagged kinase constructs were 
immunoprecipitated using the Flag tag after expression in HEK293T cells, and then combined 
with purified GST-tagged ezrin C-terminus in the presence of ATP, which was then subjected to 
pERM western blot. Both LOK and SLK kinase domains are able to phosphorylate the ezrin C-
terminal tail in vitro. (I) Cells were co-transfected with an empty vector or GFP fusions of either 
LOK or SLK along with ezrin-iFlag. The cells were lysed, and ezrin-iFlag was 
immunoprecipitated with anti-Flag (Flag IP) and the phosphorylation of ezrin-iFlag was detected 
by western blot. Both LOK-GFP and SLK-GFP overexpression cause an increase in the overall 
level of ezrin-iFlag phosphorylation. Data in C, E, and F are means ± s.d. of three independent 
experiments. 
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Erlotinib, a small molecule inhibitor of the epidermal growth factor receptor (EGFR) 
tyrosine kinase, was recently shown to inhibit LOK and SLK when used at higher concentrations 
(Yamamoto et al., 2011). A five minute treatment with 10 μM erlotinib resulted in the loss of 
ezrin phosphorylation and loss of microvilli from Jeg-3 cells, similar to 1 µM of the general 
kinase inhibitor staurosporine (Figures 3.8.F,G). Functional but not kinase-dead LOK or SLK 
kinase domains could each phosphorylate T567 in the context of the C-terminal domain of ezrin 
in vitro (Figure 4H), confirming that LOK and SLK each possess similar kinase activity towards 
ezrin. Moreover, overexpression of LOK-GFP or SLK-GFP increased the phosphorylation of co-
transfected ezrin-iFlag in vivo (Figure 3.8.I).  
I performed some additional experiments to support my conclusion that LOK and SLK 
are the ERM kinases. I found that ezrin-iFlag stable cell-lines could precipitate endogenous LOK 
(3.9.A). The effect of the LOK siRNA in Figure 3.8.C was corroborated with a second LOK-
specific siRNA (Figure 3.9.B). Jeg-3 cells also express MST4 and MINK1, two kinases that 
phosphorylate ezrin in vitro (ten Klooster et al., 2009), but validated siRNAs against these 
kinases had no effect on the level of ezrin phosphorylation (Figure 3.9.B). Furthermore, ROCK 
inhibitor Y-27632 and CDK inhibitor roscovitine had no effect on T567 phosphorylation in Jeg-3 
cells (data not shown). Collectively, my results show that LOK and SLK are functionally the 
major relevant kinases involved in the steady-state phosphorylation of ezrin in Jeg-3 cells. 
LOK activity is localized and restricted apically via the C-terminal domain 
LOK has an N-terminal kinase domain and a C-terminal domain predicted to be similar to 
the AT1-46 homology (ATH) domain of SLK (Sabourin et al., 2000) (Figure 3.10.A).To dissect 
the molecular organization of LOK, I constructed a series of truncation mutants as well as 
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Figure 3.9 Additional experiments verifying that LOK and SLK are upstream of phospho-ezrin 
and radixin in Jeg-3 cells. 
(A) Cells stably expressing empty vector or ezrin-iFlag were cross-linked and 
immunoprecipitated using anti-Flag (Flag IP), and the immunoprecipitate was western blotted to 
detect ezrin-binding phosphoprotein 50 (EBP50), a known interaction partner of ezrin, and LOK. 
Endogenous LOK interacts with stably transfected ezrin-iFlag. (B) Cells were treated with 
indicated siRNA and phospho-ERM was measured by western blot. siRNAs against other known 
ERM kinases (siMST4 and siMINK1) fail to cause any reduction in phospho-ERM levels, 
whereas two siRNAs against LOK (siLOK1 and siLOK2) cause a 40-50% reduction, and one 
siRNA against SLK (siSLK2) causes a 20% reduction. Data are means ± s.d. of three 
independent experiments. 
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Figure 3.10 Unregulated LOK causes ezrin depolarization 
(A) Schematic of truncation constructs and chimeras used. (B) LOK-RFP and truncations were 
localized relative to F-actin. LOK and the LOK C-terminal domain localized to microvilli, 
whereas the N-terminal kinase domain did not. For clarity, only a small region of the apical 
domain is shown, and the full cell is shown in vertical cross-section. (C) Cells were co-
transfected with indicated RFP-tagged LOK constructs along with ezrin-iFlag. The cells were 
lysed and ezrin-iFlag was immunoprecipitated (Flag IP), and phosphorylation of ezrin-iFlag was 
measured by quantitative western blot. The fold-increase in ezrin phosphorylation due to each 
LOK truncation was normalized to the overexpression of full-length LOK.  (D) Cells expressing 
the RFP-tagged LOK N-terminal kinase domain alone (LOK-1-348-RFP) were stained for ezrin 
and F-actin and presented as either an apical, basolateral, or side view, and cells transfected with 
full-length LOK-RFP (lower panels) are presented in side view. Cells expressing the LOK kinase 
domain alone exhibit delocalized ezrin staining, whereas cells expressing full-length LOK do 
not. (E) Cells expressing indicated LOK-RFP fusion proteins were stained as in D, and the ezrin 
depolarization phenotypes were quantified by confocal microscopy. Only when the LOK kinase 
domain is functional but unregulated does it cause ezrin to mislocalize. (F)  Cells overexpressing 
a fusion of the LOK kinase domain to the integrin-binding region (IBR) of talin were processed 
as in D. Arrows point to one F-actin containing basal-membrane associated structure. When the 
kinase domain alone is intentionally mislocalized, ezrin is preferentially located around these 
structures. (G) Cells expressing LOK-RFP and derivatives were stained with ezrin and F-actin 
and the presence of microvilli was scored as in Figs. 3B, 4D. (H) Cell expressing full-length 
LOK fused to the IBR and stained for ezrin and F-actin. Even when intentionally mislocalized 
basally, full-length LOK does not cause ezrin to mislocalize, indicating that it is only active in 
the apical domain. Active, mislocalized LOK constructs cause cells to lose microvilli. Data in B, 
E, and H are means ± s.d. of three or four independent experiments. En face images in C: scale 
bars, 1 μm. All other scale bars, 10 μm. Cross-sections were expanded 5-fold vertically for 
clarity, and yellow asterisks (*) mark transfected cells. 
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generating the K65R kinase-dead mutant previously shown to inhibit LOK activity (Belkina et 
al., 2009) (Figure 3.10.A). 
LOK has been shown to localize to the membrane of peripheral blood lymphocytes 
(Belkina et al., 2009), but a more precise location has not been reported. Although I was unable 
to determine the localization of endogenous LOK, LOK-RFP is mostly apical but also partially 
basolateral (Figure 3.10.B). The N-terminal kinase domain failed to localize to any specific 
region, whereas low-level expression of the C-terminal domain localized specifically to apical 
microvilli (Figure 3.10.B). Thus LOK is localized to microvilli via the C-terminal domain. 
To determine whether LOK distribution is important for its activity toward ezrin in vivo, I 
expressed truncations of LOK and their kinase-dead derivatives along with ezrin-iFlag and 
measured the effect on ezrin-iFlag phosphorylation (Figure 3.10.C). Unexpectedly, I found that 
all constructs containing the active N-terminal kinase domain—even those that did not contain 
the C-terminal domain necessary for localization to microvilli—yielded a similar increase in 
ezrin-iFlag phosphorylation relative to constructs lacking kinase activity (Figure 3.10.C). 
Since the overexpression of either microvillus-localized LOK or the delocalized N-
terminal kinase domain could both raise the level of phosphorylated ezrin to a similar extent 
(Figure 3.10.C), this allowed me to explore the contribution of localizing the kinase activity to 
ezrin distribution. Cells overexpressing full-length LOK were unaffected: ezrin was still highly 
enriched in microvilli (Figure 3.10.D). By contrast, cells overexpressing a delocalized kinase 
(‘LOK-1-348-RFP’) consistently exhibited mislocalized ezrin including on the basolateral 
plasma membrane below cell-cell junctions, a location at which ezrin is never normally enriched 
(Figure 3.10.D, E). This effect is due to the mislocalized kinase activity, because overexpression 
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of either the kinase domain harboring the K65R mutation (‘LOK-1-348-K65R-RFP’) or full-
length LOK never caused ezrin to localize basolaterally (Figure 3.10.D, E). Kinase-dead LOK-
RFP (‘LOK-K65R-RFP’) has a mild dominant-negative effect  reducing the number of cells with 
microvilli as discussed below (Figure 3.15.C), but the remaining ezrin did not mislocalize to 
basolateral membranes, consistent with a requirement for kinase activity in order for LOK 
constructs to have this effect. Taken together, these data suggest that LOK kinase activity must 
be apically restricted via the C-terminal domain to maintain microvilli. 
I next asked whether intentionally mistargetting just the N-terminal kinase domain to a 
specific region of the basolateral membrane would cause ezrin to accumulate in that region. The 
C-terminus of talin has been shown to bind integrins (Xing et al., 2001), so I generated a 
construct containing the LOK kinase domain fused to talin’s integrin binding region (IBR). Cells 
expressing the kinase-domain- IBR chimera (‘LOK-1-348-RFP-IBR’) mislocalized ezrin on the 
basal plasma membrane as well as to basal actin puncta to a significantly greater extent than 
those expressing the kinase domain alone (‘LOK-1-348-RFP’) (Figure 3.10.F, arrows; quantified 
in Figure 3.10.E). Therefore ezrin enrichment coincides with the location of unregulated LOK 
activity. 
Consistent with this and my earlier data showing that phosphomimetic ezrin cannot 
support microvillus formation, overexpression of a delocalized, active LOK kinase domain 
(‘LOK-1-348-RFP’ or ‘LOK-1-348-RFP-IBR’) greatly reduced the number of microvilli, 
whereas overexpression of full-length LOK (‘LOK-RFP’) did not (Figure 3.10.G). Kinase 
activity was also required, because kinase-dead versions of the delocalized kinases (‘LOK-1-
348-K65R-RFP’ or ‘LOK-1-348-K65R-RFP-IBR’) also failed to reduce microvilli (Figure 6G). 
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Thus the correct targeting and activation of LOK to microvilli by a mechanism involving its C-
terminal domain is critical for the normal function and distribution of ezrin. 
Overexpressed LOK was found to be partially mislocalized along basolateral membranes, 
but ezrin was never found associated with it (Figure 3.10.D). Furthermore, when the full-length 
kinase was fused to the IBR (‘LOK-RFP-IBR’), the chimera localized basolaterally to a greater 
extent, but ezrin remained strictly polarized in microvilli (Figure 3.10.H) and microvilli 
remained intact (Figure 3.10.G). Thus in the context of the full-length protein, factors must exist 
that restrict LOK activity apically. 
I performed additional experiments to verify that the effects of the kinase domain 
constructs acted by re-localizing phosphorylated ezrin, and that these effects could also be seen 
with SLK. By immunolocalizing phospho-T567 ezrin and phospho-T564 radixin, I could show 
that delocalized ezrin caused by overexpression of the LOK N-terminal kinase domain was due 
to delocalized ERM phosphorylation (Figure 3.11.A, upper two panels). SLK has a domain 
architecture similar to LOK, and the N-terminal kinase domain and the C-terminal ATH domain 
are conserved between them, whereas the linker region is variable in length and sequence, 
consistent with its not being required for the effects shown below (Figure 3.15). Consistently, 
overexpression of SLK or just the N-terminal kinase domain (1-353) gave equivalent results to 
those obtained with LOK and its derivatives (Figures 3.11.C-E). Thus, I conclude that the LOK 
and SLK activity must be restricted by factors in the apical domain acting through the C-terminal 
ATH region, giving rise to apically polarized ezrin and microvilli. 
Localized LOK/SLK activity is sufficient for microvillus formation 
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3.11 Additional experiments verifying that phospho-ezrin polarity requires polarized LOK and 
SLK activity 
(A) Cells expressing indicated LOK-GFP-Flag fusion proteins were acid-fixed and stained with 
pERM and Flag antibodies. LOK effects on ezrin and radixin localization are due to the 
redistribution of the phosphorylated species. (B) LOK and SLK alignments. Percent identities in 
various domains were scored using CLUSTALW. The kinase domain and the C-terminal domain 
are highly conserved, whereas the linking region (which is dispensable for the dominant effects 
described in Figure 7 and S5) is more divergent. (C) Cells were co-transfected with ezrin-iFlag 
along with various GFP fusions or vector control as indicated, lysed, and the Flag tag 
immunoprecipitated and phosphorylation measured by western blot. Co-transfection of SLK 
leads to an increase in the phosphorylation of ezrin-iFlag so long as the kinase domain is present 
and functional. As with LOK, expression of the C-terminal domain inhibits ezrin-iFlag 
phosphorylation (see Figure 7B). Note that phosphorylation on T567 of ezrin-iFlag exceeds 2-
fold. This happens because transiently transfected ezrin-iFlag is less phosphorylated than 
endogenous ezrin (Figure S1B). (D) Cells overexpressing functional or kinase-dead SLK N-
terminal kinase domain were stained for radixin and F-actin. Overexpression of the functional 
but not the inactive (K63R) kinase domain causes ERM depolarization. (E) SLK and its 
derivatives were expressed in Jeg-3 cells as GFP fusions and the cells stained for ezrin and F-
actin. Full-length SLK is present but not highly enriched in microvilli, whereas, at low 
expression level, the C-terminal domain is localized specifically in apical microvilli. At high 
expression level, the C-terminal region causes the dominant inhibition of membrane-localized 
ezrin, similar to LOK’s C-terminal region (see Figure 7). All scale bars, 10 μm. For clarity, 
yellow asterisks (*) mark transfected cells. 
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To assess the importance of LOK and SLK in microvillus formation, I set out to generate 
erlotinib-resistant forms of the kinases. Erlotinib was first identified as an inhibitor of EGFR 
(Pao et al., 2005; Pao and Chmielecki, 2010). Threonine-766 of EGFR becomes mutated to 
methionine in some erlotinib-resistant cancers and has been shown to cause the occlusion of 
erlotinib from the ATP-binding site (Pao et al., 2005). I asked whether the homologous mutation 
could be used to develop erlotinib-resistant LOK and SLK, which could then be used to test 
microvilli formation in the absence of endogenous LOK/SLK activity. Structural analysis 
revealed that the residues in the homologous positions as T766 in EGFR are I110 in LOK 
(Figure 3.12.A) and I108 in SLK. When modeled into the LOK ATP binding site, erlotinib is 
also close to L85, so we mutated this residue to M as well (Figure 3.12.A).  Expression of LOK-
I110M-GFP or LOK-L85M,I110M-GFP both similarly abrogated the loss of microvilli induced 
by erlotinib treatment after a five minute’s treatment in most cells, while overexpression of wild-
type LOK was less effective (Figure 3.12.B). To optimize the assay, cells transiently transfected 
with a control plasmid (GFP targeted to the nucleus with a nuclear localization sequence) and a 
separate population of cells expressing LOK-I110M-GFP, which enters the nucleus, were mixed 
and treated with erlotinib at different concentrations (not shown) and for different amounts of 
time (Figure 3.12.C,D). These experiments showed that ~15 minutes in 20 μM erlotinib gave the 
maximal difference between treated and untreated cells. 
Next, the assay was used to determine whether positional LOK phosphorylation affects 
the formation of microvilli. Strikingly, expression of just the erlotinib-resistant LOK kinase 
domain failed to rescue microvillus loss in the presence of erlotinib to a similar extent to the 
kinase-dead variant or the control plasmid (Figures 3.13A), and this result was highly 
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Figure 3.12 Creating drug-resistant LOK.  
(A) Green: structure of EGFR (cartoon) bound to erlotinib (sticks; Stamos et al., 2002). Blue: 
structure of LOK kinase domain with residue I110 highlighted (Pike et al., 2008). The homolog 
of T766 (EGFR) is I110, which, along with L85, is also poised to infiltrate the ATP binding 
pocket (LOK). (B) Cells transfected as indicated (along with non-transfected surrounding cells) 
were first treated with 10 μM erlotinib for 5 minutes to induce ezrin dephosphorylation then 
fixed and stained for ezrin. Cells transfected with LOK mutation always had more ezrin staining 
than surrounding non-transfected cells. (C) Cells were first transfected with LOK_110M-GFP or 
GFP-tagged nuclear localization sequence (NLS) as a control, then the cells were trypsinized and 
mixed and placed onto coverslips. Each coverslip was treated with 20 μM erlotinib for indicated 
time, then fixed and stained for ezrin and EBP50. Cells were first analyzed for the expression of 
nuclear GFP (which must have been GFP-NLS) or non-nuclear GFP (which must have been 
LOK-I110M-GFP) and then scored for EBP50-positive microvilli. (D) Representative fields 
from C. Bar is 10 μm. 
 
 
 
 
 
 
 
 
 
 
120
A.
B.
Untreated
Erlotinib, 10 min.
0.00
1.00
0.75
0.50
0.25
NL
S
LO
K-
II1
0M NL
S
LO
K-
II1
0MLO
K
LO
K-
1-3
48
-I1
10
M-
K6
5R
LO
K-
I11
0M
-K
65
R
LO
K-
1-3
48
-I1
10
M
SL
K-
I10
8M
LOK-I110M-GFP
+ Erlotinib
LOK-I110M-K65R-GFP
+ Erlotinib
LOK(1-348)-I110M-GFP
+ Erlotinib
GFP Ezrin EBP50
Figure 3.13 Regulated LOK activity is necessary 
and sufficient for microvilli in the presence of 
erlotinib.  
(A) Cells expressing erlotinib-resistant mutants of 
LOK as indicated were treated with 20 μM erlotinib 
for 10 minutes. LOK-I110M-GFP-transfected cells 
(or SLK-I108M-GFP-transfected cells, Figs. 
3.14.A,B) but not neighboring untransfected cells, 
are protected from microvillus loss due to erlotinib. 
Cells transfected with LOK-1-348-I110M-GFP 
have membrane-enriched depolarized ezrin, but do 
not form microvilli. (C) Quantification of results in 
Figs. B and 3.13.A. Data are means ± s.d. of three 
independent experiments. 
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reproducible (Figure 3.13.B). Thus, the regulation of LOK activity via the C-terminal domain is 
necessary for the presence of microvilli. 
I asked whether erlotinib-resistant SLK could also protect microvilli from erlotinib-
induced collapse. SLK-I108M-GFP-transfected cells continued to have microvilli despite 
treatment with erlotinib (Figure 3.14.A). Thus LOK and SLK are each sufficient for microvilli in 
the presence of erlotinib. 
Finally, I verified that phosphorylated ezrin and radixin could be seen in microvilli 
following erlotinib treatment in LOK-I110M-GFP-transfected cells. Strikingly, it was present in 
microvilli when full-length LOK was transfected, but in a delocalized fashion all over the plasma 
membrane when the erlotinib-resistant N-terminal kinase domain alone was transfected (Figure 
3.14.B), thus confirming that erlotinib causes microvillus collapse by specifically inhibiting 
LOK/SLK activity, which is necessary and sufficient for polarized phospho-ERM. 
The LOK C-terminal domain both localizes and regulates the N-terminal kinase domain 
To further investigate the localization of LOK activity, I examined the effect of 
expressing either full-length constructs or the C-terminal domain alone (Figure 3.15.A). Low-
level expression of the C-terminal domain of LOK (Figure 3.15.B) or the equivalent region in 
SLK (Figure 3.11.B, middle panels) showed that it localizes preferentially to microvilli. 
Strikingly, however, high level expression of the entire LOK C-terminal domain (residues 310-
968) or a smaller segment (residues 586-968) caused a significant reduction in overall ezrin 
phosphorylation (Figure 3.15.B) and a nearly complete elimination of microvilli (Figure 3.15.C). 
In addition to accumulating at cell junctions and in the cytoplasm, expression of the LOK C-
terminal domain caused and accumulated in long protrusive F-actin-containing structures devoid 
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Figure 3.14 Design and utilization of drug-resistant LOK and SLK mutants. 
(A) Cells transfected to transiently express SLK-I108M-GFP were stained for ezrin and EBP50. 
Just like LOK-I110M-GFP, SLK-I108M-GFP also restores apical ezrin and EBP50 distribution 
following erlotinib treatment. Quantified in 3.12.C. (B) Cells transfected to transiently express 
indicated GFP fusion proteins were acid-fixed and stained with pERM and GFP antibodies. 
LOK(1-348)-I110M cannot support apically-positioned phospho-T567 ezrin/phospho-T564 
radixin following inhibition of endogenous LOK/SLK function due to erlotinib treatment. All 
scale bars, 10 μm. 
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Figure 3.15 Overexpression of the LOK C-terminal domain inhibits membrane association of 
ezrin, and this effect can be limited to extremely small regions within microvilli. 
 (A) Schematic of tagged truncation constructs used. (B) Cells were co-transfected with empty 
vector or GFP or RFP fusions of LOK along with ezrin-iFlag. The cells were lysed and ezrin-
iFlag was immunoprecipitated with anti-Flag (Flag IP) and phosphorylation of ezrin-iFlag was 
detected by western blot and quantified. When the LOK C-terminal domain is overexpressed 
without an active kinase domain, ezrin-iFlag phosphorylation is inhibited. (C) Cells expressing 
indicated LOK-GFP or -RFP fusions were stained for ezrin and F-actin and assessed for the 
presence of microvilli. LOK fusions that cause decreased phospho-ERM also cause microvillus 
loss. (D) Cells expressing high levels of the LOK C-terminal domain (LOK-310-968-GFP) were 
stained for ezrin and F-actin. The overexpression of the LOK C-terminal domain causes the loss 
of microvilli and formation of F-actin positive protrusions lacking ezrin. (E) Cells expressing a 
low level of the shorter region of the LOK C-terminal domain (LOK-586-968-GFP) were stained 
for ezrin and F-actin. Bottom panels show an enlargement of the region boxed in the upper right 
panel. (F) Fluorescence intensity along the lines indicated in E of three microvilli from their 
proximal to distal ends as marked. The minimal overexpression of the LOK C-terminal region 
often causes a loss of ezrin staining from the distal ends of microvilli. Data in B and C are means 
± s.d. of three independent experiments. All scale bars, 10 μm. 
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of ezrin mostly emanating from the basolateral membrane, suggesting the possibility that it 
imparts additional defects (Figure 3.15.D). Expression of the equivalent region of SLK promoted 
a similar reduction in phospho-ERM as well as the loss of microvilli (Figures 3.11.C, E, lower 
panel). 
Surprisingly, expression of full-length kinase-dead LOK was much less efficient at 
reducing the number of cells with microvilli (Figure 3.15.C), suggesting that the strong 
inhibitory effect of the C-terminal domain is partially masked in the context of the full-length 
protein.  
At low levels of expression in the rare cells that have normal microvilli, the smaller 
fragment of the LOK C-terminal domain, LOK-586-968-GFP, localized preferentially to the 
distal ends of microvilli (Figure 3.15.E). In individual microvilli, the intensities of ezrin and 
LOK-586-968-GFP display a partially mutually exclusive relationship along microvilli (Figure 
3.15.E,F), and therefore appear to represent targeted inhibition of ezrin accumulation in discrete 
regions.  
To investigate the localization of LOK-586-968-GFP in more detail, additional cells were 
carefully imaged. Ezrin exclusion was observed in all cells expressing this domain and still 
retaining microvilli, but often it was observed at both the tip and base of the microvilli. An 
example is shown in Figure 3.16.A. Even in these examples, however, the bulk of LOK-586-
968-GFP is located toward the microvillus tip. Neither ezrin exclusion nor concentration at the 
microvillus tip was observed with full-length LOK (Figure 3.16.B), possibly hinting at 
regulatory masking in full-length LOK of a localization determinant within its C-terminal region. 
Thus, because LOK-586-968-GFP is typically more concentrated on the tip than at the base of 
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Figure 3.16 Additional controls verifying that the LOK C-terminus localizes to the ends of 
microvilli 
(A and B) Summed-intensity projection of cells expressing a dominant-negative region of the 
LOK C-terminal domain (A) or full-length LOK (B) stained for ezrin and F-actin. A portion of 
the apical membrane is shown, and line intensities for three microvilli in each image are shown. 
(A) In these microvilli, membrane-bound ezrin is reduced in both the base and the tip, as seen in 
three base-to-tip line intensity plots. (B) This is not the case for full-length LOK-GFP, which 
stains the whole microvillus, its intensity rising and falling with that of ezrin in the three 
examples. All scale bars, 10 μm. 
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microvilli (Figures 3.14.E, F), these results hint that endogenous kinase activity may be directed 
towards the growing, distal tip of microvilli, and that the C-terminus can locally displace factors 
involved in activating or derepressing LOK and SLK. 
Preliminary attempts to uncover the regulatory mechanism of LOK and SLK 
To add weight to the hypothesis that the C-terminus of LOK regulates kinase activity, a 
series of C-terminal truncation mutants of LOK were constructed as RFP fusions and expressed 
in cells. As shown in Figure 3.10.E, expression of the N-terminal kinase domain alone, but not 
the full-length causes ezrin mislocalization to basal and lateral membranes. Intermediate effects 
are seen with 1-884, but full mislocalization is achieved with 1-801 (Figure 3.17.A). Thus, 
residues lying between 801 and 968 are strictly required for ezrin’s apical restriction, while 
residues from 884-968 are partially required. 
As shown in Figure 3.15.C, the C-terminal region of LOK causes inhibition of microvilli 
in trans, most likely by inhibiting LOK and SLK activity. Thus I asked what effect the C-
terminal truncation series would have when introduced in the context of the C-terminal domain. 
Maximal inhibition is achieved with the full C-terminal domain from 310-968, and severing off 
the linker region (586-968) does not greatly diminish the effect (Figure 3.15.C, Figure 3.17.B). 
In fact, the construct can be shortened further from the N-terminus to 615-968 without loss of 
inhibitory activity (data not shown). However, truncating from the C-terminal end to 801 (either 
310-801 or 586-801) renders the domains completely incompetent to inhibit microvilli, while 
intermediate effects are seen with 310-884 or 586-884 (Figure 3.17.B). These observations 
correlate strikingly well with ezrin mislocalization in the context of full-length LOK (Figure 
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Figure 3.17 Residues at the extreme C-terminus of LOK are necessary for ezrin polarity and 
inhibition of ezrin phosphorylation in trans. 
(A) Cells expressing the indicated truncation of LOK were stained for ezrin and F-actin 
(phalloidin) and ezrin localization to lateral (light gray) or lateral (dark gray) membranes was 
scored as in 3.10.E. (B) Cells expressing the indicated truncation of LOK were stained for ezrin 
and F-actin (phalloidin) and the presence of microvilli was scored. 
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3.17.A). Thus, residues at the extreme C-terminal end of LOK appear to be necessary both for 
restriction of LOK activity in cis and inhibition of LOK activity in trans. 
I also used the newly developed erlotinib protection assay to discover LOK and SLK 
mutants incapable of rescuing polarized ezrin distribution. Many mutants were used in the assay 
as indicated in Figure 3.18.A, including S951 and T952 which are abundantly phosphorylated in 
LOK but have never been connected with any function (Hornbeck et al., 2012). Mutating these 
either to alanine or phosphomimetic residues had no effect in my assay (Figure 3.18). SLK 
regulation is better studied. Phosphorylation at S347 and S348 by casein kinase II was shown to 
inactivate SLK, and this was shown to regulate SLK function in focal adhesion dynamics and its 
phosphorylation of RhoA (Cordes et al., 2008; Guilluy et al., 2008). Phosphomimetics did not 
reproduce this inactivation in the microvillus assay, a discrepancy I can’t explain (Figure 3.18). 
A number of additional post-translational modifications still remain (curated on Phosphosite), 
and these may prove valuable in uncovering the mechanism of LOK/SLK regulation. 
Interestingly, an isoform of SLK generously provided to us by Luc Sabourin was found 
to lack a small region within the C-terminal ATH domain (‘SLK_short’). This is an isoform that 
could be produced by alternatively splicing the SLK gene, and thus could be expressed in vivo, 
though it does not appear to be the predominant isoform (Sabourin and Rudnicki, 1999). 
Intriguingly, both this isoform and the cognate deletion in LOK (‘LOK_short’) fail to protect 
against erlotinib-induced microvillus collapse in roughly half of the cells (Figure 3.18). In these 
cells, ezrin is partially mislocalized to basolateral membranes (data not shown), implicating this 
region of the ATH domain (residues 663-693 in LOK or 925-955 of SLK) in restricting kinase 
activity, as well. 
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Figure 3.18 Attempts to uncover the regulatory mechanism of LOK using erlotinib-rescue 
assays. 
(A) Cells expressing GFP-nuclear localization signal (‘NLS’) or indicated LOK or SLK protein 
with a C-terminal GFP tag were treated (gray) or not treated (red) with 20 μM erlotinib for 15 
min and then fixed and stained for EBP50, and the presence or absence of microvilli was scored 
as in figure 3.13. (B) Graphical summary of key observations from A. 
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Tryptophan (W) is often involved in coordinating protein interactions. The only W 
residue between 801 and 968 is W913, however mutating this residue has no effect on its 
protection abilities (Figure 3.18). Amazingly, a PCR-induced insertion of 9 residues following 
the mutated W also functioned fully in erlotinib protection. 
In an attempt to determine whether an intramolecular interaction between the N- and C-
terminal regions is necessary, the enhanced blue fluorescent protein (EBFP) open reading frame 
was inserted into the linker region, prying the two domains apart a bit more than normal. 
Although this partially impaired its erlotinib-protection ability (Figure 3.18), it fully restores 
microvilli in around half of the transfected cells. This makes it seem less likely that a critical 
intramolecular interaction regulates LOK and SLK activity in microvilli. 
Two speculative molecular models of LOK and SLK restriction 
Several lines of evidence in the last section (sufficiency as assessed by erlotinib-
protection assays, dominant-positive redistribution of ezrin as assessed by ezrin localization, and 
dominant-negative inhibition of microvilli) have highlighted the importance of two regions 
(Region 1: 615-693, and Region 2: 801-912) within the C-terminal domain in regulating LOK 
and SLK activity. How might this be accomplished at the molecular level? One possibility is that 
of intra- or intermolecular regulation (Figure 3.19.A). In this model the C-terminal domain 
directly interacts with the N-terminal domain on basolateral membranes. The inhibitory 
interaction is released upon binding of activating factor(s) to Regions 1 and 2 of the tail. Thus 
deleting these regions would keep the molecule constitutively active, and high levels of an intact 
tail or a LOK/SLK kinase-dead protein would titrate away these activating factors from 
endogenous LOK and SLK, thereby maintaining their repressed state. Preliminary attempts to 
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validate this model as is have been difficult. First, the N- and C-terminal domains of LOK 
interact poorly in co-immunoprecipitation experiments (data not shown), and, as shown in Figure 
3.18, disrupting the distance between the domains by insertion of an EBFP only occasionally 
disrupts its regulatory ability. 
A second, and more likely model, builds on the first but invokes another unknown factor 
interacting with both the N-terminal and C-terminal domains of LOK and SLK and repressing 
their activity when bound (Figure 3.19.B). In this model, the repressor is displaced by 
engagement with apically-localized, derepressing factor(s). 
It should be noted that the activating factor(s) could represent proteins such as kinases, 
phosphatases, or ubiquitin ligases that post-translationally modify LOK and SLK, changing their 
activation status. Indeed, large-scale phosphoproteome analysis has identified two unexamined 
phosphorylation sites (S679 and S844) and two predicted ubiquitination sites (K621 and K690) 
within regions 1 and 2 as well as another unexamined phosphorylation site just outside Region 2 
(S954) (Hornbeck et al., 2012). It is possible that mutation of these residues will affect LOK and 
SLK function, further elucidating the mechanism. 
LOK and SLK are the general ERM kinases in epithelial and fibroblastic cells 
Finally, I asked whether LOK and SLK C-terminally phosphorylate ERMs in other cell-
lines in addition to their role in placentally-derived Jeg-3 cells. I first examined ERM 
phosphorylation in colon-derived Caco-2 cells. Just as with Jeg-3, Caco-2 cells express ezrin and 
radixin but no moesin. Interestingly, Caco-2 cells express slightly more SLK and much less LOK 
than Jeg-3 cells, but steady-state ezrin and radixin C-terminal phosphorylation is nearly identical 
(Figure 3.20.A). This suggests that SLK is more active than LOK in these cells. 
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Figure 3.20  LOK and SLK function upstream of ERMs in several other epithelial cell models. 
(A) Nearly equivalent amounts of Jeg-3 and Caco-2 cell lysate were subjected to western blots 
with indicated antibodies, and the results reveal that Caco-2 cells express ~4-fold less LOK than 
Jeg-3 cells and ~2-fold more SLK. (B) Caco-2 cells treated with siRNAs as indicated for 4 days 
were subjected to pERM and ezrin Western blot to measure the percentage of T567-
phosphorylated ezrin and T564-phosphorylated radixin, plotted below. SLK and not MST4 is the 
primary ERM kinase in Caco-2 cells, and LOK and SLK siRNA exhibit partial synthetic pERM 
inhibition. (C) Cells as in B were stained for ezrin and F-actin (phalloidin) to reveal that 
microvilli are depleted in coverlip-grown Caco-2 cells depleted of LOK and SLK, but not MST4. 
In one replicate, the very same cells were lysed and analyzed by western blot to confirm the 
transfections. (D) Ezrin stainined of Caco-2 cells expressing GFP-tagged LOK or SLK tail, but 
not a truncated variant (see 3.17), causes loss of ezrin-staining microvilli. Phalloidin-staining 
microvilli-baring cell fraction was scored. (E) Left: LLC-PK1.CL4 cells were transiently 
transfected to express ezrin-iFlag along with GFP-tagged LOK C-terminus or treated with 10 μM 
erlotinib for 10 minutes as indicated, and then a denaturing Flag IP was performed, and the 
immunoprecipitate subjected to Western blot as in panel B. The fraction of pERM is plotted 
below. Right: As in Caco-2, expression of the LOK tail causes a loss of ezrin-staining microvilli. 
(F) HEK293T cells were treated with indicated siRNAs and processed as in B. SLK is the 
primary ERM kinase in HEK293T cells. (G) Primary mouse embryo fibroblasts (MEF) or 
MDCK cells were treated with indicated drugs for 10 minutes and then processed as in B. ERM 
phosphorylation is sensitive to erlotinib in MEFs and MDCK cells. 
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Consistently, siRNA-mediated depletion of SLK alone causes a 50% decrease in phospho-ERM 
level, whereas depletion of LOK has no measurable effect on its own (Figure 3.20.B); however, 
combining LOK and SLK siRNAs revealed a marginal synergy between them (p < 0.05, Fig 
3.19.C). Depletion of MST4, the ERM kinase in the single polarized Ls174T-W4 cells (ten 
Klooster et al., 2009), had no effect on ezrin phosphorylation in Caco-2 (Figure 3.20.B) or Jeg-3 
cells (Figure 3.9.B). An examination of Caco-2 cultures knocked down for LOK and SLK 
revealed a reproducible 2-fold loss of microvilli-bearing cells; whereas no such loss was 
observed when MST4 was depleted (Figure 3.20.C). I also found that similar to their expression 
in Jeg-3 cells, the expression of the intact C-terminus of either LOK or SLK inhibited ezrin 
accumulation in the apical domain of Caco-2 cells, whereas a truncated C-terminal region which 
could not inhibit microvilli in Jeg-3 cells did not (Figure 3.20.D). These results suggest that LOK 
and SLK are the ERM kinases in Caco-2 cells, and that the regulatory mechanism is conserved 
between the cell-lines. 
Because my siRNAs target human mRNA, I could not knock down LOK and SLK in 
porcine kidney-derived LLC-PK1.CL4 cells, which have been widely used for studies of 
microvilli. However, expression of the LOK C-terminus inhibited co-transfected ezrin-iFlag 
phosphorylation and the accumulation of endogenous ezrin in microvilli, and erlotinib inhibited 
ezrin phosphorylation to a similar extent to its effect in Jeg-3 cells (Figure 3.20.E). Interestingly, 
many LLC-PK1.CL4 cells expressing the LOK C-terminal domain erupted in mostly apical 
bulbous projections resembling cortical blebs, but importantly, these lacked ezrin. This may 
support a role for ezrin in resolving blebs into the cortex, as Mitchison and colleagues have 
suggested (Charras et al., 2006). Other cells produced protrusions from both the apical and 
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basolateral membrane, but all were negative for ezrin (data not shown). The results suggest that 
LOK and SLK are the ERM kinases in LLC-PK1.CL4 cells. 
Lastly, I also examined human kidney-derived HEK293T cells by siRNA (3.20.F), and 
primary mouse embryonic fibroblasts (MEFs) and dog kidney-derived MDCK cells by erlotinib 
treatment (3.20.G), and my data were always consistent with a critical role for LOK and SLK in 
phosphorylating ERMs. This is especially surprising because HEK293T cells and MEFs lack a 
truly polarized apical domain and do not possess organized microvilli, but both incorporate ezrin 
specifically into surface structures, thus retaining a crude sort of ezrin polarity (HEK293T: 
Jessica Wayt personal communication; MEF: Heiska and Carpen, 2005). Thus LOK and SLK 
appear to have a very general role in ERM phosphorylation in mammalian cell-lines regardless 
of the tissue-of-origin, morphology, or differentiation status. 
DISCUSSION 
Functional polarity requires the targeting of appropriate membrane proteins to specific 
domains but also defining the morphology of the domain by cytoplasmic factors, about which 
little is known. Here I uncover how ezrin function is restricted to the apical membrane. I first 
demonstrate that phosphocycling on T567 is critical.  Second, I identify the relevant kinases in 
epithelial cells as LOK and SLK. Third, I show that the kinases are enriched in microvilli 
through their C-terminal domain. Fourth, I show that the kinases are locally activated in 
microvilli. 
Extensive characterization of the ERM phosphomimetic corresponding to ezrin T567D/E 
has shown that it reflects the activated form (Chambers and Bretscher, 2005; Charras et al., 2006; 
Kunda et al., 2008; Matsui et al., 1999; Polesello et al., 2002; Carreno et al., 2008; Speck et al., 
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2003). Earlier studies of epithelial cells suggested that overexpressing the ezrin phosphomimetic 
can provide more numerous microvilli, but these studies were performed in the presence of 
endogenous ezrin (Fievet et al., 2004; Crepaldi et al., 1997). By contrast, I show that expression 
of the phosphomimetic in the absence of endogenous ezrin, or unopposed phosphorylation of 
ezrin, or ezrin phosphorylated by a non-localized kinase, all lead to its mislocalization to the 
basolateral membrane and the loss of its function. My results are consistent with the finding in 
fly photoreceptor cells that re-expression of wild-type Moesin but not the phosphomimetic 
T559D Moesin can restore apical microvilli following Moesin gene disruption (Karagiosis and 
Ready, 2004). 
I find that the normal ezrin phosphorylation cycle is about two minutes, which is similar 
to the turnover rate as measured by FRAP of ezrin-GFP in the same cells (Garbett and Bretscher, 
2012). Thus, my data imply that the apical membrane is a dynamic system of local ezrin 
phosphorylation. Since microvilli have been shown to undergo constant remodeling (Gorelik et 
al., 2003; Garbett and Bretscher, 2012), phosphocycling ensures that activated ezrin can be 
recruited into growing microvilli as needed. 
To identify the relevant kinases for ezrin T567 phosphorylation, I used an unbiased 
proteomic approach, leading me to LOK and SLK, two evolutionary homologs, which I found 
are necessary and sufficient for microvilli formation by localized ezrin.  LOK has previously 
been shown to regulate moesin in lymphocytes. However, mice with the LOK gene knocked out 
have reduced ERM phosphorylation and alterations in chemokine-stimulated lymphocyte 
migration and polarization, but the mice are viable (Belkina et al., 2009). I suspect that in such 
knockout mice, SLK is providing a compensating function, and predict that a double LOK and 
SLK knockout mouse would be inviable. Since the ERM kinase in Drosophila is Slik, the 
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homolog of LOK and SLK, this implies that regulation of ERM proteins by this family of 
kinases has an ancient evolutionary origin. 
Earlier work has shown that in single epithelial Ls174T-W4 cells a signal transduction 
pathway from LKB1/Strad results in the activation of the kinase MST4 to phosphorylate ezrin 
necessary for morphological assembly of the apical domain (ten Klooster et al., 2009; Gloerich et 
al., 2012). Moreover, these studies reported that phosphomimetic ezrin targets and restores 
microvilli in these MST4 knockdown cells, in apparent contradiction to my work. Although the 
expression level of phosphomimetic ezrin relative to endogenous ezrin was not reported, these 
results suggest that other mechanisms may exist under some circumstances to polarize ezrin 
apically. Furthermore, ten Klooster et al. (2009) also reported that knockdown of MST4 in Caco-
2 cells induced defects in apical morphology (ten Klooster et al., 2009).  By contrast, I have 
found that knockdown of LOK and SLK, but not MST4, in either Jeg-3 or Caco-2 results in 
reduced ezrin phosphorylation and loss of apical microvilli. I can offer no simple explanation for 
the difference in results between my and these studies. 
Although both LOK in mammalian lymphocytes and Drosophila Slik have been 
implicated in ERM phosphorylation, it was not known how their function was restricted to a 
specific domain. I now show that the C-terminal region of both LOK and SLK target the kinase 
to apical microvilli and restrict their activity apically. Accordingly, overexpression of the LOK 
C-terminal domain uncoupled from the kinase domain acts as a dominant-negative to inhibit 
ERM phosphorylation, leading to the destruction of microvilli. I find a similar effect in colon 
epithelial Caco-2 cells and kidney epithelial LLC-PK1.CL4 cells (Fig 3.19.), suggesting that 
LOK and SLK may be the general ERM kinases in epithelial cells. 
140
We have previously shown that phospho-ezrin and -radixin are enriched towards the tip 
of the microvillus, and suggested that ezrin is phosphorylated at the microvillus tip and then 
moves down with treadmilling actin (Hanono et al., 2006).  I now find a region within the LOK 
protein which, when expressed at low levels, is often confined to the tip of microvilli, as would 
be expected if it is the relevant kinase. I therefore propose that some factor enriched at the 
microvillus tip, recruits LOK and activates it there locally. Ezrin becomes phosphorylated, and, 
as it moves down the microvillus, it begins to become dephosphorylated by a cytoplasmic 
phosphatase and ultimately releases from the membrane and F-actin at the base. 
Interestingly, ERM-anchorage has been invoked as a means for maintaining the protein 
composition of the apical domain in the absence of polarized membrane trafficking (Meder et al., 
2005). The phosphocycling mechanism I describe, and thus polarized LOK/SLK, may therefore 
be a critical component of this “pre-apical” polarity pathway. 
The work presented here has uncovered local regulation of ERM proteins by LOK and 
SLK through an unidentified microvillar component. So far, no interactors of LOK are known, 
but several binding partners of SLK have been reported, including microtubules (Cordes et al., 
2008; Wagner et al., 2002; Burakov et al., 2005), F-actin (Sabourin et al., 2000), PDZ-domain 
containing protein PDZK1 (Gisler et al., 2003), and the transcription factors Lbd1/2 (Storbeck et 
al., 2009). My current efforts are aimed at determining whether these or other interactors are 
responsible for the polarized activity of LOK and SLK. 
In establishing the phenotype associated with ERM depletion, I made two striking 
observations which point to the limitations of this work in providing mechanisms for microvillus 
biogenesis. In contrast to two previous reports using potentially nonspecific antisense 
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oligonucleotide synthesis to reduce ERM expression (Tsukita et al., 1994; Bonilha et al., 1999), 
siRNAs-mediated depletion of ERMs in Jeg-3 cells cause a loss of a very specific class of F-
actin structure—microvilli—but not others, including cell-cell junctions, lamellipodia, or even 
filopodia, which are nearly structurally identical to microvilli. The same very specific defect 
occurs when EBP50 is depleted in Jeg-3 cells (Damien Garbett, personal communication). 
Secondly, I found that Caco-2 cell microvilli are only lost from cells treated with LOK and SLK 
siRNA prior to reaching confluence. When the cells were replated in smaller dishes following 
the siRNA transfection and thus allowed to reach confluence prior to the analysis, the 
microvillus defect was fully reversed (data not shown). Furthermore, in confluent Caco-2 cells, 
ERM dephosphorylation by staurosporine or erlotinib treatment caused ezrin to translocate away 
from microvilli, but did not alter the apical microvilli as observed by F-actin staining (Cécile 
Sauvanet, personal communication). Similar results were seen in EGF-stimulated A431 cells 
pretreated with staurosporine (Yonemura et al., 2002). Finally, LLC-PK1.CL4 cells made to 
almost completely lack ERMs have mostly intact microvilli, although their organization is 
significantly affected, and the results do not seem to depend upon plating density (Appendix A). 
Taken together with the observation that intestinal cells in situ retain microvilli despite severe 
morphological defects (Saotome et al., 2004), these findings hint that other pathways than the 
ERM-dependent pathway described in this thesis can provide cross-linking function between the 
plasma membrane and the cytoskeleton. It also suggests at extensive diversity in the use of these 
pathways in regulating apical morphology among different cell-types. In short, a microvillus is 
not a microvillus is not a microvillus. How might plasma membrane-cytoskeletal cross-linking 
be performed in the absence of ERMs? Obvious candidates are myosins (classes I, VI, VII, X, 
XI, and XV) which possess membrane anchoring domains in addition to their F-actin-binding 
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and motor properties. It will be interesting to test whether these or other pathways are 
additionally required for microvilli in the exceptional cases mentioned. 
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APPENDIX A 
ERM SUPPRESSION IN LLC-PK1.CL4 CELLS CAUSES VILLIN UPREGULATION 
LLC-PK1.CL4 cells have been used extensively for studies of microvilli, particularly in 
studies of brush border myosin IA. Thus, I sought to characterize the role of ezrin, radixin, and 
moesin in the microvilli of these cells. 
MATERIALS AND METHODS 
LLC-PK1.CL4 cells were kindly provided by Matthew J.Tyska (Vanderbilt University). 
They were grown in MEMα + 10% FBS at 37ᴼC in a humid incubator containing 5% CO2. 
Anti-villin antibody was rabbit polyclonal H148 (Anthony Bretscher) or 1D2C3 mouse 
monoclonal (Santa Cruz). Anti-Fimbrin and Anti-Myosin II heavy chain antibody was from 
Anthony Bretscher. 
shRNA sequences (5’-GATATGGGCTGAATACAAA-3’ for GL2 Luciferase control; 
5’-GGAAGAGGATGATGTGTTC-3’ for villin) were cloned into pSUPER.retro.puro 
(Oligoengine) following the manufacturer’s instructions. They were packaged in the Pheonix 
Ampho cell-line, and the supernatant was used to infect LLC-PK1.CL4 cells, which were then 
selected in 2 μg/mL puromycin.  
siRNAs were as follows: AAAGUCAGGUGCCUUCUUGuu-3’ (Ezrin); 
UGAAGAUGUUUCUGAGGAAuu-3’ (Radixin); 5’-GGCUGAAACUCAAUAAGAAuu-3’ 
(Moesin). These were premixed at a ratio of siEzrin:siRadixin:siMoesin::1.7:1:1.6 (siERM), 
which reflects the expression level difference between ezrin, radixin, and moesin in LLC-
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PK1.CL4 cells. 50 nM of siERM were transfected by Lipofectamine 2000 (Invitrogen) following 
the manufacturer’s protocol into LLC-PK1.CL4 cells three times over 9 days prior to processing. 
All immunofluorescence, western blotting, and additional antibodies were as described in 
chapters 2 and 3. 
RESULTS AND DISCUSSION 
Transfection of siERM into LLC-PK1.CL4 cause knockdown to undetectable levels for 
each ERM (Fig. A.1.A). Blotting for other microvillar components showed that fimbrin and 
EBP50 remained constant, myosin II went slightly down, whereas the levels of villin 
dramatically increased (Fig. A.1.A). An examination of the proteoglycans on the cell surface 
using pre-permealization WGA revealed few cells lacking microvilli following the depletion of 
ERMs (Fig. A.1.B), however the composition of the microvilli changed, as more microvilli now 
contained villin, whereas it was predominantly cytoplasmic in control cells (Fig. A.1.C). 
To test whether the upregulation of villin was obscuring a defect in microvilli, I 
suppressed villin in addition to knocking down ERMs. This works, because cells treated with 
both villin shRNA and ERM siRNA indeed had undetectable levels of phosphorylated ERMs 
while still having less villin than cells treated without any targeted RNAi (Fig. A.1.D) 
The downregulation of villin on its own or in combination with ERM suppression had no 
effect on the number of cells with microvilli (data not shown). ERM knockdown in LLC-
PK1.CL4 cells caused a general disorganization of the apical surface of cells. Blindly scoring the 
subjective attribute showed that villin suppression rendered no enhancement of this defect 
regardless of plating density (Fig. A.1.E). Thus, villin upregulation is a genuine consequence of 
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Figure A.1 Ezrin, radixin, and moesin depletion in LLC-PK1.CL4 causes villin upregulation and 
disorganization of the apical membrane without loss of microvilli-baring cells 
(A) LLC-PK1.CL4 cells transiently transfected with control siRNA or siRNAs against all three 
ERMs for 9 days were western-blotted with indicated antibodies. ERM removal causes a specific 
increase in the expression of villin, but no increase in the levels of ERM-associated EBP50 or 
another actin cross-linked protein, fimbrin. (B) Cells as in B were grown on glass coverslips, 
fixed and stained with fluorescent WGA to illuminate the plasma membrane (as in E) and scored 
for the presence of microvilli. ERM removal has a marginal impact on the number of microvilli-
baring cells. (C) Control or ERM-depleted cells were stained for villin and F-actin. ERM-
depletion resulted in a 10-fold increase in the number of cells expressing villin in microvilli. (D) 
Cells stably transfected to express indicated shRNA were transiently transfected to deplete 
ERMs and western blotted as indicated. Note that the level of villin in villin shRNA-expressing, 
ERM-depleted cells is less than the amount of villin in control/control cells. (E,F) Cells as in D 
were stained with WGA (green) and phalloidin (red), and the number of disorganized brush-
borders scored. Note: all cultures had similar numbers of cells with microvilli, and ERM-
depletion-induced loss of brush border organization was not synthetically enhanced by villin 
depletion. 
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ERM suppression, perhaps reflecting accelerated differentiation of a subset of cells. However, 
this specific change does not affect microvillar morphology. 
ERM suppression in situ causes many specific developmental defects (Saotome et al., 
2004; Casaletto et al., 2011) which cannot easily be explained by its biophysical role in 
imparting membrane tension or its cell biological role in microvillar morphology. For instance, 
villus fusion is blocked in ERM-deficient developing intestinal epithelial cells (Saotome et al., 
2004). The work here suggests that expression-level changes are caused—however indirectly—
by ERM suppression in tissue culture cells, as well. Examining these systematically (by 
microarray or whole-proteome SILAC methods) may prove useful to explain the changes in situ. 
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APPDENDIX B 
INVESTIGATIONS INTO THE FUNCTION OF NADRIN, AN EBP50 PDZ LIGAND 
Nadrin (also known as RICH-1 or ARHGAP17) was identified as a ligand of the first 
PDZ domain of EBP50 (Reczek and Bretscher, 2001). Thus we asked whether Nadrin and 
EBP50 biology intersect in some way. EBP50 has an established role in microvillar morphology 
(Hanono et al., 2006b). During these investigations, a second role for Nadrin in establishing tight 
junctions (Wells et al., 2006) and Nadrin ligand Par3 in primary ciliogenesis (Sfakianos et al., 
2007) were claimed. Therefore we asked what role Nadrin plays in these three processes. 
MATERIALS AND METHODS 
T23 MDCK cells were kindly provided by Keith Mostov (Univeristy of California, San 
Francisco) and maintained in DMEM with 10% FBS at 37ᴼ in a humidified incubator containing 
5% CO2.  All other cells were as described previously. 
Anti-Nadrin antibody was primarily B85AP1, made against recombinant, bacterially-
produced Nadrin. Anti-RICH-2 was from Fabbgenix. Anti-ZO-1 antibody was from Zymed. 
Anti-acetylated tubulin antibody was from Sigma. 
shRNA sequences (5’-GATATGGGCTGAATACAAA-3’ for GL2 Luciferase control; 
5’- GAA TGACACAAGTTGCAA -3’ for Nadrin of human, mouse, or dog origin and 5’- 
GAATGGACGCAAGTTGCCA-3’ for Nadrin of pig origin) were cloned into 
pSUPER.retro.puro (Oligoengine) following the manufacturer’s instructions. They were 
packaged in the Pheonix Ampho cell-line, and the supernatant was used to infect target cells, 
which were then selected in puromycin.  
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Nadrin siRNA was the following sequnence: 5’-GGUGCUUUAAAAUCCUAUUtt-3’. 
siRNAs were transfected into Jeg-3 cells using Lipofectamine RNAiMAX (Invitrogen)  
previously described. 
Calcium switch experiments were performed by growing MDCK cells to confluence on 
coverslips, and then changing the media to SMEM containing 10 % FBS for 18-24 hours, and 
then switching the media back to DMEM + 10% FBS for indicated times. 
All additional procedures were as described in chapters 2 and 3 or appendix A. 
RESULTS AND DISCUSSION 
The Nadrin gene produces two spliceforms, p120 Nadrin and p100 Nadrin (aka RICH-1). 
A related gene product called RICH-2 shares homology in the N-terminal region, encoding a 
membrane-curvature sensing N-BAR domain and a Rho GTPase activating protein domain, but 
contains almost no discernible homology in the C-terminal region, although both contain 
polyproline-rich regions which bind a number of SH3 domains. Strikingly, all Nadrins end in the 
same final 6 amino acids –E-E-S-T-A-L, a predicted PDZ consensus site (Figure B.1.A). 
Consistently, both Nadrin and RICH-2 can interact with EBP50 from lysates (Figure B.1.B) but 
this interaction is disrupted by the addition of residues to the C-terminal region (Figure B.1.C). 
Antibodies against Nadrin and RICH-2 do not cross-react (Figure B.1.D), and so could be used 
in immunofluorescence where they predominantly illuminate the cytoplasm (Figure B.1.E,F). 
Some Nadrin can be seen in microvilli when overexpressed (Figure B.1.E). 
We first investigated whether Nadrin is requied for microvilli. Jeg-3 cells contain p120 
Nadrin but no RICH-2 (Figure B.2.A). When >80% of Nadrin is depleted from Jeg-3 cells, there 
is no significant decrease in the number of cells with microvilli (Figure B.2.C). A similar lack of 
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Figure B.1 Nadrin and RICH-2 bind to EBP50 through a C-terminal PDZ motif, and localize 
primarily to the cytoplasm when expressed in Jeg-3 cells. 
(A) Schematic of Nadrin and RICH-2. N-BAR, N-termainl Bin, Amphiphysin, Rvs161/167 
domain; RhoGAP, Rho GTPase activating domain; PP, poly proline regions; STAL, C-terminal 
PDZ binding motifs. (B) Jeg-3 cell extract was subjected to GST-pulldowns using indicated 
regions of Nadrin or RICH-2 or GST only control, resolved and western blotted for EBP50. 
EBP50 interacts with the C-termini of both Nadrin and RICH-2. (C) LLC-PK1 cell extract, 
which has very little endogenous Nadrin, transfected with Nadrin constructs as indicated was 
subjected to GST-pulldowns using the PDZ1+ region of EBP50 (Reczek and Bretscher, 2001), 
and western blotted for endogenous and overexpressed Nadrin. Nadrin binds to EBP50 only 
when the C-terminus is unmodified. (D) 293T cells expressing untagged Nadrin or RICH-2 were 
western blotted for either Nadrin (B85AP1) or RICH-2 (Fabgennix 1141) validating the 
antibodies. (E,F) Cells overexpressing untagged Nadrin (E) or RICH-2 (F) were stained with 
antibodies detecting Nadrin (E) or RICH-2 (F) showing mostly cytoplasmic expression. Nadrin 
partially localizes in microvilli when overexpressed. 
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Figure B.2 Nadrin and RICH-2 are not required for microvilli in three epithelial cell-lines. 
(A) Cells as indicated were western blotted for RICH-2, revealing that Caco-2 cells express 
RICH-2 as previously described (Rollason et al., 2009). (B) Nadrin western blot using indicated 
amounts of Jeg-3 cell lysate transiently transfected with Nadrin siRNAs revealing that ~80% of 
Nadrin can be depleted from Jeg-3 cells. (C) Cells transfected as in B were fixed and stained 
with ezrin antibodies and the number of microvilli-baring cells scored revealing no significant 
differences. (D) Nadrin western blot using indicated amounts of LLC-PK1.CL4 cell lysate 
transiently transfected with Nadrin siRNAs revealing that ~90% of Nadrin can be depleted stably 
from LLC-PK1.CL4. (E) Cells as in D were fixed and stained with phalloidin to reveal apical F-
actin, revealing no differences. (F) Nadrin western blot using indicated amounts of T23 MDCK 
cell lysate transiently transfected with Nadrin siRNAs revealing that ~90% of Nadrin can be 
depleted stably from MDCK. (G) Cells as in F were fixed and stained with phalloidin to reveal 
apical F-actin, revealing no differences. 
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effect on microvilli is seen in LLC-PK1.CL4 and MDCK cells stably expressing Nadrin shRNA, 
which depleted the gene product by greater than 90% in both cases (Figure B.2.D-G). These 
experiments suggest that Nadrins have no unique role in microvilli biogenesis or maintainance. 
We next investigated whether Nadrin-depleted MDCK cells could still recruit ZO-1 into 
tight junctions, a process which others have claimed is defective in the same cells (Wells et al., 
2006). Contrary to the previous report, MDCK cells with a >90% reduction in Nadrin protein 
levels retained tight junctions at steady-state (Figure B.3.A) and formed them with normal 
kinetics following calcium switch (Figure B.3.B,C). These experiments suggest that Nadrin has 
no unique role in tight junction biogenesis or maintainance. 
In the course of generating various cells lacking Nadrin, I observed that depleting Nadrin 
from Caco-2 cells caused a subtle delay in cell spreading (Figure B.4). 
In the course of my observations of Nadrin trunctations, I noticed that Nadrin (B.5.A) and 
especially the Nadrin N-BAR domain (Figure B.5.B), localized in puncta. Some of these were 
identified as endocytic sites, as they were enriched in PI(3)P. Thus Nadrin localizes to some 
endosomes, as has been claimed (Wells et al., 2006). We examined degradation of EGF receptor 
as a model endocytic cargo, and found no significant delay its degradation following activation 
by EGF treatment (Figure B.5.C). Thus, Nadrin may have a role in endocytosis, but the pertinent 
cargo is not the EGF receptor. 
Because the N-BAR domain of Nadrin localizes to curved membranes in vitro and in vivo 
(Peter et al., 2004; Galic et al., 2012) and that the microvillus base (which is partially tapered at 
the extreme proximal region) potentially represents a curvature hotspot, we examined whether 
the fine localization of Nadrin relies upon the N-BAR domain. Endogenous Nadrin localizes to 
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Figure B.3 Nadrin is not required for ZO-1-labeled tight junctions at steady-state or during 
reformation. 
(A) T23 MDCK stable cell-lines as in B.2.F,G were seeded at confluence for 7 days on 0.4 μ-
pore polycarbonate filters, fixed, and stained with ZO-1 antibody (Zymed) revealing no 
differences. (B) Cells as in B.2.F,G and A were seeded at confluence for 4 days on coverslips 
and then subjected to calcium depletion and repletion for 4 hours as indicated, then fixed and 
stained for ZO-1 revealing no differences in contrast with (Wells et al., 2006). (C) Cells as in B 
were calcium-repleted for indicated times, fixed, and stained for ZO-1 and F-actin (not shown). 
~300 cell-cell junctions per treatment were scored for the presence or absence of ZO-1, and the 
data plotted revealing no significant difference in ZO-1 recruitment to cell-cell junctions 
following calcium switch in contrast with (Wells et al., 2006). 
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Figure B.4 Nadrin is required for spreading in Caco-2 cells. 
(A) Caco-2 cells expressing Nadrin shRNA were western blotted for Nadrin and RICH-2. (B) 
Cells expressing Nadrin shRNA were analyzed by DIC microscopy after 24 hours of seeding. 
Nadrin knockdown appears to cause delayed spreading. 
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Figure B.5 Nadrin is recruited to a subset of endosomes. 
(A) Jeg-3 cells overexpressing untagged Nadrin and a PI(3)P-flare, the FYVE domain of EEA-1 
tagged with GFP, were stained for Nadrin to reveal partial co-localization. (B) Cells 
overxpressing the Nadrin N-BAR domain tagged C-terminally with HxP and a PI(3)P-flare were 
stained for the HxP tag to reveal partial colocalization to a subset of large vacuole-like structures 
coated with the endosome marker PI(3)P. (C) Jeg-3 cells transfected as in B.2.B,C were treated 
with 100 ng/mL epidermal growth factor (EGF, Invitrogen) for indicated times, lysed, resolved 
and western blotted for EGF receptor and loading control E-cadherin. Intensity of EGF receptor 
divided by E-cadherin (N=1) were graphed. EGF receptor degradation rates are similar to control 
suggesting that EGF receptor activation and internalization are more or less unaltered following 
Nadrin depletion. 
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the cytoplasm but concentrates at the microvillus base (Abraham Hanono, personal 
communication). This is partially recapitulated by expression of an EBP50-binding-deficient 
form of Nadrin (tagged on the C-terminus with HxP), suggesting that EBP50 binding is not 
strictly required for this localization (Figure B.6.A). The ezrin-binding-site (EBS) of EBP50 
localizes to the full-length of microvilli (Garbett et al., 2010) by binding directly to ezrin 
(Reczek et al., 1997; Figure B.6.A). Appending either Nadrin or RICH-2 to the N-terminal end 
of the EBS forced it to localize specifically to microvilli and accumulate just at the base (Figure 
B.6.A). A truncation analysis of Nadrin or RICH-2 within the chimera indicated that the N-BAR 
was necessary and sufficient for the restriction to the base (Figure B.6.B). Western bloting 
indicates that the chimeras were expressed as expected without degradation (Figure B.6.C). 
These results are consistent with microvillus base presenting a curved platform to which 
Nadrin’s N-BAR can be recruited. They additionally add to the existing data which suggests that 
tissue culture cell microvilli can segregate their protein components into discrete domains 
(Hanono et al., 2006a). 
As Nadrin interacts with Par3 (Wells et al., 2006) and EBP50 and its interacting proteins 
may modulate ciliogenesis (Francis et al., 2011), we investigated whether Nadrin regulates 
primary ciliogenesis. MDCK cells stably knocked down for Nadrin by >90% were grown at 
confluence for either 6 or 9 days on 0.4 μ pore-size filters, and then fixed and stained for 
acetylated tubulin, which accumulates predominantly in primary cilia. Significantly fewer Nadrin 
knockdown cells had elongated primary cilia at both timepoints (Figure B.7). However, these 
results could not be recapitulated in either LLC-PK1.CL4 cells or NIH3T3 cells lacking Nadrin, 
where ciliogenesis proceeded at the normal pace (data not shown). Additionally, neither Nadrin 
nor EBP50 was found to be a component of primary cilia (data not shown). Therefore, Nadrin 
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Figure B.6 Nadrin is recruited to a subset of endosomes. 
(A) Jeg-3 cells overexpressing indicated, HxP-tagged proteins and chimeras were fixed and 
stained for the Xpress tag and ezrin. Whereas, the ezrin-binding site of EBP50 localizes to the 
full-length of microvilli, Nadrin- or RICH-2 fused to the ezrin-binding site localize specifically 
to the microvillus base. (B) Summary of localization of indicated truncations and chimeras. The 
N-BAR domain is necessary and sufficient to localize to the microvillus base in the chimera of 
Nadrin fused to EBP50’s ezrin binding site. (C) Expression of selected, intact fusion proteins 
was verified by EBP50 western blot. 
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Figure B.7 Nadrin may be required for the proper timing of primary cilium biogenesis 
(A) MDCK stable cell-lines expressing control shRNA (shGL2) or Nadrin shRNA (shNadrin) as 
in Figure B.2.F were grown at confluence on 0.4 μ-pore-size filters for 6 days to induce 
formation of the primary cilium, and then fixed and stained for acetylated tubulin (marking the 
primary cilium) and F-actin (phalloidin). (B) shGL2 (dark gray) or shNadrin (light gray) cells as 
in A were scored for no primary cilium (‘No’) a punctate pro-cilium (‘Pro’) or an elongated 
primary cilium (‘Elongated’) after indicated number of days at confluence.
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knockdown may have an effect on ciliogenesis in MDCK cells, but this may reflect a delay in 
any of the downstream polarity processes required to be intact prior to ciliogenesis. 
Thus, despite interacting tightly with EBP50, Nadrin does not appear to be involved in 
the same function. Interestingly, Lauffer et al. reached a similar conclusion regarding sorting of 
the β2 adrenergic receptor (Lauffer et al., 2010). Though the tail of the receptor binds tenaciously 
to EBP50’s first PDZ domain in vitro (Cao et al., 1999), it is the PDZ domain from a different 
protein, SNX27, that regulates its endocytic sorting. Along with many others, such findings 
imply that evolutionarily recent protein interaction pairs such as the PDZ-PDZ binding motif 
interaction may have been incompletely selected for specificity. 
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APPENDIX C 
AN ISOFORM-SPECIFIC INTERACTION BETWEEN EBP50 AND IRSP53-T 
Work on EBP50 in Jeg-3 cells strongly indicated that an unknown ligand interacting with 
EBP50’s first PDZ domain brings about microvilli (Garbett et al., 2010; Hanono et al., 2006). In 
the previous appendix, it became clear that Nadrin was not this ligand, because removing it did 
not affect microvilli in several cell types (Appendix B). Although there is a strong interaction 
between EBP50 and Nadrin in vitro, this interaction could not be recapitulated by 
immunoprecipitation with or without DSP cross-linking prior to lysis (data not shown). Thus, we 
sought to determine the EBP50 PDZ1 immunoprecipitation-defined interactome in order to 
identify the true EBP50 PDZ1 ligand(s). 
MATERIALS AND METHODS 
EBP50 and PDZ mutant cDNAs were obtained from Damien Garbett (Garbett et al., 
2010) and cloned by tailored PCR into pQCXIP-3XFLAG. IRSp53-S and -T were amplified 
from Jeg-3 cDNA and cloned into pEGFP-C1 or pTagRFP-T-C1. 
For immunoprecipitations, 2 x 108 cells per construct were grown in SILAC media, 
scraped directly into lysis buffer (25 mM Tris pH 7.4, 150 mM NaCl, 2.5% glycerol, 1% 
IGEPAL, 0.1 mM Na3VO4, 50 mM NaF, 10 mM β-GP, 1X Roche Protease inhibitor tablet), 
homogenized by 5 strokes of a loose-fitting dounce homogenizer, clarified, and 
immunoprecipitated with 20 μL of Flag-M2 affinity gel (Sigma) for 2 hours and then processed 
for mass spectrometry as described in Chapter 2. High confidence interactors were those for 
which at least 2 peptides were identified at a wild-type-to-PDZ1 mutant ratio of at least 4.0. 
165
Liposomes and liposome flotation assays were exactly according to (Santiago-Tirado et al., 
2011). GST-EBP50-PDZ1+ was as previously described (Reczek and Bretscher, 2001). 
GST-IRSp53 tail was made by PCR amplifying IRSp53 434-520 with or without an 
additional alanine and inserting it into pGEX6P1, transforming Rosetta2DE3 bacteria with the 
resulting plasmid, and purification using glutathione agarose resin (GE Healthcare). 
The IRSp53 siRNA (5’-CAGAAUCAGCUGGAAGAAAtt-3’) was Silencer Select from 
Ambion. 
The pan-IRSp53/58 antibody was from Milipore. All other reagents are as described in 
chapters 1-3 and appendices A and B. 
RESULTS AND DISCUSSION 
Jeg-3 cells expressing 3XFLAG-EBP50 and PDZ mutants singly or in combination as 
well as 3XFLAG-EBP50 incapable of interacting with ezrin (MAWA) (Garbett et al., 2010) 
were generated. As a control, quantitative flag immunoprecipitates from the stable lines were 
probed for EPI64, and it was found to associate with all versions of 3XFLAG-EBP50 except 
those lacking an intact PDZ1 domain (Figure C.1.A). Mutating PDZ2 decreased EPI64 
interaction as expected (Garbett et al., 2010). Cells expressing 3XFLAG-EBP50 were grown in 
light SILAC medium, cells expressing 3XFLAG-EBP50-PDZ1mut in heavy SILAC medium, 
and immunoprecipitates were prepared and their contents quantitatively compared by mass 
spectrometrometry. Amongst the small list of high-confidence interactors were two previously 
identified PDZ1 ligands, EPI64 and PLCβ3, as well as a previously characterized PDZ2 ligand, 
YAP65 (Mohler et al., 1999), which we determined actually binds to PDZ1 and not PDZ2 in 
agreement with our results (Damien Garbett, personal communication). Additionally, we 
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Figure C.1 An isoform of IRSp53 specifically interacts with the PDZ1 domain of EBP50. 
(A) Jeg-3 stable cell-lines expressing 3XFlag-EBP50 with indicated mutations (MAWA blocks 
binding to ezrin, (Garbett and Bretscher, 2012) were subjected to flag immunoprecipitation, and 
the immunoprecipitates western blotted for known EBP50 PDZ1 ligand, EPI64. (B) Jeg-3 cells 
expressing either 3XFlag-EBP50 (‘WT’) or 3XFlag-EBP50_PDZ1mut (‘PDZ1mut’) were 
differentially labeled using the SILAC procedure. The flag tag was immunoprecipitated, the 
immunoprecipitate trypsin-digested, and tryptic fragments subjected to mass spectrometry. Top 
differential candidates are presented. A red asterisk (*) denotes previously known EBP50 
ligands. (C) Sequence of IRSp53-T isoform with sequence coverage mapped in orange. The most 
C-terminal peptide identified the recovered protein unequivocally as IRSp53-T. (D) Jeg-3 cells 
transfected with vector control or 3XFlag-EBP50 with indicated mutation and GFP-IRSp53-T 
were subjected to flag IP. The IP results can be recapitulated manually with western blots. (E) 
Jeg-3 cell lysate was subjected to GST-pulldown using GST or GST IRSp53-T C-terminus with 
or without an alanine following the PDZ-binding motif, and the precipitate was western blotted 
for EBP50. EBP50 interacts with the IRSp53 C-terminus. (F) Jeg-3 or Caco-2 cell lysate as 
indicated was subjected to GST-pulldown using GST or GST-EBP50-PDZ1+ (Reczek and 
Bretscher, 2001), and the precipitate western blotted for IRSp53/58. IRSp53 but not IRSp58 
interacts with EBP50 PDZ1+ in a GST-pulldown. (G) IRSp53-T was expressed in bacteria and 
purified using the His-SUMO system and subjected to liposome flotation assay, revealed by 
amido-black total protein stain. Recombinant IRSp53-T was found to bind only 
phosphoinositide-phosphate-containing liposomes. 
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identified a PDZ-interacting MAGUK of unknown function (DLGAP4) and IRSp53, a protein 
with an N-terminal I-BAR domain and a C-terminal SH3 domain and PDZ-binding motif 
previously implicated in forming filopodia and microspikes in response to activated Rac1 and 
Cdc42 (Figure C.1.B; Krugmann et al., 2001; Bockmann et al., 2002; Millard et al., 2005; 
Disanza et al., 2006). 
Sequence analysis of the identified peptides unequivocally identified the bound isoform 
of IRSp53 as IRSp53-T, which had not previously been characterized, but is predicted to end in –
V-A-R-F, a potential PDZ binding motif (Figure C.1.C). Co-expression-immunoprecipitation 
experiments showed that IRSp53-T interacts directly with wild-type but not PDZ1 mut (Figure 
C.1.D). Furthermore, the tail of IRSp53 precipitated EBP50 from cell extracts, whereas the 
addition of a single alanine to the C-terminus blocked the interaction completely (Figure C.1.E). 
Finally, immobilized EBP50 PDZ1+ precipitated IRSp53 from extracts of placental epithelial 
Jeg-3 or colon epithelial Caco-2 cells, suggesting that an EBP50-binding isoform of IRSp53 is 
generally expressed in epithelial cells. In preparation for future studies, I prepared IRSp53 as a 
SUMO fusion. The C-terminus is intact because it interacts with EBP50 (data not shown) and the 
N-terminus is intact because it interacts with liposomes in a phospholipid-dependent manner 
(Figure C.1.F). 
Overexpressed IRSp53 localized throughout the full-length of microvilli like EBP50 and 
Ezrin (Figure C.2.A) as well as minimally to cell-cell junctions and filopodia (data not shown). 
The best studied isoform of IRSp53 is IRSp53-S, which differs from –T in the last 10 residues 
(ending in –V-S-T-V rather than –V-A-R-F) and binds to the PDZ domain of cell-cell junction 
and filopodia-localized protein LIN-7. While the localization of the two isoforms partially 
overlap, IRSp53-S was more enriched at cell-cell junctions while IRSp53-T was more enriched 
169
in microvilli when expressed in the same cell, reflecting the different localization of their 
cognate PDZ domains (Figure C.2.B). 
We knocked down the expression of IRSp53 by about 70% (Figure C.2.C), and cells 
were fixed, stained for ezrin, and blindly scored for both microvilli presence and abundance. 
Unfortunately, loss of IRSp53 resulted in only a small change in which the density of microvilli 
in the transfected cells was partially reduced according to one scoring strategy (Figure C.2.D) not 
reduced at all according to another (Damien Garbett, personal communication). These results 
seem surprising in the face of studies in which overexpression of IRSp53 creates microspikes 
and filopodia in fibroblastic cells (Krugmann et al., 2001; Bockmann et al., 2002; Millard et al., 
2005; Disanza et al., 2006) and one study in which IRSp53 knockdown in MDCK cells caused a 
dramatic loss of microvilli as well as eliminating stress fibers and delaying cell spreading (Cohen 
et al., 2011). Thus, we may not have knocked the protein down far enough. 
Still, the same conclusions have not been reached by genetic studies of IRSp53. IRSp53 
knockout mice have minimal effects (Sawallisch et al., 2009), and the single slime mold ortholog 
of all I-BAR proteins was found to be dispensible for filopodia (Veltman et al., 2011). This may 
hint that though it can, IRSp53 does not function in making actin protrusions but in some other 
process entirely such as endocytosis or cell signaling. Since we have limited assays to probe 
EBP50 function, we may never know what role this interaction is really serving. 
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Figure C.2 IRSp53-T is more highly enriched in microvilli than IRSp53-S, but IRSp53 is 
dispensible for microvilli. 
(A) IRSp53-T was overexpressed in Jeg-3 cells with an N-terminal TagRFP-T tag along with 
EBP50 with an N-terminal GFP tag, and the cells fixed and stained for ezrin, and the apical 
projections shown. All three markers colocalize in microvilli. (B) Two isoforms of IRSp53 were 
differentially tagged and co-expressed in Jeg-3 cells. Whereas IRSp53-S, which has a different 
C-terminal PDZ binding motif that does not interact with EBP50, localizes more to cell-cell 
junctions, IRSp53-T localizes more to microvilli. (C) IRSp53/58 or ezrin were knocked down in 
Jeg-3 cells using siRNAs, and the lysates resolved and western blotted for ezrin and IRSp53/58. 
(D) Cells as in C were fixed and stained for ezrin, and the presence and density of microvilli 
were subjectively scored. IRSp53/58 knockdown causes a subtle decrease in microvillus density 
(N=4, p < 0.03).   
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